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Abstract 
Zinc is an essential trace element that plays a crucial role in catalytic, structural and regulatory 
functions of many proteins including enzymes and transcription factors; thus maintenance of 
zinc balance is critical for normal cellular function. Cellular mechanisms that maintain zinc 
balance include the regulation of genes coding for proteins that play vital roles in zinc 
homeostasis. These proteins include zinc transporters belonging to the ZIP (SLC39A) and ZnT 
(SLC30A) families as well as the zinc-binding metallothionein proteins. In contrast to bacterial 
and yeast systems, a transcription factor responsible for mediating transcriptional repression of 
a suite of genes in response to elevated zinc levels in mammals has hitherto not been identified. 
Using Caco-2 cells as a model of human intestinal epithelial cells and detection of protein 
binding by electrophoretic mobility shift analysis, we show that zinc finger protein ZNF658 
binds specifically to the zinc transcriptional regulatory element (ZTRE), previously 
demonstrated to mediate this response in a panel of three genes: SLC30A5 (ZnT5 zinc 
transporter), SLC30A10 (ZnT10 zinc transporter) and CBWD (whose prokaryotic homologs are 
emerging players in metal biology). We also demonstrate that siRNA-driven reduction of 
ZNF658 attenuated or abrogated transcriptional repression in response to elevated zinc levels 
of these same genes by measuring transcript abundance using RT-qPCR and using promoter-
reporter gene constructs. In addition, the region of ZNF658 responsible for binding to the 
ZTRE was identified (the C-terminal zinc finger domain) and the requirement for both sides of 
the palindromic ZTRE sequence for function was demonstrated. This study therefore identifies 
the first metazoan transcription factor that plays a pivotal role in the orchestrated cellular 
response to increased zinc levels to restore cellular zinc balance necessary to achieve a broad 
spectrum of zinc-dependent functions and begins to probe its molecular action. We also report 
an important role for the mammalian CBWD gene product in protection of cells from either 
depleted or excess zinc by virtue of the fact that overexpression of recombinant CBWD protein 
altered cellular tolerance to both elevated and depleted levels of zinc consistent with a 
homeostatic function. In addition, we present preliminary evidence that changes in the 
expression of ZNF658 and its target genes, in particular SLC30A10 (ZnT10), may be related to 
cell senescence, suggesting that changes in zinc homeostasis are  components of this process. 
Overall, the work presented contributes to understanding zinc regulated gene expression and 
cellular zinc homeostasis. 
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Chapter 1 : Introduction 
1.1 The chemistry of zinc  
Zinc is an important naturally occurring metallic element. It is a member of group 12, period 
4, block d and number 30 on the periodic table. It is the 25th most abundant element and 
comprises a reasonable segment of the Earth’s crust, where the divalent cation preferentially 
forms complexes as sulphides, chlorides, carbonates and oxides. Zinc has an atomic number of 
30 and 5 stable isotopes: namely 64Zn, 66Zn, 67Zn, 68Zn and 70Zn. 64Zn is the most stable isotope 
and has a half-life of 7.0 x 1020 years. Other synthetic forms, such as radioactive 65Zn with a 
half-life of about 244 days, are often used for research. Although credit for the discovery of 
pure metallic zinc is often given to Andreas Sigismund Marggraf in 1746, his fellow German 
alchemist Paracelsus gave the name zinc after the German word Zinke meaning tooth-like, 
which is reminiscent of its crystal appearance. Zinc compounds are used for industrial and 
commercial purposes while the divalent ion is of great biological interest owing to its 
prevalence in many proteins, which is generally attributed to redox stability endowed by the 
completely filled d-orbital (with 10 outer shell electrons) and to its interaction with ligands in 
polypeptide chains. These ligands include cysteine, sulphur, histidine, nitrogen and glutamate 
or aspartate (Berg and Shi, 1996, Maret, 2005) affording a role for zinc in specific protein 
structural folds such as zinc fingers. 
1.2 Zinc as an essential biological micronutrient 
Zinc is present in minute quantities in many food sources (Table 1.1).  The multiple outcomes 
of biochemical and/or physiological perturbation of zinc is due to its involvement in a panoply 
of cellular processes that are essential to life. Zinc is the second most abundant trace element, 
after iron, in the human body. It is estimated that an average 70-kg adult contains 2.3 g of zinc 
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(McCall et al., 2000). However, zinc distribution is not easily determined since the element is 
bound to many macromolecules. In addition, there is no robust, sensitive or specific biomarker 
of zinc status. The work of Bert Valle (Field et al., 2002) established the presence and 
importance of zinc in metalloproteins, and it was much later estimated based on the available 
genome information that up to 10% of the human proteome may require zinc for activity 
(Andreini et al., 2005). This figure may be an underrepresentation since more recent 
bioinformatics analysis revealed classes of protein overlooked earlier that may bind zinc 
(Andreini et al., 2009).  
 
Table 1.1: Food sources for zinc (taken from http://ndb.nal.usda.gov/) 
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1.2.1 Zinc absorption and excretion 
Zinc absorption from the diet occurs predominantly in the proximal regions of the human small 
intestine. The ability of zinc to cross biological membranes by passive diffusion is impaired by 
the hydrophilicity of the divalent cation, thus specific transport proteins are required for its 
absorption across the enterocyte brush border membrane and for its translocation from one 
compartment to another. Zinc absorption could be affected by the chemical form in which it is 
present in the diet and/or supplementation. The Food and Agriculture Organisation/World 
Health Organization (FAO/WHO) joint report of 2001 states that zinc in aqueous forms are 
better absorbed than solid forms, and zinc carbonate is less absorbable compared with zinc 
sulphate (reviewed by (Krebs, 2000)). Zinc absorption is also affected by age and disease 
(Rink, 2000). Concurrent consumption of alcohol also inhibits zinc absorption, and has been 
suggested as a possible cause of zinc deficiency (Mehta et al., 2011), although the type of 
alcoholic beverage and the strength of the alcohol content are important factors to consider in 
interpreting such observations. Other factors that may affect zinc absorption include the 
presence of other divalent metals such as calcium and iron in the gastrointestinal tract (GIT), 
as well as zinc-binding amino acids such as glycine, cysteine and histidine. Zinc excretion from 
the body is predominantly via the gut, as intestinal secretions, but also through the skin and 
kidney.  
1.2.2 Physiological roles of zinc 
Zinc is distributed throughout the body tissues (see Table 1.2) consistent with the ubiquitous 
requirement for zinc at the level of cellular function. Zinc is essential to myriad processes 
including reproduction (Ebisch et al., 2007), immune response (Salgueiro et al., 2000, Bogden, 
2004, Rink and Haase, 2007), cell proliferation (Beyersmann and Haase, 2001), DNA and RNA 
replication and in response to oxidative stress through its influence on the synthesis  and redox 
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state of the antioxidant glutathione (Kojima-Yuasa et al., 2005). All of the six sub-classes of 
enzymes include members that are zinc metalloproteins (see Table 1.3). 
 
 
Table 1.2: Zinc distribution within the body tissues (adapted from Rink & Gabriel, 2000) 
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Table 1.3: Examples of zinc-utilizing enzymes (adapted from Rink & Gabriel, 2000) 
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Newly uncovered roles for zinc include modulation of epithelial cell tight junctions. Wang and 
colleagues demonstrated that zinc supplementation of Caco-2 cells at 100 µM modified tight 
junction properties (Wang et al., 2013), indicating a potential therapeutic use in managing tight 
junction leakages caused by many disease conditions. Zinc also plays an important role in 
facilitating cumulus expansion, which is stimulated by follicle stimulating hormone (FSH) and 
the release of the egg to the oviduct. This role is exemplified by the observation that ovulation 
was arrested in mice made zinc-deficient by using the zinc chelator, TPEN, a few days prior to 
egg release (Tian and Diaz, 2012). It has been shown that zinc is required for the interaction of 
heparin and fibrinogen necessary for promoting the haemolytic processes (Vu et al., 2009, 
Fredenburgh et al., 2013). The involvement of zinc in aetiology of many disease conditions 
such as Alzheimer’s disease and age-related macular degeneration (AMD) has been proposed. 
For instance, the discovery that sub-retinal pigment epithelial deposits accumulate high levels 
of zinc in AMD patients compared with their control counterparts (Lengyel et al., 2007) 
suggests a plausible target for managing this condition.  A very important role for zinc and a 
very active area of research  through which understanding is increasing rapidly, is its role as a 
cellular second messenger in signal transduction pathways (Beyersmann and Haase, 2001, 
Yamasaki et al., 2007), partly orchestrated by activation of protein kinase CK2 through the 
phosphorylation of the zinc transporter ZIP7 (Taylor et al., 2012). This role of zinc as a 
signalling molecule has huge implications for intervention in human health and disease thus 
will sustain the attention of some of the most established researchers in the field of zinc biology 
over future years. 
1.2.3 Zinc deficiency and toxicity 
Zinc deficiency was recognised late in humans (Allen et al., 1981, Prasad, 1996) compared 
with other organisms such as yeast. About one-fifth of the world’s population is affected by 
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zinc deficiency, and the condition is linked with increasing morbidity and mortality rates 
particularly among young children. Zinc deficiency is thus a global health problem (Ananda, 
2003), with estimated prevalence at greater than 20% (World Health, 2002). The biggest 
burden of zinc deficiency-induced death is borne by developing African and South-Eastern 
Asian countries where most staple foods contain high levels of anti-nutritional factors such as 
phytates (Kambe et al., 2008 ) that limit zinc absorption from diets. Although incidences of 
severe zinc deficiency occur rarely in humans (except for those associated with acrodermatitis 
enteropathica; AE), mild to moderate cases (often called marginal zinc deficiency) exist, and 
can be classified as either primary (acquired from malnutrition) or secondary (arising from 
genetic alterations that can impair expression of genes coding for zinc homeostatic proteins). 
Due to the differences in dietary zinc intake as well as the rate of absorption/excretion among 
individuals, certain subsets of the human population such as children, pregnant/lactating 
women, strict vegetarians and the elderly are more vulnerable to incidences of zinc deficiency 
(Prasad, 2012). Additionally, an ageing-related decline in absorptive efficiency as well as 
epigenetic modifications that may impact on expression of zinc transport proteins (Fairweather-
Tait et al., 2008) may further predispose the elderly to zinc deficiency even with adequate zinc 
intake. A concerted effort to address the inter-individual variations in zinc requirements led the 
relevant agencies such as the United States Food and Nutrition Board (FNB) and the United 
Kingdom Scientific Advisory Committee on Nutrition (SACN) to establish dietary 
requirements for zinc at different life stages. Table 1.4 shows zinc requirement for the UK 
population, as LRNI (Lower Reference Nutrient Intake), EAR (Estimated Average 
Requirement) and RNI (Reference Nutrient Intake) values.  
An increasing body of evidence associates zinc deficiency with impaired physiological 
conditions (or diseases). These diseases include altered innate and adaptive immune responses, 
which were shown to be restored by zinc supplementation, consistent with the essentiality of 
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zinc as an important player in immune cell function (Ibs and Rink, 2003, Prasad, 2008). Other 
disease conditions shown to be associated with zinc deficiency include respiratory infections 
(Aggarwal et al., 2007), pneumonia (Mossad et al., 1996), age-related macular degeneration 
(AMD) (Evans, 2006), diarrhoea (Saper and Rash, 2009) and attention deficit hyperactivity 
disorder (ADHD) in children characterised by low plasma zinc concentration (Zamora et al., 
2011). A recent meta-analysis of clinical data suggests an association between low zinc levels 
and depression in humans (Swardfager et al., 2013). In many of the cases, plausible molecular 
mechanisms underlying these associations are still being elucidated. Zinc supplementation, 
either as a single component or in concert with other antioxidants such as vitamin A or vitamin 
C, has been shown to ameliorate these conditions.  
On the other hand, excess accumulation of zinc can result in zinc toxicity classified as acute or 
chronic forms. Acute zinc toxicity is characterised by conditions such as nausea and vomiting. 
Secondary copper deficiency, characterized by anaemia, decreased  levels of erythrocyte SOD 
as well as increased levels of LDL and decreased HDL levels, is believed to be a consequence 
of chronic zinc toxicity (Hassan et al., 2000, Willis et al., 2005). The association of excess zinc 
with these conditions led to the recommendation of an upper limit for zinc intake as shown in 
Table 1.5. The underlying mechanism of zinc-induced copper deficiency appears to be the 
spontaneous induction of metallothionein, which in turn sequesters intracellular copper ions 
thereby impairing systemic copper absorption and circulation. Interestingly, however, zinc-
induced copper malabsorption (or vice-versa) does not occur at normal levels of consumption 
of either of these micronutrients. At the cellular level, excess zinc can produce changes leading 
to loss of cell membrane integrity, reduced cell proliferation and production of reactive oxygen 
species that can damage the DNA. The negative impact of zinc deficiency and/or toxicity 
highlights the need for continued research-driven effort to address these nutritional problems. 
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Table 1.4: UK Dietary reference values for zinc (mg/kg). LRNI - Lower Reference Nutrient 
Intake; EAR - Estimated Average Recommended Requirement; RNI - Reference Nutrient 
Intake. * Indicates no increment. Adapted from the UK National Diet and Nutrition Survey, 
2003.  
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Table 1.5: Tolerable upper intake levels (UL) for zinc. Adapted from the Institute of 
Medicine Panel report, 2001. 
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1.3 Zinc homeostasis 
Zinc homeostasis refers to the maintenance of optimal levels of zinc in the face of variations 
in external supply or release from transient storage. This is achieved in many organisms 
through a carefully orchestrated mechanism that involves several players. In mammals, zinc 
homeostasis occurs at three domains: primary, secondary and tertiary. At the primary level, 
zinc homeostasis is achieved by balancing zinc absorption and endogenous zinc loss within the 
gastrointestinal tract (GIT), which has the principal role of maintaining whole body zinc 
homeostasis (Krebs and Hambidge, 2001). The secondary level of zinc homeostasis involves 
adjustments in urinary zinc concentration and a shift in plasma zinc turnover, which contribute 
to maintaining the exchangeable zinc pool (EZP) at an appropriate size (Krebs, 2000). The 
tertiary level involves the activities of zinc homeostatic proteins, which include metallothionein 
proteins (located mainly within the cytosol) and zinc transporters (localised to the plasma 
membrane and intracellular compartments). Many of these proteins have been identified across 
different species and studies on their mechanisms of action as well as their contribution to 
human disease conditions currently engage many researchers in the field of zinc biology. 
1.3.1 Metallothioneins  
Metallothioneins (MTs) were first discovered by Margoshes & Valee over five decades ago as 
cadmium-binding proteins in horse kidney (reviewed in (Klaassen et al., 1999). They are low-
molecular weight, cysteine-rich, intracellular metal-binding proteins present in all domains of 
life. Metallothioneins are attributed roles in heavy metal detoxification (for example cadmium 
detoxification), maintenance of essential metal homeostasis (such as zinc and copper 
homeostasis) and antioxidant function (for instance protection against the impact of free 
radicals). In mammals, four distinct subgroups of MTs encoded by more than 10 different genes 
(Tai et al., 2003) have been identified and designated MT-1 to MT-4 based on a variety of 
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features highlighted in Table 1.6. In addition, a recent study using a bottom-up variant of mass 
spectrometric analysis of enriched acetylated N-terminal tryptic peptides from human cells and 
tissues identified up to twelve isoforms (Mehus et al., 2014).  The mammalian isoforms 1 and 
2  are expressed in all organs while MT-3 and MT-4 are found in the central nervous system 
and stratified tissues respectively (Bell and Vallee, 2009), with other isoforms expressed in 
different organs including kidney (Andrew Nguyena et al., 2000). Structural studies using X-
ray crystallography and nuclear magnetic resonance (NMR) spectroscopy revealed that 
mammalian MTs contain between 60-68 amino acids with about 20 conserved cysteine 
residues that form the metal-binding domain. These studies also revealed two distinct globular 
domains: a more stable alpha domain containing 11-12 cysteine residues and a more reactive 
beta domain that contains 8-9 cysteine residues (Coyle et al., 2002, Ruttkay-Nedecky et al., 
2013) (Figure 1.1). Although MTs bind different numbers of metal ions such as mercury (Hg2+) 
and lead (Pb2+) with varying degrees of affinity, they predominantly bind zinc, with a 
stoichiometry of up to 7 ions per molecule (which represents about 20% of the total cellular 
zinc content under physiological conditions), and  copper, also with a stoichiometry of  7 ions 
per molecule (Andrews, 2001). Studies in several models, including whole animals and cell 
lines, have shown that expression of the MT proteins is elicited by a number of stimuli 
including increased abundance of metals such as zinc and copper and bacterial infection as well 
as other stresses such as hypoxia (Tanji et al., 2003). Metallothionein proteins contribute to 
zinc homeostasis by sequestering excess zinc when the levels are high, which could be from 
increased external supply, or by releasing zinc to the various zinc-requiring metalloenzymes 
under conditions of limited zinc availability (reviewed by (Choi and Bird, 2014)). Effects of 
changes in zinc levels on MT expression have been documented extensively. For instance, 
zinc-induced regulation of MT expression in the monocytic cell line (THP-1) (Cao et al., 2001), 
and zinc-driven changes in MTs at both the transcript and protein levels have been reported in 
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human tissues as well as cell lines (Wei et al., 2008). Although the involvement of 
metallothionein proteins in zinc homeostasis is well acknowledged, detailed mechanisms of 
action are not fully understood. Furthermore,  the response to many other stimuli such as free 
radicals, for example those generated by  hydrogen peroxide (H2O2) (Chung et al., 2005, 
Ruttkay-Nedecky et al., 2013), coupled with the difficulty of detection by ‘‘traditional’’ 
methods (owing to their lack of aromatic amino acids that means they evade usual protein 
detection methods), means that there is much still to be discovered about the functions of these 
proteins and justifies further research in this field. 
 
 
Table 1.6: Classification of metallothionein isoforms. Adapted from Thirumoorthy et al., 
2011 
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Figure 1.1: Structure of metallothionein proteins 
A model of metallothionein structure showing two binding sites to 7 zinc atoms (large red 
beads) through the sulphur ligands (small yellow beads). The two domains as well as amino 
acid sequence and the conserved cysteine residues within each domain are indicated. 
Adapted from Ruttkay-Nedecky, 2013. 
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1.3.2 Zinc uptake proteins (the ZIP family) 
The zinc-regulated transporters, iron-regulated transporter-like proteins (also called ZRT-IRT-
related proteins or ZIPs) are encoded by the SLC39 gene family. Members of this transporter 
family belong to the larger family of metal ion transporters that are found at all phylogenetic 
levels, including archaebacteria, eubacteria and eukaryotes (Gaither and Eide, 2001b). They 
are  named after the first members identified as Zrt1/Zrt2 and Irt1, which transport zinc with 
low-affinity in Saccharomyces cerevisiae and iron with high-affinity in roots of Arabidopsis 
thaliana respectively (Eide, 2004). Across several species, more members of the ZIP family 
have been identified and characterised over the years. Based on sequence conservation, 14 
members belonging to 4 subfamilies (designated I through IV) have been identified in human 
and mouse (Gaither and Eide, 2001b). Subfamily I comprises the plant and fungal proteins as 
well as mammalian ZIP9; subfamily II consists of ZIPs 1,2,3; subfamily  III or LIV(LZT) 
contains the mammalian ZIPs 4-8,10 and 12-14; while the fourth subfamily, also called gufA, 
consists of proteins homologous to the Myxococcus xanthus proteins (Cousins et al., 2006). 
The SLC39 proteins are predicted to have eight transmembrane domains (TMDs), with short 
carboxyl and amino termini both located extracellularly. In addition, they possess a 
cytoplasmic variable histidine-rich motif on the loop between TMDs III and IV (Figure 1.2). 
This motif is believed to confer a zinc-binding property, features of which are determined by 
its length (Guerinot, 2000). Some members of this protein family, specifically ZIPs 11, 12 and 
13, do not possess this histidine-rich loop (Kambe et al., 2004). Better conserved between the 
family members is a motif between TMDs IV and V, which is amphipathic and forms the 
aqueous channel through which zinc ions pass (Taylor et al., 2007). Members of the ZIP family 
generally transport zinc from an extracellular compartment (or in some cases from intracellular 
compartments) to the cytosol, and thus appear to play opposing roles to members of the ZnT 
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family (see section 1.3.3) in zinc mobilization. Expression patterns and zinc transport activity 
of the known members are described below.  
Human ZIP1 (hZIP1), is encoded by the SLC39A1 gene located on chromosome 1. Its cDNA 
clone was isolated from a prostate library using PCR screening and full-length hZIP1 was 
found to comprise 324 amino acids (Gaither and Eide, 2001b). hZIP1 possesses the predicted 
membrane topology of the ZIP family and is expressed ubiquitously in human tissues and in a 
variety of cell types. Zinc uptake activity was inferred as a result of the mRNA being increased 
in prostate epithelial cells (PC-3 cell line) under the influence of physiological levels of 
prolactin and  testosterone, which also increased zinc uptake (Costello et al., 1999). 
Overexpression of the hZIP1 coding sequence tagged with the haemagglutinin epitope from a 
CMV-driven plasmid in human K562 erythroleukemia cells showed its localisation at the 
plasma membrane and accumulation of radioactive 65Zn in transfected cells compared with 
control cells, indicating zinc uptake function (Gaither and Eide, 2001b). Overexpression of 
hZIP1 in the human prostate cell line, PC-3, demonstrated its Km for zinc uptake to be in the 
nanomolar range (Franklin et al., 2003). Mouse Zip1 was shown to be localised to the 
basolateral membrane of normal glandular epithelial cells (Dufner-Beattie et al., 2003a), 
consistent with a role in zinc uptake from interstitial fluids. On the other hand, transient 
expression of an EGFP/FLAG-tagged hZIP1 construct showed vesicular localisation to 
endoplasmic reticulum in human cells (Milon et al., 2001), suggesting a role in mobilizing zinc 
sequestered in intracellular organelles presumably to supplement the cytosolic level during 
periods of zinc limited supply. These results, in addition to the recent findings showing that 
overexpression of hZIP1 resulted in enhanced zinc accumulation, whereas siRNA-mediated 
reduction in its expression caused reduced zinc accumulation in Caco-2 cells (Michalczyk and 
Ackland, 2013), demonstrate the involvement of ZIP1 in redistribution of cellular zinc, and 
thus a possible function in cellular zinc homeostasis. A physiological role for ZIP1 in buffering 
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the effect of zinc deficiency was indicated using knock-out mice. Embryos of pregnant mice 
that had the Zip1 gene removed were more susceptible to the effects of zinc restriction revealed 
as teratogenic defects, when compared with the wild-type mice (Dufner-Beattie et al., 2006). 
Also, hZIP1 has been shown to be important in prostate cancer. Prostate glands normally 
express ZIP1 at high levels coupled with accumulation of zinc (Costello et al., 1999). However, 
in adenocarcinomatous gland expression of the hZIP1gene was down-regulated at the mRNA 
and protein levels with concomitant depletion of zinc levels (Franklin et al., 2005). These 
findings were corroborated in clear cell renal carcinoma tissues, in which the expression of 
hZIP1, measured by RT-qPCR, was also down-regulated (Dong et al., 2014). These results 
were also supported by a report of hZIP1 expression levels of African American males at risk 
of prostate cancer compared with their Caucasian counterparts. hZIP1 expression was down-
regulated in the former group compared with the latter (Rishi et al., 2003). These findings  led 
to the proposal that ZIP1 gene may be a tumor suppressor gene (Desouki et al., 2007), however, 
further studies are required to support this position.  
Human ZIP2 (hZIP2) is encoded by the SLC39A2 gene located on chromosome 14. The gene 
encodes a protein of 309 amino acids, which belongs to sub-family II of the ZIP family. hZIP2 
was first identified on the basis of sequence homology to ZIP members found in fungi and 
plants (Gaither and Eide, 2000). ZIP2 shows a more restricted expression profile in human 
tissues compared to ZIP1, but the mRNA was detected in the prostate, uterus and peripheral 
blood monocytes by RT-PCR (Cao et al., 2001). The expression profile of hZIP2 appears to 
differ from that observed in mouse tissues where the mRNA was detected in the liver, ovary 
and visceral yolk sac also by RT-PCR (Dufner-Beattie et al., 2003a). It was observed in both 
human embryonic kidney (HEK293) and erythroleukaemia (K562) cells transfected with either 
a human or mouse overexpression construct for ZIP2 that the protein localised to the plasma 
membrane and increased uptake of 65Zn (Gaither and Eide, 2000). ZIP2 zinc uptake activity 
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was shown to be stimulated by bicarbonate ions (HCO3
-), suggesting a mechanism of co-
transport of zinc along with HCO3
- ions. However, uptake activity, unlike that demonstrated 
for ZIP1, was dependent on factors including time, temperature and concentration but in an 
energy-independent manner. In addition, substrate specificity appeared not to be restricted to 
zinc since other transition metals were shown to inhibit zinc uptake activity by hZIP2 (Gaither 
and Eide, 2000).  Indeed, a role for ZIP2 in iron sequestration was suggested in Zip2 knock-
out mice, in which a reduction in the liver iron store was observed compared with wild-type 
animals (Peters et al., 2007). A role for ZIP2 in the development of prostate malignancy was 
also implicated following an observation of its differential expression and a different zinc 
accumulation pattern in normal prostate gland compared with adenocarcinomatous gland 
(Desouki et al., 2007). Also, mice made zinc-deficient and in which the Zip2 gene was deleted 
showed a greater number of abnormal embryos compared with wild-type (Peters et al., 2007), 
suggesting a role in adaptation to zinc-limiting conditions including during pregnancy. 
The ZIP3 (SLC39A3) gene is located on chromosome 19 and encodes a 314-amino acid protein. 
Human ZIP3 was identified in a manner similar to hZIP2 based on sequence similarity to plant 
and fungal homologues. hZIP3  expression was first reported in normal prostate gland with 
localisation to the apical membrane (Desouki et al., 2007). High levels of hZIP3 expression 
have been reported in bone marrow and spleen, with lower expression levels in small intestine 
and liver (Liuzzi and Cousins, 2004). Compared to ZIPs 1 and 2 , ZIP3 appears to have broader 
substrate specificity since metals including copper, cadmium, manganese, nickel and cobalt 
were shown to inhibit uptake of zinc by this protein  in mice (Dufner-Beattie et al., 2003a). 
Experiments using knock-out mice showed that, in comparison with wild-type mice whose 
embryos were refractory to the effect of zinc deficiency, mice deficient in the ZIP3 gene 
exhibited abnormal phenotypic outcomes (Dufner-Beattie et al., 2006).  A role in mammary 
tissue zinc transport was demonstrated following siRNA-mediated reduction in the expression 
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of ZIP3 mRNA that resulted in decreased zinc uptake and eventual death of HC11 mouse 
mammary epithelial cells (Kelleher and Lönnerdal, 2005). Similar to the expression of ZIP1 
and ZIP2, ZIP3 expression was down-regulated along with loss of zinc accumulation both at 
early stages of prostate malignancy and as the tumor progressed (Franklin, 2011), adding ZIP3 
to the list of putative tumor suppressor genes. 
Human ZIP4 is encoded by the SLC39A4 gene located on chromosome 8 at q24.3 and encodes 
a protein of 622 amino acids. The SLC39A4 gene is now known to be the gene responsible for 
acrodermatitis enteropathica (AE) in humans (Wang et al., 2002). Acrodermatitis 
Enteropathica is an autosomal recessive genetic disorder of zinc metabolism resulting from 
zinc deficiency caused by insufficient absorption of zinc from the intestine, and manifests as 
symptoms including dermatological lesions and weight loss. Interestingly, these changes due 
to AE are relieved by zinc supplementation, thus indicating that other transporters in the 
intestine can contribute to zinc uptake from the diet. High levels of ZIP4 expression were 
detected in human small intestine and kidney, as well as in the mouse visceral yolk sac (Dufner-
Beattie et al., 2004, Wang et al., 2002). Localisation of ZIP4 to the apical membrane of 
enterocytes revealed by immunohistochemical techniques (Huang et al., 2006) is consistent 
with a role in dietary zinc absorption. A role in zinc homeostasis was implied by an observed 
reduction in Zip4 mRNA abundance in response to zinc limitation (Liuzzi et al., 2004). The 
ability of ZIP4 to mediate zinc uptake was demonstrated in HEK293 cells transfected with 
mouse Zip4 cDNA (Wang et al., 2004a), by virtue of the transfected cells showing greater 
uptake of 65Zn compared with untransfected cells. A role for ZIP4 in mouse embryogenesis 
was demonstrated using knock-out mice in which a homozygous deletion of the gene resulted 
in death of embryos at the post-implantation stage (Dufner-Beattie et al., 2007). However, 
heterozygous Zip4 embryos survived but were more sensitive to zinc deficiency than their wild-
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type litter mates (Dufner-Beattie et al., 2007) indicating an important role for ZIP transporters 
in maintenance of zinc homeostasis during these developmental stages. 
Mammalian ZIP5, encoded by the SLC39A5/Slc39a5 gene is located on chromosome 12 at 
q13.13 in human and 10 D3 in mouse with amino acid sequence of 540 and 535 for human and 
mouse respectively. ZIP5 is a member of the LIV-1 subfamily and possesses the conserved 
peptide motif (HEXPHEXGDFAXLLXXG) in TMD 5, which is characteristic of this 
subfamily both in human and mouse species (Taylor et al., 2003). ZIP5 mRNA expression has 
been detected abundantly in tissues including small intestine and pancreas, commensurate with 
the importance of these tissues in systemic zinc homeostatic control. ZIP5 expression was also 
detected in breast cells propagated under laboratory conditions but a specific role in this tissue 
has not been clearly documented (reviewed by (Kelleher et al., 2009)). Unusually, however, its 
expression is not induced transcriptionally under zinc-limiting conditions (Weaver et al., 2007). 
Overexpression of ZIP5 in cultured MDCK cells showed its localisation to the basolateral 
membrane (Wang et al., 2004b, Weaver et al., 2007) suggesting zinc mobilization from the 
serous membrane into the cytoplasm. Similarly, mouse Zip5 was shown to be localised to the 
basolateral membrane of murine enterocytes (Huang et al., 2006) and of the visceral yolk sac 
(Dufner-Beattie et al., 2004), consistent with a role in zinc import from the portal circulation 
or mammalian circulation respectively. Zip5 zinc uptake activity was demonstrated in HEK293 
cells, in which cells transfected with mouse Zip5 cDNA accumulated more zinc compared with 
untransfected cells (Wang et al., 2004b). Recent studies on the regulation of intestinal zinc 
metabolism by ZIP5 revealed its ability to modulate zinc excretion in Zip5 knockout mice as 
well as  mobilization into pancreatic acinar cells (Geiser et al., 2013), indicating a central role 
in zinc homeostasis and in protection against zinc toxicity.  
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ZIP6 is encoded by the SLC39A6 gene located on chromosome 18 at q12.2 in human and at 18 
A2 in mouse. ZIP6 shows sequence similarity with other members of the oestrogen-regulated 
LIV gene family, thus the gene product is also called LIV-1. hZIP6 comprises  of 755 amino 
acids and possesses many characteristic features of the ZIP family. However, ermelin, a mouse 
homologue of LIV-1, appears to possess 6, rather than the typical 8 transmembrane domains 
(Suzuki and Endo, 2002, Taylor and Nicholson, 2003). ZIP6 is expressed at high levels in 
hormonally modulated tissues such as placenta, kidney, prostate and corpus callosum region of 
the brain with the highest expression level detected in mammary glands (Taylor et al., 2003). 
Zip6 expression was detected in mature, elongated spermatids along with Zip1 suggesting a 
role for ZIP proteins in spermatogenesis and male fertility (Croxford et al., 2011). 
Overexpression of a V5-tagged ZIP6 construct in Chinese hamster ovary (CHO) cells showed 
localisation to the plasma membrane, and zinc uptake activity was also demonstrated by virtue 
of the fact that cells that overexpressed recombinant ZIP6 protein showed increased zinc uptake 
compared with control cells (Taylor and Nicholson, 2003). Similarly, zinc uptake in SH-SY5Y 
neuroblastoma cells by ZIP6 has been demonstrated (Chowanadisai et al., 2008). Expression 
of the SLC30A6 gene is induced by hormones such as insulin and IGF-1 and has been suggested 
to be a factor in the etiology of many cancer types including cancer of the breast (Shen et al., 
2009), pancreas (Unno et al., 2009) and cervix (Zhao et al., 2007). However, it remains to be 
fully understood whether changes in ZIP6 expression observed in these malignant tumors is 
causal or it is an effect of cancer development. 
Human ZIP7 protein is encoded by the SLC39A7 gene located on chromosome 6 at p21.3. This 
gene was first discovered along with the major histocompatibility complex and later shown to 
have sequence homology with LIV-1 (Taylor et al., 2004). The protein (469 amino acids in 
humans) is also called KE4 (a membrane protein that possesses a similar histidine-rich region 
at TMD 5) (Eide, 2004). Analysis of a panel of human and mouse tissues showed abundant 
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expression of ZIP7/Zip7 mRNA detected by northern blotting and western blotting also 
detected the protein in mouse brain and liver tissues (Huang et al., 2005). 
Immunohistochemistry studies revealed that ZIP7 was localized to the Golgi apparatus, 
suggesting a role in mobilizing zinc out of this compartment into the cytosol. Zinc transport 
activity was demonstrated in CHO cells, in which overexpression of a V5-tagged recombinant 
ZIP7 resulted in increased cytosolic zinc levels in transfected cells compared with 
untransfected cells (Taylor et al., 2004). Similarly, the role of ZIP7 in  facilitating zinc release 
from the endoplasmic reticulum into the cytosol was demonstrated in mast cells (Yamasaki et 
al., 2012). Similar to ZIP5 and ZIP6, ZIP7 expression was regulated by iron in addition to zinc 
(Nam and Knutson, 2012), suggesting a broader substrate specificity. Physiological importance 
of a zinc transport function for ZIP7 was suggested by the observation that zip7 knock-out in 
zebrafish have a phenotype that is rescued by zinc supplementation (Yan et al., 2012). A mouse 
model of alcoholic liver disease showed altered expression of Zip7 mRNA, and alcohol-
induced zinc deficiency was proposed to be mediated through oxidative stress affecting Zip7 
expression (Sun et al., 2014). Recent studies showed that ZIP7 may play a role in glucose 
metabolism in skeletal muscle by virtue of the fact that siRNA-driven reduction in ZIP7 
expression in C2C12 cells resulted in down-regulation of  a suite of genes including the glucose 
transporter GLUT4 (Myers et al., 2013). Although the mechanism underlying this link has not 
been elucidated, the finding lend support the role in signalling pathway that may be mediated 
by the activity of ZIP7. 
Human ZIP8 is encoded by the SLC39A8 gene located on chromosome 4 between 4q22 and 
4q24. In comparison to other members of the ZIP family, ZIP8, which is also known as 
BIGM103 (for BCG-induced integral membrane protein in monocyte clone 103 protein), 
showed the highest degree of sequence similarity with ZIP14 albeit both proteins possess 
distinct tissue expression with ZIP8 expressed at higher level in brain tissues compared with 
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ZIP14 (Taylor et al., 2005). These two proteins differ only in about thirty amino acid residues 
(460 in ZIP8 compared with 492 in ZIP14) located within the amphipathic region between 
TMDs IV and V. The amphipathic region is predicted to be the channel through which the zinc 
ion passes (Eng et al., 1998). Mouse Zip8 protein was detected by immunoblotting in 
membranes of matured red blood cells (RBC) and mRNA expression was shown to be 
regulated by zinc deficiency in the same cell type during zinc deprivation (Ryu et al., 2008), 
implying involvement in zinc mobilization for erythroid differentiation and maturation. ZIP8 
zinc uptake ability was demonstrated in CHO cells overexpressing the recombinant protein, 
and zinc uptake was stimulated by inflammatory cytokines (Begum et al., 2002). The protein 
has been shown to translocate to the plasma membrane or to mitochondria in response to 
inflammatory signals (Begum et al., 2002). Although ZIP8 was initially associated with 
transport of only zinc, its ability to transport iron across the plasma membrane has been 
demonstrated in human embryonic kidney 293T cells expressing mouse Zip8 (Wang et al., 
2012). Other metals that appear to be substrates for ZIP8 include manganese and cadmium 
(Himeno et al., 2009). ZIP8 has been shown to be a critical protein in zinc-mediated 
cytoprotection of lung epithelial cells (Besecker et al., 2008), highlighting its importance in 
cell membrane integrity. ZIP8 also appears to play a role in the response to both cadmium and 
manganese toxicity (Fujishiro et al., 2012). 
ZIP9 is encoded by the SLC39A9 gene located on human chromosome 14 at q24.1 and contains 
307 amino acids. It appears to be a less studied member of the ZIP family partly because of its 
existence as a single member of the vertebrate subfamily I (Eide, 2004). However, its sub-
cellular localization and involvement in zinc removal from the trans-Golgi network was 
inferred from work in chicken DT40B cells stably expressing a HA-tagged hZIP9 construct, 
which caused a decrease in the activity of the zinc-dependent Golgi localised enzyme alkaline 
phosphatase (ALP) (Matsuura et al., 2009). A reduction in alkaline phosphatase activity may 
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be attributable to removal of zinc from the Golgi apparatus by the overexpressed ZIP9, thus 
limiting the supply available to the enzyme. In DT40 cells, knockout of  the ZIP9 gene 
suppressed phosphorylation of AKT and ERK, which is necessary to activate the beta cell 
receptor signalling pathway (Taniguchi et al., 2013).  
Mammalian ZIP10 is encoded by the SLC39A10/Slc39a10 gene located at 2q33.3 and 1C1.1 
in human and mouse respectively. hZIP10 was identified through bioinformatics analysis as a 
protein of 385-amino acids with features characteristic of the ZIP family. ZIP10 expression 
was detected in kidney, liver, pancreas, brain and intestine (showing the highest expression 
level) among other human tissues tested (Kaler and Prasad, 2007). Rat Zip10 was first isolated 
from renal brush border membrane as a 40 kDa protein that showed the highest affinity for zinc 
in preference to other metals tested (Kumar and Prasad, 1999). The cDNA was later cloned by 
the same group from renal cortex  (Kumar and Prasad, 2000). Overexpression of recombinant 
ZIP10 in pig kidney epithelial-like cells (LLC-PK1) showed that it was localised to the plasma 
membrane, and its involvement in zinc uptake was also demonstrated (Kaler and Prasad, 2007).  
The protein appears to have a role in breast cancer metastasis that is independent of the similar 
function attributed to ZIP6 (Kagara et al., 2007).   
Human ZIP11 (342 amino acids) is encoded by the SLC39A11 gene located at 17q21.31. It is 
a unique member of the ZIP family by virtue of being the only known member of the gufA 
sub-family, which is named after the Gram-negative bacterium Myxococcus xanthus, owing to 
its similarity with the predicted metal transporters designated as channels or porins in this 
organism (Getsin et al., 2013). Zip11 mRNA was detected in a panel of murine tissues such as 
pancreas, jejunum, ileum, with the highest expression detected in cecum by RT-PCR (Yu et 
al., 2013). Mammary cells were also shown to have significant levels of ZIP11 expression 
consistent with involvement in redistribution of the mammary zinc pool during lactation 
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(Kelleher et al., 2012b). Immunohistochemistry in cultured mammary cells showed localisation 
to intracellular compartments, especially the Golgi apparatus and ER, but a specific role has 
not been identified (Kelleher et al., 2012a). Overexpression of murine Zip11 in human 
embryonic kidney 293T (HEK293T) cells resulted in increased intracellular zinc accumulation 
in transfected cells compared with control cells (Yu et al., 2013). In addition, siRNA-mediated 
reduction in Zip11 expression resulted in a decrease in intracellular zinc levels (Yu et al., 2013) 
consistent with a zinc uptake function for ZIP11. The plant orthologue of Zip11 has also been 
recently identified and functionally characterised in maize (zmZIP11) as a potential divalent 
metal transporter (Li et al., 2013).  
The ZIP12 gene (SLC39A12) is mapped to 10p12.33 in human and the protein is predicted to 
have 654 amino acids. ZIP12 expression has been detected in the human eye (Wistow et al., 
2002) and brain (Suzuki et al., 2004). In contrast to the apparent localisation of hZIP11 in the 
intracellular compartment of the mammary gland, hZIP12 protein was associated particularly 
with the apical cell membrane (Kelleher et al., 2012a), consistent with zinc influx to the cytosol 
from the extracellular space. ZIP12 has been linked to schizophrenia, a neurological disorder 
characterised by low brain zinc concentration (reviewed by (Lichten and Cousins, 2009)), but 
a specific function in this context is not yet defined.  
Human ZIP13 (SLC39A13) gene, located at 11p11.2, codes for a member of the LIV-1 
subfamily with 371 amino acids. The protein topology was first  reported by (Bin et al., 2011), 
who also demonstrated a ZIP13-enhanced increase in metallothionein expression in HEK293T 
cells and that homodimerization of ZIP13 subunits is necessary for zinc transport. Expression 
of ZIP13 and zinc-dependent regulation has been shown in many human tissues including testis 
and pancreas (Yang et al., 2013). Subcellular localization to vesicular compartments under 
different conditions of zinc availability was demonstrated through immunofluorescence of a 
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GFP-tagged ZIP13-containing plasmid in both HEK293T and HepG2 cells (Jeong et al., 2012). 
Similarly, a role in vesicular export of zinc was evident in HEK293T cells transfected with a 
ZIP13 overexpression construct. Loss-of-function mutation in the SLC39A13 gene is 
implicated as a genetic cause of a heritable disorder of connective tissue known as 
spondylocheiro dysplastic Ehlers-Danlos Syndrome (SCD-EDS) (Beighton et al., 1998, 
Fukada et al., 2008). A role for ZIP13 in SCD-EDS and in tooth/bone development was 
identified using knockout mice (reviewed by (Fukada et al., 2011)), but the molecular 
mechanisms underlying ZIP13-mediated activities are largely unclear. 
Human ZIP14 (492 amino acids), which is encoded by the SLC39A14 gene located at 8p21.3, 
was identified as a gene product that was induced during adipocyte differentiation (Tominaga 
et al., 2005). ZIP14 was reported first in 2005 as a member of the LIV-1 subfamily that lacks 
the characteristic histidine-rich residue in transmembrane domain V (Taylor et al., 2005). 
Northern blotting analysis of a panel of normal human tissues and tissues from cancer cell lines 
showed ubiquitous and abundant expression in the liver, pancreas and intestine (Taylor et al., 
2005). However, low levels of expression were detected in the brain in comparison with ZIP8, 
which is the most closely-related family member. ZIP14 was demonstrated to localise to the 
plasma membrane in K562 cells. Zinc transport activity was demonstrated in spite of the 
absence of the ‘essential’ histidine signature motif, thus challenging the widely accepted role 
of this module in zinc transport. The role of ZIP14 in facilitating uptake of metals additional to 
zinc, including iron, manganese, nickel and cadmium, was demonstrated in Xenopus oocytes 
injected with the murine Zip14 cDNA (Pinilla-Tenas et al., 2011). ZIP14 mRNA expression 
and concomitant accumulation of manganese in response to interleukin 6 treatment was shown 
in neuroblastoma (SH-SY5Y) cells (Fujishiro et al., 2014). Expression of ZIP14 at both mRNA 
and protein levels was up-regulated by lipopolysaccharides (LPS) treatment in wild-type mice 
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compared with Zip14 knockout mice (Beker Aydemir et al., 2012), suggesting that ZIP14 could 
be a marker of immune response disorders. 
1.3.3 Zinc efflux proteins (the ZnT family) 
The mammalian ZnT transporters belong to the cation diffusion facilitator (CDF) superfamily 
of intermembrane divalent metal ion transporters. The CDF transporters have more than 100 
members, which are found in all organisms at all phylogenetic levels (Gustin et al., 2011). On 
the basis of sequence similarity the CDF superfamily members are divided into three classes 
designated I to III. Class I are mainly prokaryotic members while classes II and III contain both 
prokaryotic and eukaryotic members in similar proportions (Gaither and Eide, 2001a). The 
mammalian homologues have representatives spread across classes II and III, and comprise 10 
members named ZnT1-10, which are subdivided into 4 subfamilies designated I to IV (Huang 
and Tepaamorndech, 2013). Subfamily I is made up of ZnTs 5 and 7; subfamily II comprises 
ZnTs 2, 3, 4 and 8; subfamily III is composed of ZnTs 1 and 10, while ZnTs 6 and 9 belong to 
subfamily IV (Huang and Tepaamorndech, 2013). Most members of the ZnT proteins are 
predicted to have six transmembrane domains with an intracellular histidine/serine-rich loop 
region between TMDs IV and V (Figure 1.2) and long C-terminal tails. Many features 
characterise the ZnT family, including zinc efflux from the cytosol to the extracellular 
compartment or into intracellular vesicles, and homodimerization (for example homo-
oligomerization of ZnT7), which has been shown to be important for zinc transport activity. 
An emerging phenomenon shown by some members is heterodimerization, in which 2 different 
members form heteromeric complexes to facilitate zinc transport to targeted cellular 
compartments. This phenomenon is exemplified by heterodimerisation between  Msc2 and 
Zrg17, which directs zinc to the endoplasmic reticulum in Sacchoromyces cerevissiae (Ellis et 
al., 2005), and the dimerization between mammalian ZnT5 and ZnT6 necessary for zinc 
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transport to the secretory pathway (Suzuki et al., 2005a).  In the latter example, ZnT6 is thought 
to play a structural role owing to the absence of what is described as the transient zinc-binding 
module; a potential zinc-binding site comprising of 2 aspartate and 2 histidine residues present 
only in ZnT5 (Ohana et al., 2009, Wu et al., 2011). In spite of many similar features of ZnT 
transporters, members can be distinguished from one another on the basis of the length as well 
as the amino acid sequences located upstream of TMD 1, which contains the targeting signal. 
ZnT1 is encoded by the SLC30A1 gene, which is mapped to chromosome 1 in both humans 
and mice, and it was the first cloned mammalian zinc transporter of the CDF family. ZnT1 (507 
amino acids) shows ubiquitous tissue distribution but higher levels of expression were detected 
in tissues known to be involved in zinc acquisition, recycling and transfer such as the small 
intestine (Liuzzi et al., 2001, Kambe et al., 2004). Subsequently, localisation to the basolateral 
membrane in the epithelial cells of the intestine (enterocytes) and kidney was demonstrated, 
indicating a role in zinc transfer to the portal circulation for systemic distribution and zinc 
recovery from glomerular filtrate (Cousins et al., 2006). Znt1 has also been shown to localize 
to the mouse villous yolk sac membrane suggesting involvement in mediating zinc transport 
from maternal zinc pool to the foetus. Znt1 conferred  resistance to high extracellular zinc 
concentrations in zinc-sensitive baby hamster kidney (BHK) cells, which were  transfected 
with the mouse Znt1 cDNA (Palmiter and Findley, 1995) indicating an efflux function. 
Immunofluorescence revealed high levels of ZnT1 at the plasma membrane of HepG2 
hepatoma cells exposed to zinc and cadmium compared with basal levels, indicating that 
cadmium, in addition to zinc can induce ZnT1 expression (Urani et al., 2010). The zinc 
transport activity of ZnT1 has  been studied in several cell types including HEK293 cells, 
leading to the proposal that ZnT1 is a Zn2+/H+ exchanger (Shusterman et al., 2014). A global 
expression profile of zinc efflux transporters in different subsets of leukocytes in response to 
changes in zinc concentration identified ZnT1 as the most regulated member of this group 
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(Overbeck et al., 2008), consistent with a role in mediating zinc homeostasis. Importance of 
ZnT1 function at the systemic level was reported by Andrews and colleagues in a study 
showing that homozygous knockout of Znt1 in the mouse resulted in early embryonic lethality 
(Andrews et al., 2004). 
ZnT2 is encoded by the SLC30A2 gene, also located on human chromosome 1. The gene 
produces 2 variants ‘‘a’’ and ‘‘b’’ by alternative splicing with the longer variant encoding a 
protein of 383 and the shorter one encoding 334 amino acids. Bioinformatics analysis showed 
that the two isoforms differ only at the N-terminal region (Liuzzi and Cousins, 2004, Lopez 
and Kelleher, 2009). Znt2 mRNA has been detected in placenta, kidney, small intestine and 
mammary gland in the rat (Liuzzi et al., 2003). High levels of Znt2 were also detected in rat 
prostate, where it was found to be restricted to zinc-rich regions of the lateral and dorsal lobes 
(Iguchi et al., 2002). Dietary zinc was shown to modulate expression levels of Znt2 in rat by 
inducing increased mRNA expression (Liuzzi et al., 2001). In contrast to ZnT1, which 
primarily localises to the cell membrane and facilitates zinc efflux into extracellular space, 
ZnT2 was shown to localise to subcellular organelles (endosome /lysosome vesicles) in BHK 
cells transfected with rat Znt2 cDNA (Palmiter et al., 1996a). Immunohistochemical staining 
of intestine tissues excised from pregnant rats maintained on zinc diet revealed localisation of 
Znt2 to the apical region of enterocytes, consistent with involvement of Znt2 in mobilising zinc 
from the maternal pool to maintain adequate supply to the foetus (Liuzzi et al., 2003). 
Overexpression of ZnT2 as an HA-tagged recombinant protein revealed localisation of the two 
isoforms to different compartments, the longer variant to the secretory compartment and the 
shorter one to the plasma membrane (Lopez and Kelleher, 2009). Clinical relevance of ZnT2 
was identified when it was found that mutation in the ZnT2 gene resulted in infant zinc 
deficiency in women with a low milk zinc concentration (Chowanadisai et al., 2006), 
suggesting a role for ZnT2 in mammary gland zinc homeostasis. 
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Mammalian ZnT3 was identified through screening a mouse cDNA library using rat Znt2 
cDNA (Palmiter et al., 1996b). In mouse, Znt3 is encoded by the Slc30a3 gene located on 
chromosome 5. The protein has a predicted topology that is characteristic of the ZnT family 
members. The human homologue is located on chromosome 2 at p23.3 and encodes a protein 
of 388 amino acids, which shares greater than 80% identity with both rat and mouse Znt3 
proteins (Gaither and Eide, 2001a). Znt3 mRNA was detected in rodent brain and testis and in 
a human breast epithelial cell line PMC42) (Palmiter et al., 1996b), whereas the protein was 
detected in mouse spinal cord (Danscher et al., 2003), thus a role in mediating zinc homeostasis 
between cerebrospinal fluid and the brain was suggested. Although ZnT3 expression was 
thought to be restricted to brain cells, later studies detected expression in other cell populations 
including duodenal epithelial cells (Wongdee et al., 2009), human airway cells (Ackland et al., 
2007), human adipose cells (Smidt et al., 2007), mouse retina cells (Redenti and Chappell, 
2004) and leucocytes (Overbeck et al., 2008). These findings are consistent with a versatile 
involvement of ZnT3 in cellular zinc homeostasis. In contrast to ZnTs 1 and 2, overexpression 
of ZnT3 did not affect the response of BHK cells to zinc load, but evidence from knock-out 
models support the premise that Znt3 may be important in zinc efflux particularly to synaptic 
vesicles (Cole et al., 1999). Zinc transport activity of ZnT3 is thought to be enhanced by 
homodimerisation involving tyrosine residues on the protein, a phenomenon that was shown to 
be induced by oxidative stress, and is required for targeting zinc to synaptic-like micro-vesicles 
(Salazar et al., 2009). Modulation of ZnT3 expression by factors such as age, hormones and 
glucose (Patrushev et al., 2012, Beyer et al., 2009), may imply involvement of ZnT3 in multiple 
disease conditions. 
The human ZnT4 gene (SLC30A4) located on chromosome 15 encodes a 430 amino acid-long 
protein, which is similar to ZnT2 and ZnT3 (Huang and Gitschier, 1997). ZnT4 was originally 
identified unexpectedly by positional cloning while searching for the gene whose mutation was 
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responsible for the heritable zinc deficiency in the lethal milk (lm) mouse, characterised by 
insufficient zinc in the milk to support the development of suckling pups (Huang and Gitschier, 
1997). This mutation (nonsense mutation) was identified as a single nucleotide substitution of 
C by T at 934 bp within the arginine codon that represents the 297th amino acid on the protein 
(Huang and Gitschier, 1997). In silico analysis revealed that the protein contains a leucine 
zipper motif (Murgia et al., 1999), a unique feature, which is additional to the characteristic 
features ZnT4 shares with other members of the ZnT family. High levels of expression were 
detected in rat small intestine, where it was found localised to the apical membrane in suckling 
pups but predominantly at the basolateral area in older rats (Murgia et al., 1999). Similarly, 
high levels of mRNA expression were detected in a panel of human samples including testis, 
brain and small intestine (Liuzzi et al., 2001), as well as mammary gland (Liuzzi et al., 2003) 
and in adult rat kidney (Ranaldi et al., 2002). Immunohistochemical evidence of stained 
sections of rat small intestine revealed localisation of Znt4 to endosomes at the basolateral 
region of enterocytes, consistent with a role in zinc efflux. However, in cultured mouse 
mammary epithelial cells, Znt4 was found localised to the trans-Golgi network, consistent with 
a role supplying zinc proteins of the secretory pathway (McCormick and Kelleher, 2012). Zinc 
efflux function of ZnT4 was demonstrated using a zinc-sensitive yeast strain lacking the Zrc1 
gene (∆Zrc1), in which expression of mouse Znt4 cDNA conferred resistance to zinc (Huang 
and Gitschier, 1997). The zinc transport function of ZnT4 was demonstrated to involve the 
metal-binding loop located between TMDs  IV and V by affinity chromatography using GST-
His construct containing the Znt4 putative metal-binding domain  (Murgia et al., 1999).  
ZnT5 was identified through database searches with sequences homologous to the human ZnT1 
and yeast Zrc1. ZnT5 exists as splice variants A and B. Variant A (ZnT5A) contains 15 
predicted transmembrane domains (TMD) and encodes a protein of 765 amino acids with a 
predicted molecular weight of 84 kDa (Kambe et al., 2002). Variant B (ZnT5B) has 12 
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predicted TMD and is a protein of 523 amino acids with a molecular weight of 57 kDa (Cragg 
et al., 2002). ZnT5 mRNA was detected in human endocrine pancreas, prostate, ovary, kidney 
and testis (Inoue et al., 2002) and both variants were also detected in a panel of normal human 
tissues by RT-PCR including kidney, brain, and small intestine (Thornton et al., 2011). 
Overexpressed ZnT5A was shown to be localised to the Golgi apparatus in Hela cells (Kambe 
et al., 2002), and was shown to mediate zinc uptake into this compartment in a concentration-
dependent manner.  ZnT5B on the other hand, was shown to localise to the apical membrane 
in enterocytes and zinc uptake into Xenopus laevis oocytes expressing the protein was shown 
to be dependent on the pH (Cragg et al., 2002). Though not proven, differential localization of 
ZnT5 splice variants was proposed to be dependent on their alternative C-terminal sequences, 
which thus appears to include the localisation signal (Thornton et al., 2011). The observation 
that ZnT5B mediated zinc uptake as well as efflux in Xenopus laevis oocytes (Valentine et al., 
2007) and increased expression of a zinc-induced reporter in Caco-2 cells revealed that the 
protein is capable of bidirectional zinc transport, thus challenging the paradigm that members 
of the ZnT family are primarily zinc effluxers. Zinc transport activity of ZnT5 was shown to 
involve hetero-oligomerisation between ZnT5 and ZnT6 to mediate zinc mobilisation to the 
secretory pathway (Ellis et al., 2005), a phenomenon that was corroborated by another group 
as an emerging feature of the CDF zinc transporters (Lichten and Cousins, 2009). The findings 
above were recently supported by visualisation of ZnT homodimers and hetrodimers in live 
cells using bimolecular fluorescence complementation (BiFC) (Lasry et al., 2014). A role for 
ZnT5 in normal function at the systemic level was demonstrated by virtue of the fact that 
deletion of the gene encoding this protein in mice resulted in a plethora of abnormalities 
including poor growth, cardiac bradyarrhythmia  and low bone density (osteopenia) (Inoue et 
al., 2002). Also, a role for ZnT5 in the cellular stress response was suggested by work in DT40 
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cells, where a ZnT5/ZnT6 double knock-out meant that cells could not survive tunicamycin-
induced stress (Ishihara et al., 2006). 
Human ZnT6 is encoded by the SLC30A6 gene located on chromosome 2 at a position between 
p21and p22. The Slc30a6 gene that codes for the mouse homologue is located on chromosome 
17. Znt6 was identified through a search of the EST database using mouse Znt4 amino acid 
sequence as a protein of 460 amino acids, which possesses a unique serine-rich region in place 
of the conserved histidine-rich region (Huang et al., 2002). ZnT6 can also be distinguished 
from other members of the ZnT family by virtue of the fact that it possesses the longest C-
terminal sequence made up of 203 amino acids (Huang and Tepaamorndech, 2013). High levels 
of ZnT6 mRNA expression was detected in tissues such as kidney, liver, brain and small 
intestine by Northern blotting, however, this mRNA expression did not correlate with protein 
expression detected using immunoblotting in some tissues especially liver (Huang et al., 2002), 
suggesting that ZnT6 expression may be subject to some forms of post-transcriptional 
modification that might influence tissue-specific expression. Indeed, potential sites for 
phosphorylation or N-glycosylation have been predicted for ZnT6 using bioinformatics tools 
(Huang et al., 2002). Immunohistochemical analysis of mouse gastrointestinal tract detected 
Znt6 expression in columnar epithelial cells of the jejunum, colon and cecum and in the gastric 
chief cells, consistent with a role in intestinal zinc absorption and secretion (Yu et al., 2007). 
Immunofluorescence studies in normal rat kidney epithelial cells (NRK) using affinity purified 
antibody against the C-terminal sequence, revealed that ZnT6 was localised to the Golgi 
network (TGN) but translocates to the cell periphery in response to increased extracellular zinc 
concentration (Huang et al., 2002), consistent with a role in zinc mobilization from the cytosol 
into the TGN or zinc export into the extracellular space. ZnT6 expression was shown to be 
regulated by pro-inflammatory molecules by virtue of the fact that mice treated with 
lipopolysaccharides (LPS) showed increased ZnT6 mRNA expression compared with 
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untreated controls (Liuzzi and Cousins, 2004), suggesting that ZnT6 may be involved in the 
inflammatory response. Zinc transport function of ZnT6 was inferred from studies using wild-
type yeast and mutants (∆Zrt1, ∆Zrt3 and ∆Msc2) that are deficient in cytoplasmic zinc, in 
which overexpression of Znt6 resulted in growth inhibition compared with mutants 
transformed with vector only construct (Huang et al., 2002). Studies in DT40 cells deficient in 
ZnT5/ZnT6 complex showed that hetero-oligomerisation of these two proteins is required for 
its zinc transport function (Ishihara et al., 2006). Altered expression of ZnT6 in brain sections 
of patients with mild cognitive impairment and early stage of Alzheimer’s disease (AD) (Smith 
et al., 2006), as well as in brain tissues of mouse model of AD suggests that ZnT6 may be 
involved in the etiology of AD (Zhang et al., 2010). 
Human ZnT7 is encoded by the SLC30A7 gene located on chromosome 1 and was identified 
through a search of EST databases with the amino acid sequence of mouse Znt1. The protein 
has 376 amino acids and shares up to 95% amino sequence identity with mouse Znt7 (Kirschke 
and Huang, 2003) documenting the highest sequence similarity by any 2 members of the 
mammalian ZnT family (Liuzzi and Cousins, 2004). Znt7 mRNA expression was detected in 
many mouse tissues including liver, spleen, heart, brain, lung and small intestine (Kirschke and 
Huang, 2003) but the protein showed more restricted expression and was detected only in 
tissues of small intestine and lung (reviewed by (Lichten and Cousins, 2009). Some levels of 
Znt7 expression were also detected in mouse retina (Wang et al., 2006), GIT (Yu et al., 2007) 
and cerebellar cortex (Gao et al., 2009). Overexpression of mouse Znt7 in CHO cells visualised 
by immunofluorescence microscopy showed localisation to the Golgi apparatus with 
concomitant accumulation of zinc consistent with a role in zinc efflux from the cytoplasm into 
the Golgi lumen (Kirschke and Huang, 2003). ZnT7 has been shown to mediate zinc transport 
to enzymes of the secretory pathway such as alkaline phosphatase (Suzuki et al., 2005a). This 
role appears less significant compared to that played by  the duo of ZnT5 and ZnT6 via hetero-
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oligomerisation by virtue of the fact that mutation in the Znt7 gene in DT40 cells only resulted 
in a 20% loss in the activity of tissue non-specific alkaline phosphatase (TNAP) (Suzuki et al., 
2005b). The reason for this perceived lesser contribution of ZnT7 in activating TNAP may be 
due to the fact that pull-down assay in DT40 cells transfected with recombinant Znt7 revealed 
homo-oligomers (Suzuki et al., 2005b), rather than hetero dimerization between ZnT5 and 
ZnT6 that was demonstrated in earlier studies to facilitate zinc transport into the secretory 
pathway. Overexpression of mouse Znt7 in pancreatic RIN5mf cells was shown to modulate 
the expression of insulin through MTF-1-dependent mechanism (Huang et al., 2010), thus the 
protein may be important in glucose metabolism. It was recently reported that overexpression 
of Znt7 in MC3T3-E1 cells (mouse osteoblast precursor cell line) resulted in significant 
protection of these cells from hydrogen peroxide-induced apoptosis (Liang et al., 2013) 
suggesting an antioxidant role for ZnT7. 
Human ZnT8 was identified through a search of EST databases with amino acid sequence of 
all known human ZnT proteins (Chimienti et al., 2004). The SLC30A8 gene is mapped to 
chromosome 8. The protein has 369 amino acids and shows about 42% sequence with ZnT3. 
Analysis of a panel of 22 mouse tissues by RT-PCR showed that Znt8 mRNA expression was 
detected in mouse liver and pancreatic cells with the highest expression detected in mouse islet 
of Langerhans (Chimienti et al., 2004, Lemaire et al., 2012). Although ZnT8 appears to be 
expressed predominantly in insulin-secreting beta cells, significant levels of both ZnT8 mRNA 
and protein expression has been detected in human retinal pigment epithelial (ARPE19) cells 
(Leung et al., 2008) and in human lymphocytes as well as adipocytes (reviewed by (Davidson 
et al., 2014). Confocal immunofluorescence analysis of an EGFP (enhance green fluorescent 
protein) tagged recombinant ZnT8 expressed in insulin-secreting pancreatic cell line (INS-1) 
showed localisation in the secretory pathway granules, which was observed to overlap with 
insulin staining pattern (Chimienti et al., 2004) consistent with involvement of ZnT8 in 
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providing zinc for insulin maturation. Zinc transport function of ZnT8 was demonstrated in 
Hela cells stably expressing an EGFP-tagged ZnT8 protein by virtue of the fact that cells 
transfected with ZnT8-EGFP construct accumulated more zinc compared with cells expressing 
the vector only construct (Chimienti et al., 2004). Zinc efflux of ZnT8 was observed to be 
stimulated by glucose thus a role in glucose metabolism in general, and diabetes in particular 
has been attributed to this protein. Furthermore, a single nucleotide polymorphism (SNP) 
designated rs13266634, which was found to be more prevalent in subjects of type II diabetes 
compared to their control counterparts (Sladek et al., 2007) gave evidence in support of the 
importance of ZnT8 in etiology of diabetes. In addition, aberrant expression of ZnT8 in the 
retina has been proposed as an underlying factor in the etiology of ischemic retinopathy 
(DeNiro and Al-Mohanna, 2012). These findings suggest that ZnT8 may be involved in 
multiple disease conditions. 
Human ZnT9 was originally identified on the basis on its similarity to the HUEL gene, which 
was isolated from human embryonic lung cells (MRC-5) (Sim and Chow, 1999). The HUEL 
gene has been mapped to chromosome 4 at p12-p13. The gene encodes a protein of  568 amino 
acids, which was detected on western blot as a band of ~70 kDa present in both cytosolic and 
nuclear fractions (Sim et al., 2002). The protein has been found to contain DNA excision repair 
motif and a nuclear receptor interaction consensus signature LXXLL (where X represents any 
amino acid (Cousins et al., 2006)). An established role in zinc transport has not been 
demonstrated for this protein, but evidence based on observed translocation of HUEL from the 
cytoplasm to the nucleus in human primary hepatocellular carcinoma cell line (PLC/PRF/5) in 
response to growth arrest inhibitor mimosine, suggests a role in gene regulation rather than in 
zinc efflux (Sim et al., 2002). Recently, however, ZnT9 was identified among ‘‘zinc-
transporting network’’ that may play important role in redistributing zinc within mammary 
gland and secretion into milk (Kelleher et al., 2012a). Furthermore, RT-PCR analysis of a 
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cohort of zinc transporters in obese subjects compared to control subjects revealed down-
regulation of ZnT9, suggesting that altered expression of this protein may be a possible marker  
in the aetiology of obesity (Noh et al., 2014). 
ZnT10 is encoded by the SLC30A10 gene located on human chromosome 1 at q41. The protein 
was identified through an in silico analysis of the human genome with known ZnT cDNA and 
protein sequences (Seve et al., 2004). ZnT10 shows the highest sequence similarity with the 
ZnT1 compared to other members of ZnT family. ZnT10 expression was thought to be 
restricted to fetal tissues including liver and brain (Seve et al., 2004), however, evidence from 
recent studies detected ZnT10 mRNA expression in adult mouse and human brain 
(Bosomworth et al., 2012) as well as in human liver (Yang et al., 2013). Zinc transport function 
was demonstrated in neuroblastoma cell line (SH-SH5Y) expressing recombinant ZnT10 
protein tagged with a FLAG epitope, which showed translocation to the plasma membrane 
from the Golgi apparatus in response to zinc (Bosomworth et al., 2012) consistent with zinc 
efflux role. In addition, ZnT10 has been implicated in manganese homeostasis, evidenced by 
the observation in SH-SH5Y cells that IL-6-induced reduction in ZnT10 expression affected 
efficiency of manganese excretion (Fujishiro et al., 2014). Recent observations associating 
altered ZnT10 expression with Alzheimer’s disease (Bosomworth et al., 2013) and a form of 
brain tumour (glioma) (Lin et al., 2013) suggest that this protein may be involved in etiology 
of AD. 
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Figure 1.2: Schematic representation of predicted general topologies of ZIP and ZnT 
transporters. 
The predicted membrane topologies of SLC39/ ZIP and SLC30/ZnT zinc transporters are 
shown with the transmembrane domains and conserved histidine-containing regions as well as 
direction of zinc transport in the cell. 
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1.4 Transcriptional regulation of zinc homeostatic proteins by zinc   
The expression of many genes whose products play important roles in maintaining zinc 
homeostasis is controlled at the transcriptional level. Transcription factors that have this 
function are found across all kingdoms of life and include both activators and repressors. A 
common feature underlying the action of these regulatory proteins in response to altered zinc 
availability is the recognition of specific sequence elements within promoter regions of their 
target genes to which they bind and thus effect the transcriptional response. In prokaryotes, the 
Escherichia coli transcriptional regulator ZntR, a homologue of the MerR protein, binds to an 
inverted repeat sequence comprising 11-11 bp located between -10 and -35 motifs in the zntA 
promoter to mediate zntA gene induction in response to increased zinc concentration 
(Brocklehurst et al., 1999). In contrast to the action of ZntR, the Bacillus subtilis 
metalloregulator Zur effects transcriptional repression of a suite of genes including yciC (a 
homologue of CobW gene in Pseudomonas denitrificans) under condition of zinc deficiency 
through binding to a zur box in the promoter of its target genes (Gaballa et al., 2002). Unlike 
other members of the Fur metalloregulators such as Bacillus subtilis peroxide-sensing (BsPerR) 
(Lee and Helmann, 2006) and Pseudomonas aeruginosa iron-responsive Fur (PaFur) (Pohl et 
al., 2003), Zur appears to require a more extended binding site comprising the inverted repeat 
sequence 9-1-9 in the yciC promoter for high affinity binding (Gabriel et al., 2008). In 
comparison with the 7-1-7 repeat element previously demonstrated to be adequate for zinc-
dependent transcriptional regulation (Gaballa et al., 2002), this flexibility may be useful in 
either allowing identification of additional candidate genes that may be regulated by this 
metalloregulator or in gaining mechanistic insight into its already identified targets in bacterial 
systems (Gabriel et al., 2008). In eukaryotes, the zinc-responsive transcription factors bzip19 
and bzip23 of Arabidopsis thaliana belonging to group F of the 10-group basic-region leucine-
zipper (bzip) transcription factor family (reviewed by (Jakoby et al., 2002)) have been reported 
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as factors involved in plant zinc homeostasis. These factors have been shown to play important 
roles in adaptation to zinc-limiting conditions in Arabidopsis thaliana by controlling the 
expression of zinc uptake proteins such as zips 1, 3, 4, 5, 9 and 12 through binding to one or 
more copies of a 10 bp palindromic zinc deficiency response element (ZDRE) in the promoter 
of their gene targets (Assunção et al., 2010). The Saccharomyces cerevissiae zinc uptake 
regulator ZAP1 is a central mediator of yeast zinc homeostasis and it binds to an 11 bp 
palindromic sequence (zinc response element; ZRE) in the promoters of its target genes 
including Zrt1 and Zrt2, which have been shown to mediate high zinc affinity and low affinity 
zinc uptake respectively (Zhao et al., 1998). Although the primary mode of ZAP1-mediated 
gene regulation in response to zinc limitation is activation of target genes, it also represses 
certain genes including Zrt2 under zinc-replete condition (Bird et al., 2004). In the fission yeast 
Schizosaccharomyces pombe, a zinc-dependent transcriptional repressor Loz1 (for loss of zinc 
sensing) has been shown to mediate transcription of the adh4 gene in response to excess zinc 
by interacting with a 50 bp adh4 promoter fragment containing a 7 bp cis-acting element 
thought to be important for this interaction by virtue of the fact that mutation in this element 
resulted in loss of complex formation between the recombinant Loz1 and the DNA fragment 
(Corkins et al., 2013). Although a minimal region that conferred zinc responsiveness to Loz1 
has been mapped to the C-terminal end of the protein comprising the double zinc fingers 
(Ehrensberger et al., 2014), a specific zinc-response element is yet to be defined thus the 
detailed molecular mechanism of zinc-induced, Loz1-mediated transcriptional regulation is not 
fully established. The presence of multiple binding sites for Loz1 in the adh4 promoter for 
other putative transcriptional regulators and the location downstream of the transcription start 
site of Loz1 DNA response elements appear to contribute to the difficulty in elucidating its 
mechanisms of zinc-induced transcriptional regulation (Ehrensberger et al., 2014). In higher 
eukaryotes, regulation of expression of metallothioneins, as well as some members of the ZnT 
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zinc transporter family in response to changes in zinc levels, is achieved through binding of the 
metal response element-binding transcription factor (MTF-1) to a consensus metal response 
element (MRE) in the promoters of these genes (Heuchel et al., 1994, Langmade et al., 2000). 
In addition to transcriptional activation, MTF-1 also mediates transcriptional repression of a 
subset of its gene targets, by binding to the same consensus element at positions different from 
that established for the classical mode of regulation. Both human and murine selenoprotein H 
genes display this mode of transcriptional regulation, involving the binding  of MTF-1 to an 
MRE located downstream of the transcription start site (Stoytcheva et al., 2010). Mouse  
(Lichten et al., 2011) and zebrafish Zip10 (Zheng et al., 2008) are also  regulated by MTF-1 in 
this manner. The zinc finger transcription factor Kruppel like factor 4 (KLF-4) has been found 
to mediate the response of mouse Zip4 to zinc limitation in mouse intestine and in mouse 
intestinal epithelial cell line MODE-K (Liuzzi et al., 2009). Use of EMSA revealed a binding 
site for KLF4 within the Zip4 promoter, however the zinc specific response element has not 
yet been identified. 
The regulation of ZnT5 appears complex. The two splice variants have different subcellular 
localisations but their transcription is driven by a single promoter (Thornton et al., 2011).  
Down-regulation of SLC30A5 promoter activity (assessed through measurement of β-
galactosidase expression using a gene-reporter construct, in which the expression of β-
galactosidase reporter gene was under the control of SLC30A5 promoter) and ZnT5 mRNA 
expression was demonstrated in Caco-2 cells in response to elevated extracellular zinc 
concentrations (Jackson et al., 2007). Efforts to understand the molecular mechanism of this 
zinc-induced transcriptional repression led to the identification of a sequence element in 
SLC30A5 promoter that mediates this response. This sequence element, now called the zinc 
transcriptional regulatory element (ZTRE), was demonstrated to be independent of an MRE 
consensus element, which was also found in the SLC30A5 promoter (Coneyworth et al., 2012).  
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1.5 Aims and objectives  
Following the finding that transcriptional down-regulation of the SLC30A5 gene in response to 
elevated extracellular zinc concentration is mediated by the zinc transcriptional regulatory 
element (ZTRE), a search for the transcriptional factor that acts at this site became a priority. 
Therefore, the overarching aim of the work described in this thesis was to identify this 
regulatory factor and investigate its role in mediating zinc homeostasis using the Caco-2 cell 
line model. A secondary aim that evolved as work progressed was to investigate the effect of 
zinc on endothelial cell senescence using human coronary endothelial cells. Specific objectives 
are stated in each chapter. 
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Chapter 2 : Materials and Methods 
2.1 Tissue culture techniques  
All tissue culture work described in this thesis was performed in a containment level II 
laboratory. Mammalian cell cultures were aseptically handled under a class II laminar flow 
hood. All solutions and reagents as well as plastic consumables were routinely sterilised using 
high pressure autoclave equipment and were frequently sprayed with 70% ethanol before use 
in the hood and incubators to avoid cross contamination. 
2.1.1 Growth and maintenance of mammalian cells 
Human epithelial colorectal adenocarcinoma (Caco-2) and Chinese Hamster Ovary (CHO) 
cells were used in this study. Cells were grown routinely in 75 cm2 flasks (Greiner Bio-one, 
Gloucestershire, UK) in Dubelco modified Eagle’s medium (DMEM, Invitrogen) containing 
glutamax plus 4.5 g/L glucose and supplemented with 10% v/v fetal bovine serum (FBS, 
Sigma, Poole, Dorset, UK), 60 µg/ml gentamycin and 1% v/v non-essential amino acid 
(NEAA)(Life Technologies, UK) (hereafter referred to as medium). Cells were maintained in 
an incubator with 5% CO2 at 37
oC and regularly visualised using an inverted phase contrast 
microscope (Olympus CK2). Growth medium was replaced twice weekly and cells were 
routinely passaged 5- or 7-day intervals post seeding when they had reached >80% confluence. 
For sub-culturing, growth medium was removed and cells were washed with 10 ml 1 x PBS 
(phosphate buffered saline containing 137 mM NaCl, 2.7 mM KCl, 4.3 mM NaHPO4.7H2O, 
1.4 mM KH2PO4, pH 7.4). Cells were detached from the bottom of culture flasks by addition 
of 2-3 ml solution of 0.05% trypsin plus 0.02% EDTA (Sigma-Aldrich) and incubation for 5 – 
10 minutes. Trypsinised cells were diluted in 7-8 ml fresh medium, collected in a 20 ml 
universal tube and spun at 100 g for 5 minutes. Following centrifugation, the supernatant fluid 
was discarded and cell pellets were resuspended in 10 ml fresh medium. Fifteen microliters of 
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this cell suspension was added to an equal volume of 0.4% Trypan blue (Sigma-Aldrich, 
Dorset, UK) and allowed to incubate for 2 minutes. Cell seeding density was determined by 
counting cells using Haemacytometer (Neubauer). Cells were reseeded into sterile flasks at 1 
million cells per 75 cm2 flask for continuous culturing or other appropriate cell density 
depending experimental need (as stated for specific experiments). Cells not required for 
immediate experiments were frozen in freezing medium containing 90% DMEM and 10% 
dimethysulphoxide (DMSO, Sigma) as liquid nitrogen stocks. Cells in freezing medium were 
dispensed into 1 ml cryovials (Corning, UK), pre-frozen overnight to -80 oC in isopropyl 
alcohol-containing freezing boxes (Nalgene®), which maintain a gradual reduction in 
temperature at 1 oC per minute.  Frozen cells were transferred to liquid nitrogen for long-term 
storage (cryopreservation). When required, frozen cells were thawed by placing the cryovials 
into a water bath at 37 oC. Cells were then mixed with 9 ml pre-warmed fresh medium. The 
mixture was transferred into 20 ml universal tubes and centrifuged at 100 g for 5 minutes. The 
supernatant fluid was discarded and 7 ml of fresh DMEM was added to resuspend cell pellets 
before transferring to a 75 cm2 flask. 
2.1.2 Transient transfection with promoter-reporter/expression plasmids 
Confluent cells were washed with 10 ml PBS, trypsinised and counted as described in section 
2.1.1. Cells were typically seeded at 3.5×105 cells/ml – 5.0 ×105 cells/ml in 6- or 12-well plates 
(Greiner) for transfection experiments. Transfections were carried out when cells had reached 
about 60-70% confluence, 24 h post-seeding using promoter-reporter plasmids containing 
promoter sequences of interest or with expression constructs containing protein coding 
sequence (ORF). Transfection mix was prepared by adding 100 µl DMEM (without 
supplements) or Opti-MEM® reduced-serum medium (Invitrogen) to 4 µl per well of 
transfection reagent GeneJammer (Strategene,Europe, Netherlands) or Lipofectamine® 2000 
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(Invitrogen) and incubated for 5 minutes at room temperature.  Following incubation, 1-2 µg/ 
µl of plasmid was added to the mixture and allowed to incubate for a further 20–30 minutes 
under the same condition. Culture medium in which cells were grown was replaced with 400 
µl or 900 µl fresh medium (for 12 or 6  well plate respectively) prior to addition of 100 µl 
transfection mix in a drop-wise manner. Cells were then incubated at 37 oC for 3 - 4 h prior to 
topping up with 500 µl or 1 ml for 12 or 6 well plate with complete DMEM. Transfected cells 
were incubated for a further 24 h.  
For transfection of cells with small interfering RNA (siRNA), two transfection mixes were 
prepared by adding 5 µl of Lipofectamine® 2000 to 250 µl Opti-MEM® reduced serum 
medium (mix A) and 10 nM of either target siRNA or control siRNA was  added to 250 µl 
Opti-MEM® (mix B). Each reaction was gently mixed and incubated at room temperature for 
5 minutes after which the two reaction mixes were mixed together and incubated for a further 
20 minutes at room temperature. Culture medium was replaced with 5% FBS-supplemented 
DMEM and 500 µl of the transfection mix was added to cells. Cells were incubated in this 
medium for 24 h prior to metal treatment or total RNA extraction. 
2.1.3 Metal treatment  
Cells were incubated in serum-free medium containing ZnCl2 at 3 µM (used here as control 
medium for zinc treatment) or 100 µM; CoCl2 at 100 µM; CuCl2 at 20 µM and NiCl2 at 20 µM 
24 h post-transfection. For all metal treatments, metal stock solution was prepared to 1000 x in 
each case by dissolving the appropriate amount of the metal chloride in deionised water. The 
solution was filtered through a 0.2 µm sterile syringe filter (Corning) and serially diluted when 
required to achieve the specified concentrations. 
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2.2 Cell viability assay  
A viability assay was conducted to assess cell survival at increasing concentrations of zinc and 
N, N, N', N'-tetrakis [2-pyridylmethyl] ethylenediamine (TPEN; dissolved in DMSO) in cells 
transfected with a CBWD overexpression construct. This was carried out using two 
complementary approaches: the dye exclusion method and MTT assay. 
2.2. 1 Dye exclusion method (Trypan blue) 
For this procedure, Caco-2 cells were seeded in 6-well plates at 3 × 105 cells/ml 24 h prior to 
transfection with 2 µg/µl of pCMV6-CBWD3-Myc-DDK (Origene, UK) (section 2.4.2). Cells 
were treated with different concentrations of zinc ranging from 0 to 200 μM or TPEN at 
concentrations ranging from 0 to10 μM for 24 h. Cells were prepared for counting as described 
in section 2.1.1. Relative cell viability (in percentage) was expressed as (number of viable 
treated cells/number of viable control cells) X 100. 
2.2.2 The MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide) assay 
For measurement of viability by MTT assay, Caco-2 cells were seeded in 96-well format at 
1x105 cells/ml and allowed to grow in complete DMEM (final volume of 100 µl) for 24 h. 
After a further 24 h, cells were transfected with the pCMV6-CBWD3-Myc plasmid followed 
by zinc or TPEN treatment at the specified concentrations. Following treatment, cells were 
incubated with 20 µl 5 mg/ml MTT solution per well at 37oC for 4 h. Formazan (generated 
from the reduction of tetrazolium salt (Figure 2.1) was then dissolved by the addition of 200 µl 
DMSO. Absorbance was measured at 570 nm using the FLUORstar Omega plate reader (BMG 
Labtech). Blank absorbance was measured at 630 nm, which was subtracted from the 
absorbance of each sample.  
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Figure 2.1: Schematic representation of enzymatic reduction of MTT to formazan  
 
  Mitochondrial reductase catalyses the reduction of tetrazolium salt to formazan crystals.      
   Picture adapted from http://en.wikipedia.org/wiki/File:Mttscheme.png  
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2.3 Generation and manipulation of DNA/plasmid constructs 
2.3.1 Design of primers  
Primers for PCR were designed in line with general guidelines including appropriate length 
(18 -25) and GC content (50-60%) using software such as primer3 at http://primer3.ut.ee/ or 
primerQuest at https://www.idtdna.com/primerquest/Home/Index. Primers were checked for 
self-complementarity, potential for hairpin formation (using the Thermo scientific Tm 
calculator at http://www.thermoscientificbio.com/webtools/tmc/ or Oligo Calc at 
http://www.basic.northwestern.edu/biotools/OligoCalc.html). In some instances, primers 
included restriction sites as appropriate. Furthermore, primers used in real time PCR were 
designed to span introns to avoid amplification of genomic DNA. All oligonucleotide primers 
were synthesised by Eurofins MWG Biotech, UK). 
2.3.2 Generation of amplicon by PCR 
Amplicons were generated by PCR were using the TaqPCR master mix kit (Qiagen). Typical 
reactions (final volume of 50 μl) included the following: 
 25 μl HotStar Taq mix (containing Taq DNA polymerase, 2X buffer, MgCl2, dNTPs) 
 1 μl of 10 μM forward primer 
 1 μl of 10 μM reverse primer 
 2 μl of DNA template (concentration was dependent on the template source for example 
plasmid or genomic DNA) 
 Rnase-free water to make up the final reaction volume 
In all reactions, a no template reaction containing water in place of DNA was included as 
negative control. Each reaction was mixed by briefly centrifuging the mixture for 30 – 45 
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seconds before thermal cycling. Specific reactions were optimised as required by changing 
the reaction parameters empirically. 
2.3.3 Generation of DNA insert for cloning 
DNA fragments used for cloning into pBlue-TOPO vector were amplified from Caco-2 
genomic DNA using PCR (see section 2.3) and cloned using appropriate restriction 
endonucleases. PCR products and vector were mixed in ligation reaction, which typically 
contained appropriate concentration of vector and insert in 1:3 molar ratio. For preparation of 
CBWD expression plasmid, the human CBWD3 ORF was excised with HindIII and XbaI 
restriction enzymes from pCMV6 vector (Origene,UK) and sub-cloned into p3xFLAG-10 
expression vector (Invitrogen).  
2.3.4 Agarose gel electrophoresis of DNA 
Agarose gels (typically 1 - 2%) were prepared for analysis of DNA products in 1 X TBE buffer 
(Tris/Borate/EDTA containing 89 mM Tris-base, 89 mM Boric acid, 2 mM EDTA). Agarose 
was melted in a microwave and then allowed to cool at room temperature to about 55oC before 
adding ethidium bromide (2 µg/ml) and pouring. Samples were mixed with 1/5 volume of 5X 
DNA loading dye (containing 50 mM Tris (pH 8.0), 5 mM EDTA, 50% glycerol (v/v), 50% 
bromophenol blue (w/v) before loading. Gels were run in 1 X TBE buffer at 100 V for 35 
minutes and visualised using UV transillumination (Uvitec BTS-26M, UK). 
2.3.5 Purification of DNA products from agarose gels  
Required DNA fragments were excised using sterile scalpel blades under UV light into clean 
microcentrifuge tubes and were weighed before purification using QIAquick gel extraction kit 
(Qiagen, Crawley, UK) following the manufacturer’s instructions. Briefly, weighed gel slices 
were dissolved with 5 volumes of solubilisation buffer PBI and heated at 65 oC for about 10 
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minutes with 2-minute intermittent vortexing until the gel was completely dissolved. The 
mixture was then transferred to spin columns in 2 ml collection tubes and centrifuged at 13,000 
g for 60 s at room temperature. Flow-through was discarded and columns were washed with 
0.75 ml wash buffer PE to remove any residual salt and then spun for another 60 s. A further 
centrifugation step was performed at the same speed and time to dry the columns. Columns 
were removed and inserted into fresh microcentrifuge tubes. Products were eluted with 30 µl 
elution buffer (EB) added at the spin column centre for 120 s at room temperature before 
centrifugation for 60 s at 13,000 x g. Products were immediately placed on ice. DNA 
concentration was measured using a Nanodrop spectrophotometer and products were stored at 
-20 oC for further use. In some cases, phenol:chloroform was used for DNA purification. This 
procedure involved making the sample volume up to 200 µl with deionised dH2O and then 
adding an equal volume of phenol:chloroform (1:1; pH 8) (Invitrogen) followed by vigorous 
vortexing for 30 seconds before centrifugation at 13,000 g for 15 minutes at 4 oC. The upper 
aqueous phase was then transferred to sterile 1.5 ml microcentrifuge tubes while the organic 
phase containing contaminants was discarded. A 1/10 volume of 3M sodium acetate (pH 5.2) 
and 2 volumes of ice-cold 100 % ethanol were added and samples were held at -20 oC 
overnight. The mixture was then centrifuged as described above. The supernatant was 
discarded and the pellet was resuspended in 20 – 30 µl of nuclease-free sterile water and stored 
at -20 oC.  
2.3.6 Transformation of chemically competent E coli cells 
Plasmid or ligation product was used to transform One Shot® chemically competent E. coli 
cells (Invitrogen) for propagation following the manufacturer’s protocol. Transformation 
reaction typically involved the addition of 1-2 µl of DNA to one vial (50 µl) of competent cells 
followed by incubation on ice for 30 minutes. Cells were then heat-shocked at 42 ºC for 45 
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seconds and immediately incubated on ice for 2 minutes. Following incubation, 250 µl of LB 
(Luria Bertani) medium (containing 10 g 2 % tryptone, 5 g 0.5 % yeast extract and 10 g 1 % 
NaCl per 1000 ml of the medium) pre-warmed (37 ºC) was added and transformations were 
incubated at 37 °C with shaking for 1 hour. One hundred microliters of transformation reaction 
was spread on antibiotic-treated LB agar plates (containing either 100 µg/ml ampicillin or 50 
µg/ml kanamycin). Colonies were grown at 37 ºC for 24 h. 
2.3.7 Screening of transformants (inoculation) 
Randomly selected colonies were screened by incubating a single colony in 5 ml LB medium 
containing appropriate antibiotic at 37 ºC overnight. 
2.3.8 Purification of plasmid from bacterial cultures 
Small scale plasmid preparation was carried out using Quicklyse Miniprep kit (Qiagen) to 
purify plasmid DNA from bacterial culture grown overnight following the manufacturer’s 
instructions. Briefly, bacterial culture was pelleted by centrifugation at 12,000 g for 60 s, 
followed by alkaline-based buffer lysis and a series of further centrifugation steps culminating 
in DNA elution with 20 µl elution buffer QLE into clean microcentrifuge tubes. Large scale 
plasmid purification involved inoculation of a single colony in a starter culture containing 
appropriate antibiotics for 7 h at 37oC. Five millilitres of starter culture was used to inoculate 
200 ml of LB medium containing 100 µg/ml ampicillin and grown overnight at 37 oC. Cells 
were pelleted by centrifugation at 6000 g for 15 minutes at 4 oC and DNA was extracted using 
endotoxin-free maxiprep kit (Qiagen, Crawley, UK). 
2.3.9 Determination of Nucleic acid (DNA/RNA) concentration 
DNA or RNA was routinely quantified by spectrophotometric methods using Nanodrop 1000 
(Thermo Fisher Scientific Inc. USA). This procedure was carried out by measuring the optical 
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density (OD) of the samples at two different wavelengths (i.e. 260 nm and 280 nm). The ratio 
of 260/280 was determined for each sample and the value of 1.8 or 2.0 was acceptable for good 
quality DNA or RNA respectively. A measure of salt contamination is determined by 
measuring absorbance ratio at 260/230 and the range of 2.0 - 2.3 was considered acceptable for 
nucleic acid preparations. The procedure involved taking a blank measurement with 2 µl of 
water or the buffer in which the samples were dissolved, then 2 µl of each sample was pipetted 
onto the instrument’s pedestal to measure concentrations. 
2.3.10 Digestion of plasmid DNA with restriction endonucleases 
Plasmid DNA was digested with restriction endonucleases in appropriate buffer. Typical 
restriction reactions contained 10 % (v/v) reaction buffer, 5-10 units of the enzyme in 
microcentrifuge tubes and the reaction made up to a final volume of 20 µl with sterile water. 
Reacions were incubated in a water bath at 37oC for 1 – 2 hours. Digested products were then 
analysed by agarose electrophoresis (section 2.3.4). 
2.3.11 Site-directed mutagenesis (SDM) 
Site-directed mutagenesis (SDM) was carried out to delete either 5’ or 3’ component of the 
ZTRE from the pBlueSLC30A5prom construct using PCR. Similarly, specific zinc finger 
motifs of the transcription factor ZNF658 were deleted from the pCMV6-ZNF658-myc-DDK 
plasmid. PCR products were treated with DpnI (New England Biolabs) to digest the parent 
(methylated) plasmid, then circularised by T4 DNA ligase in the presence of a phosphate donor 
(polynucleotide kinase, PNK) (New England Biolabs). Plasmids were gel-purified, quantified 
and sequenced to ascertain the correct orientation and fidelity of the remaining sequence.  
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2.3.12 DNA sequencing 
All PCR products and/or plasmids were sequenced by Eurofins MWG Operon (MWG Biotech, 
UK). Plasmid preparations were sent at 100 ng/µl concentrations along with primers at 
concentrations of 5 – 10 µM in a 15 µl total volume. Sequencing Results were examined 
manually or by using CLUSTALW2 multi sequence alignment software. 
2.4 In vitro methylation  
In vitro methylation of pBlueCBWD1prom plasmid was carried out using the MSssI/SAM kit 
(New England Biolabs). The methyl group donor SAM (S-Adenosyl methionine) was diluted 
with sterile water in 1:8 ratio and the plasmid was diluted to the concentration of 0.2 µg/µl. 
Methylation reaction contained 0.2 µg/µl pBlueCBWD1prom, 10 x buffer 2, 1600 µM SAM, 4 
U/µl enzyme and the volume was made up to 100 µl with water. Mock methylation was 
prepared with all the components except the methyltransferase enzyme. The reaction was 
incubated in a water bath at 37 oC for about 120 minutes. More substrate (SAM) and enzyme 
(MSssI) were added then further incubation for 90 minutes. The efficiency of methylation was 
confirmed by digesting the product with the isoschizomers HpaII (CpG methylation sensitive) 
and MspI (CpG methylation insensitive). DNA was extracted using phenol: chloroform method 
(see section 2.3.5), resuspended in RNase-free water and the concentration was determined 
spectrophotometrically (see section 2.3.9). 
2.5 Reporter-gene assays  
2.5.1 Preparation of cell lysate  
Whole cell lysate was prepared for reporter gene (β-Galactosidase) assay from cells harvested 
24 h following metal treatment. Cells were washed with 1 ml PBS/well in a 12- or 6-well plate 
then PBS was replaced with 100 μl or 200 μl lysis buffer (containing 0.25 M Tris pH 7.4, 
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0.25 % (v/v) NP-40, 2.5 mM EDTA). Cells were frozen in lysis buffer at -20 ºC for 30 minutes 
then thawed at room temperature and collected into 1.5 ml microcentrifuge tubes using sterile 
cell scrapers (Greiner). Cells were centrifuged at 13,000 g for 5 minutes at 4 ºC. Supernatant 
was transferred to fresh tubes, kept on ice and used the same day for measurement of β-
Galactosidase activity. 
2.5.2 Measurement of reporter activity (β-Galactosidase specific activity) 
β-Galactosidase activity was determined colorimetrically by measuring absorbance of samples 
at 560 nm following the release of chlorophenol red from the breakdown of the substrate 
chlorophenol red-β-D-galactopyranoside (CPRG, Sigma). Twenty microliters of cell lysate 
was combined with 130 μl 1.2 mg/ml CRPG (prepared in buffer A containing 100 mM NaCl, 
25 mM MOPS & 10 mM MgCl2 pH 7.5) in a 96-well plate. Similarly, 20 µl of cell lysate 
prepared from cells transfected with vector (pBlue TOPO) containing no insert (used as 
negative control) was combined with the CPRG substrate. The reaction was incubated at 37 ºC 
until a colour change was observed. Reactions were terminated by the addition of 0.5 M 
Na2CO3 and absorbance was measured using a plate reader (Multiscan Acent). Data were 
expressed as β-Galactosidase specific activity (U/mg sample protein concentrations determined 
using the Bradford assay (see section 2.6). 
2.6 Determination of protein concentration 
Protein concentration was determined using Coomassie Brilliant Blue G-250 dye (Bradford 
reagent), which when bound to protein under acidic condition undergoes a shift in the 
wavelength at which absorbance is maximal from 465 nm to 595 nm. In this assay (Bradford 
assay), a standard solution of 0.1 mg/ml bovine serum albumin (BSA) was diluted to make a 
concentration range from 0 - 100 μg/ml BSA.  Fifty microliters (50 μl) of each standard solution 
was pipetted in triplicate into a 96 well plate (SLS Ltd, UK). Cell lysates were diluted 1 in 50 
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and 50 μl of each sample was pipetted into wells in a 96 well plate. Bradford reagent (Biorad, 
UK) was diluted 1 in 5 from the stock solution with Milli-Q water and 200 μl was added to 
each well containing either standard or sample. Absorbance was measured at 595 nm using a 
plate reader (ThermoLab Systems Multiscan Acent). A standard curve was generated from 
absorbance readings of the standards and protein concentration of samples was determined 
from this plot. 
2.7 RNA extraction and RT-PCR  
2.7.1 RNA extraction from cultured mammalian cells 
RNA was extracted with TRIzol® reagent (Invitrogen, UK). Cells were homogenised with the 
addition of 1 ml TRIzol per 10 cm2 surface area (i.e. for each well in a 6-well plate). Cells were 
incubated at room temperature for 5 minutes, followed by the addition of 200 µl chloroform 
(Sigma) per ml of TRIzol reagent and the mixture was mixed vigorously by hand for 15 
seconds. RNA was extracted using the Purelink® RNA Mini Kit (Life Technologies) following 
the manufacturer’s protocol. Briefly, homogenised cells were incubated at room temperature 
for 2-3 minutes and centrifuged at 12,000 g for 15 minutes at 4 οC. Four hundred microliters 
of the aqueous layer was transferred into fresh microcentrifuge tubes and an equal volume of 
isopropanol was added to precipitate RNA. Seven hundred microliters of the solution was 
transferred into spin columns in 2 ml collection tubes and centrifuged at 12,000 g for 60 
seconds. RNA pellet was then washed with 700 µl of 70% ethanol and centrifuged at 12,000 g 
for 15 seconds. After an additional wash step, the columns were dried and RNA was eluted 
into clean microcentrifuge tubes with 30 µl RNase-free water. RNA was quantified and stored 
at -80 οC for use.  
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2.7.2 Treatment of RNA with Dnase I 
RNA samples were treated with RQ1 RNase-free Dnase I (Promega) enzyme to remove 
residual genomic DNA. Typically, reactions included, 2 µl of Dnase I buffer, 4.5 units Dnase 
I, 1 – 2 μg/μl RNA and the volume was made up to 20 µl. Reactions were run in a thermocycler 
at 37 oC for 30 minutes. Reactions were terminated by addition of 4 µl stop solution (20 mM 
EGTA (pH 8.0)) and the enzyme was heat-inactivated at 65oC for a further 10 minutes.  
2.7.3 Synthesis of cDNA by reverse transcription reaction (RT-PCR) 
RNA was reversed-transcribed to generate complementary DNA (cDNA) using Superscipt® 
III reverse transcriptase (Invitrogen). Reactions contained 1 μl 150 ng/ul random primers 
(Promega, Southhampton, UK), 0.4 μl 0.5 mM dNTPs (Bioline, London, UK) and water to the 
final volume of 20 μl. Reactions were heated to 65oC for 5 minutes on a thermocycler then put 
on ice prior to the addition of 1 μl 0.1 mM DTT, 4 μl first strand buffer (200 mM Tris-HCl (pH 
7.5), 30 mM MgCl2, 10 mM spermidine, 50 mM NaCl), 1 μl, 30 U RNasin® (Promega) and 1 
μl 200 U reverse transcriptase enzyme. Reverse transcription was carried out at 50 oC for 45 
minutes in a single cycle. The enzyme was inactivated at 65 oC for 15 minutes.  
2.7.4 Measurement of mRNA expression by RT-qPCR  
Transcript levels of SLC30A5, SLC30A10, CBWD, ZNF658 and GAPDH (reference) genes 
were measured by relative quantification method using the LightCycler® 480 (Roche Applied 
Sciences, Burgess Hill, UK). Reactions were performed in a LightCycler 96-multiwell using 
SYBR Green I master mix and composed of 5 μl SYBR Green mix, 1 μl of sense and antisense 
primers (0.5 μM each), 1 μl of cDNA, and 3 μl water to a final volume of 10 μl. Threshold 
cycles (CT) at which the fluorescence went above the background threshold were used for 
calculations. Each sample was run in triplicate in parallel with negative control wells, which 
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contained water in place of cDNA as no template control (NTC). In addition, melt curve 
analysis was included in the programme to assess specificity of gene amplification.  
2.7.5 Generation of standard curves 
Standard curves were generated for both target and reference genes and were used to confirm 
linear amplification and to determine efficiency of each amplification. A 1: 4 dilution of cDNA 
obtained from control samples (untreated cells or cells transfected with control siRNA) was 
used to generate standard curves. Logarithm of concentration was plotted against CT values to 
yield amplification curves. Analysis was performed in triplicate and each RT-qPCR analysis 
was checked to be within the limits of the standard curve. Efficiency values (ranging from 1.8 
– 2.0) for either gene of interest or reference gene was calculated using the equation E = (10 ^ 
(-1/slope). Expression of each gene was calculated by taking the mean value of triplicate CTs 
relative to those of the reference gene using the modified delta delta CT method (Livak and 
Schmittgen, 2001). The change in CT value (ΔCT) between target gene relative to reference 
gene (s) was calculated for both control and treated samples; ΔCT= CT target gene - CT 
reference gene. Data were normalised to control condition by subtracting ΔCT value for the 
control group from ΔCT value of the treated group (i.e. ΔCT treated group - ΔCT control 
group).  
2.8 Statistical analysis 
Graphs were prepared using GraphPad Prism software version 5. Data used for statistical 
analysis were either from three replicate measurements in three independent experiments or six 
replicate measurements in two separate experiments (except otherwise stated in specific figure 
legends). Data are presented as mean ± standard error (SE) of the mean. Significant differences 
were determined as p < 0.05 by Student’s t test or one-way ANOVA followed by appropriate 
post-hoc test (s).  
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2.9 Immunoblotting techniques (western blotting) 
2.9.1 Preparation of protein sample 
Cells were harvested by incubating in 1 ml of cold PBS (prepared by addition of 1 tablet of 
protease inhibitor to 10 ml PBS) and scraped into microcentrfuge tubes using cell scraper 
(Fisherbrand® Disposable Cell Lifters, Fisher Scientific). Cells were pelleted by centrifugation 
at 13,000 g for 5 minutes. Cell pellet was resuspended in 50 µl protein resuspension buffer 
(containing 5 M NaCl, 1 m Tris-HCl (pH 7.6), 0.5 M EDTA plus 1 tablet of protease inhibitor 
cocktail) and centrifuged at the same speed for 30 minutes. Supernatant was transferred into 
fresh microcentrfuge tubes and protein concentration was determined by Bradford assay (see 
section 2.6).  
2.9.2 SDS-PAGE electrophoresis 
Protein sample (5-10 µg) was electrophoresed through 12.5% Sodium Dodecyl Sulphate 
Polyacrylamide Gels (SDS-PAG). A 12.5 % resolving gel (40% acrylamide-bis-acrylamide in 
37:5:1 raatio, 0.75 M Tris-HCl pH 8.9, 0.1 %SDS, 5.7 mM TEMED, 0.1%  ammonium 
persulfate (APS) and 2 µl TEMED) and 5% stacking gel (40% acrylamide, 0.06 M Tris-HCl 
pH 6.7, 0.1% SDS, 13.8 mM TEMED, 0.1% APS) were prepared. All gel solutions were 
purchased from Sigma. Separation solution was poured into pre-set glass plates (BioRad) and 
overlaid with 1 ml isopropanol and allowed to polymerise for 30 minutes. Stacking gel was 
added and comb was inserted then allowed to set for a further 20 minutes. Protein samples were 
prepared for loading by adding each sample to loading buffer (containing 45 mM Tris-HCl pH 
6.8, 10% glycerol, 1% SDS, 0.01% bromophenol blue, 50 mM DTT) and heated at 95oC for 5 
minutes before loading onto the gel along with ColorBurst Marker MW 8-220 kDa, (Sigma). 
The gel was immersed in electrophoresis buffer comprising 0.5 M Tris-HCl pH 8.8, 1.9 M 
glycine and 0.1% SDS and run at 100-120 V for 1 hour.  
59 
 
2.9.3 Protein transfer to PVDF membranes and blocking  
Gels were blotted onto PVDF membrane (Hybond P, Amersham), which was pre-activated by 
immersing it in 100 % methanol for 30 s and then in transfer buffer (0.04 Tris-HCl pH 8.8, 1.5 
M glycine, 0.08% SDS, 20% methanol) for 15 minutes. A gel sandwich was prepared using 
Whatman 3 mm paper and the gel was transferred onto PVDF membrane at 15 V for 1 h using 
electroblotting cassette (TE22, GE Life Sciences). PVDF membrane was washed once with 
PBS containing 0.1 % (v/v) tween 20 in PBS (TPBS) for 5 minutes and membrane was blocked 
in blocking solution (5% milk powder (w/v), 0.05% Tween-20 (v/v) in PBS) for 1 h. In some 
cases, membranes were stained using Coomassie staining solution consisting of 10% (v/v) 
acetic acid, 10% (v/v) Isopropanol and 0.1% (w/v) Coomassie brilliant blue to confirm the 
presence of protein.  In those experiments, gels were incubated in Coomassie stain for 20-30 
minutes at room temperature on a rocker.  Gels were thereafter destained by immersing in a 
solution of 25% propanol for 10 minutes and washed with water until blue bands were no 
longer visible on the gel.  
2.9.4 Detection of immunoreactive protein band  
Membranes were probed with primary antibody diluted to 1:1000 in blocking solution for 60 
minutes with gentle shaking at room temperature. Following washing with 0.1 % (v/v) TPBS, 
membranes were incubated with secondary antibody diluted in blocking solution to 1:5000 for 
1 hour. After further washing, protein bands were detected by chemiluminescence method 
using ECL Plus (Amersham). In this method, membranes were incubated in ECL solution at 
room temperature for 5 minutes, then exposed to X-ray film and visualised with 
autoradiography. Membranes were stripped using stripping buffer (containing 1.5 % (w/v) 
glycine, 0.1 % (w/v) SDS and 1 % Tween 20 (v/v) and re-probed with loading control specific 
antibody (anti-alpha tubulin) diluted 1in 1000 to confirm equal protein loading. 
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2.10 Immunofluorescence microscopy  
Caco-2 cells were seeded at 5x105 cells/cm3 onto 13 mm round cover slips (Thermo Scientific) 
inserted into 6-well plates and maintained in complete DMEM for 24 h. Cells were transfected 
with protein expression constructs using Lipofectamine 2000™ transfection reagent 
(Invitrogen). Cells were treated with zinc at 3 µM or 100 µM concentration 24 h post-
transfection. Cells were washed with 1 ml of cold 1x PBS fixed at room temperature with 4% 
(w/v) paraformaldehyde for 20 minutes. Following fixation, cells were permeabilised in 
permeabilisaion buffer (0.3% (v/v) Triton x-100 + 0.3% (w/v) BSA) for 15 minutes after which 
1% SDS was added and incubated at room temperature for 5 minutes to unmask the antigen. 
Cells were washed in blocking solution (1.6 g BSA, 0.5 g Glycine made up in 200 ml 1x PBS) 
and probed with primary antibody diluted in blocking solution to 1:250 overnight at 4 oC. Cells 
were then incubated in fluorophore-conjugated secondary antibody (Alexa Fluor 488; 
excitation/emission wavelength 495/519 nm) diluted to 1:1000 in blocking solution for 1 h in 
the dark. After washing, cover slips were mounted in Vectashield mounting medium 
(containing DAPI for DNA counterstaining; Vector Laboratories Ltd.). Images were visualised 
using fluorescence microscope (Olympus BX61). 
A zinc-specific fluorophore was used to investigate co-localization of CBWD protein with zinc. 
Transfected Caco-2 cells were pre-loaded with cell-permeable zinc-sensitive fluorochrome 
(FluoZin-3 AM; (bis-(1, 3-dibutylbarbituric acid; Invitrogen, UK) prepared in phosphate 
buffered saline to the final concentration of 5 µM and incubated at 37oC for 30 minutes. Cells 
were washed and incubated in PBS for additional 30 minutes at 37oC to allow for cleavage of 
the AM ester. Cells were then incubated with primary antibody and probed with secondary 
antibody conjugated to Alexafluor 594 (excitation/ emission wavelength of 560/617 nm) for 
detection of CBWD protein. Zinc levels were visualized with FluoZin-3-AM 
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(excitation/emission wavelength 494/516). Images were acquired with confocal microscope 
(Leica SP2 UV). 
2.11 Electrophoretic mobility shift assay (EMSA) 
2.11.1 Preparation of probes 
Oligonucleotide primers representing the region of SLC30A5 containing the ZTRE were 
synthesised by Integrated DNA Technologies (IDT; Iowa, USA) and labelled at 5’ end of the 
primer with infra-red dye (IRD700). PCR reactions were carried out using SLC30A5 promoter-
reporter construct as template to generate a double stranded labelled probe. For competition 
experiments, double-stranded competitor oligonucleotide was prepared by annealing two 
complementary sequences (50 bp) incorporating the ZTRE using annealing buffer (10 mM 
Tris, 1 mM EDTA, 50 mM NaCl) at 96 oC on a heating block for 10 minutes. The reaction was 
cooled slowly to room temperature and then stored at -20 oC for use in binding reactions.  
2.11.2 Preparation of protein extract 
Protein extracts were prepared from Caco-2 cells transiently transfected with myc-tagged 
expression constructs (pCMV6ZNF658-myc or pCMV6ZnT8-myc).Cells were washed with 
1X PBS and scraped into microcentrifuge tubes, then centrifuged at 1500 g for 5 minutes at 4 
oC. Supernatant fluid was removed and cell pellet was resuspended in 1 ml lysis buffer 
containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 25% glycerol, 
0.1 NP-40 (v/v) and 1 x EDTA-free protease inhibitor cocktail (Roche Applied Bioscience, 
UK). The mixture was vortexed vigorously and incubated on ice for 15 minutes before 
centrifuging at 5000 g for 5 minutes. Supernatant containing the cytoplasmic extract was 
preserved (for ZnT8-transfected cells), while cells transfected with pCMV6ZNF658-Myc 
construct, the cytoplasmic extract was discarded and the cell pellet resuspended in 100 µl 
nuclear lysis buffer containing 20 mM HEPES (pH 7.9), 1.5 mM MgCl2, 400 mM KCl, 0.5 mM 
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DTT, 25% glycerol and protease inhibitor. The mixture was incubated on ice for 30 minutes 
and then centrifuged at 15,000 g for 15 minutes. Supernatant containing the nuclear extract was 
then collected, quantified and stored at -80 oC for use.  
2.11.3 Binding reactions 
Binding reactions were prepared to a final volume of 20 µl using Odyssey EMSA kit (Licor 
Biosciences, Cambridge, UK). Each reaction contained 1 x binding buffer (10 mM Tris), 50 
mM KCl, 1 mM DTT (pH 7.5), 0.25% Tween-20, 1 µg Poly(dI.dC), 50 fmol IRD700-labelled 
probe and 5 µg protein extract. Binding reactions were incubated at room temperature for 20 
minutes in the dark. In competition experiments, 200-fold molar excess over the probe of 
double stranded competitor oligonucleotide was included in the binding reaction. Supershift 
experiments included in the binding reactions 1 µg anti-Myc/FLAG antibody added to the 
binding reaction after an initial 20 minutes pre-incubation. After a further 20 minutes, 2 µl of 
10x orange loading dye was added to each reaction tube and the mixture was loaded onto 7.5 % 
precast gels (Bio-Rad Laboratory, Hemel Hemstead, UK), which were pre-run in 0.5 x TBE 
(44.5 mM Tris-Base, 44.5 mM Boric acid, 1 mM EDTA) at 100 V for 45 minutes to remove 
excess SDS. Gels were run at 100 V for 75 minutes at 4 oC in the dark. 
2.11.4 Image detection 
Images were detected using the Odyssey infrared imager (Licor Biosciences, Cambridge, UK) 
with resolution set at 169 µm and focus offset at 1.5 mm (which equals the thickness of the 
plate plus half of the thickness of the gel). Scans were performed at different intensities to 
optimise image quality. Data were collected using the 700 nm channel, as optimum to detect 
the IRD700 dye.  
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Chapter 3 : Investigation of the mechanism of zinc-induced down-
regulation of genes; the role of the zinc transcriptional regulatory          
element (ZTRE) 
3.1 Introduction 
3.1.1 Identification of the zinc transcriptional regulatory element (ZTRE) 
In preceding work, a zinc-induced transcriptional repression of the promoter of the zinc 
transporter gene SLC30A5 was observed in Caco-2 cells exposed to elevated levels of 
extracellular zinc (100 µM or 150 µM) compared to 3 µM zinc. The possibility that this zinc-
induced repression may be mediated by a metal response element (MRE) consensus motif 
present within the SLC30A5 promoter (at position -404 to -410) was excluded by showing the 
response was retained when it was deleted (Jackson et al., 2008). The zinc-responsive region 
in this promoter was mapped to within the region -154 to +50 relative to the transcription start 
site. Use of a series of overlapping double-stranded oligonucleotides spanning this region as 
competitors in electrophoretic mobility shift analysis (EMSA) identified a palindromic 
sequence (CACTCCC(CC)GGGAGTG) at the -91 to -76 bp site of the predicted transcription 
start site (TSS) as the binding site of a protein or protein complex presumed to mediate the 
response to zinc. The element,  now called the Zinc Transcriptional Regulatory Element 
(ZTRE), was shown by mutation in a promoter-reporter construct to be responsible for the zinc-
induced repression of SLC30A5 (Coneyworth et al., 2012). The ZTRE had also been identified 
in the region upstream of the transcription start in the genes SLC30A10 (coding for number 10 
member of the efflux zinc transporter family) and CBWD (coding for a COBW domain-
containing protein) (Coneyworth et al., 2012).   
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3.2 Specific objectives 
The specific objectives of the work presented in this chapter were to investigate if: 
 the transcript levels of the CBWD gene is reduced by increased zinc; 
 SLC30A5 and CBWD promoter activities were down-regulated by elevated zinc; 
 the zinc transcriptional regulatory element was responsible for zinc-induced 
transcriptional repression of SLC30A5 and CBWD genes. 
3.3 Results 
3.3.1 The effect of zinc on transcript levels of SLC30A5 and CBWD genes 
Zinc regulation of SLC30A5 and SLC30A10 at transcript levels was previously reported as an 
observation that increasing extracellular zinc concentration reduced mRNA abundance for both 
genes in both Caco-2 and SH-SY5Y cell lines (Jackson et al., 2007, Bosomworth et al., 2012). 
To examine if CBWD genes are regulated in a similar manner by zinc, endogenous transcript 
levels of CBWD genes, along with those of SLC30A5 as a positive control, were measured by 
RT-qPCR in Caco-2 cells exposed to zinc at control and elevated levels.  Caco-2 cells were 
incubated in a medium containing zinc at concentrations of 3 µM and 100 µM for 24 hours, 
after which total RNA was extracted using Trizol reagent and reversed transcribed to 
complementary DNA (cDNA). Measurements were carried out using the LightCycler 480 
(Roche) with SYBR Green master mix I in a 96-well plate format. Primers and cycle parameters 
are as listed in Table 3.1. Amplification plots and standard curves (Figure 3.1) for SLC30A5, 
CBWD and GAPDH (control) were generated from 1:2 or 1:10 serial dilutions of cDNA from 
control cells. Efficiency for each target amplification was calculated from standard curves 
using the formular E = 10^ (-1/slope). Melt curve analysis was also included in the programme 
as a post amplification analysis to confirm specificity of the amplified product (Figure 3.2). 
Messenger RNA (mRNA) levels of target genes were expressed relative to transcript levels of 
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GAPDH and normalised to the 3 µM zinc control condition. The results indicated significant 
reduction in transcript levels of both genes in response to an extracellular zinc concentration of 
100 µM compared with the control condition (Figure 3.3), confirming previous results for 
SLC30A5 and demonstrating the regulation of CBWD genes by zinc. 
 
 
Table 3.1: Oligonucleotide sequences and cycle parameters used for RT-qPCR 
measurements 
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Figure 3.1: Representative real-time PCR amplification plots and standard curves. 
For each gene, panel A shows the amplification plots generated using primers listed in Table 
3.1 for SLC30A5, CBWD and GAPDH genes using cDNA from untreated cells diluted serially 
two fold (for the GAPDH gene) or tenfold (for SLC30A5 and CBWD genes). Panel B shows 
each corresponding standard curve.  
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Figure 3.2: Representative melt curves generated from RT-qPCR. 
Melt curves were generated as a post amplification process included in the RT-qPCR 
programme to test for primer specificity in amplifying individual genes. DNA was incubated 
at 65 oC for 60 s then dissociated by increasing the temperature up to 95 oC at 1 oC per every 
15 s interval.  
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Figure 3.3: Increased zinc concentration down-regulates transcript levels of SLC30A5 
and CBWD genes. 
Caco-2 cells were seeded at 5 x 105 cells/well in 6-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were maintained in serum-free DMEM containing zinc 
chloride added at 3 µM (control medium) or 100 µM. After a further 24 h, total RNA was 
extracted from cells using Trizol reagent and reverse-transcribed to cDNA. Transcript levels 
of SLC30A5 and CBWD genes were measured by RT-qPCR relative to transcript levels of 
GAPDH (reference gene) and are expressed normalised to the control condition. Data are 
expressed as mean ± SEM for n = 9. ***P<0.001 determined by Student’s unpaired t-test. 
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3.3.2 The effect of zinc on promoter activity of SLC30A5 and CBWD genes  
To investigate the molecular mechanism underlying the reduction in endogenous transcript 
levels of SLC30A5 and CBWD genes in response to increased zinc concentration, the region 
upstream of the start of transcription for each gene was used to generate promoter-reporter 
constructs. The  SLC30A5 plasmid contained the promoter region spanning the bases -950 to + 
50 relative to the transcription start site (TSS), and including the ZTRE (here called 
pBlueSLC30A5prom) while the CBWD promoter-reporter construct included the promoter 
sequence corresponding to the bases -680 to + 262 relative to the TSS, which includes the 
ZTRE (here referred to as pBlueCBWD1prom). The respective promoter sequences were 
generated using genomic DNA extracted from Caco-2 cells in a standard polymerase chain 
reaction (PCR). The PCR products were purified then subcloned into the vector pBLUE TOPO 
(Invitrogen) upstream of the bacterial β-galactosidase gene (lacZ). Plasmid purified from 
positive clones of E. coli was sequenced to confirm the correct sequence of the insert and its 
orientation. Production of endotoxin-free plasmid was then carried out using purification kits 
as described in section 2.3.8. Caco-2 cells were transfected with each plasmid construct, treated 
with zinc 24 h post-transfection and cell lysates were prepared for measurement of reporter 
gene activity (β-galactosidase activity) after a further 24 h. A negative control (pBlue TOPO 
vector with no insert) was included and the β-gal specific activity values were subtracted from 
all data. Results showed reduction in the levels of β-galactosidase activity in cells treated with 
100 µM zinc compared with 3 µM zinc (Figure 3.4; panel A), suggesting a ZTRE-dependent 
transcriptional repression in response to elevated zinc level. As a positive control, the promoter 
activity of a zinc-responsive human metallothionein 2a (MT2A) promoter spanning bases -358 
to +40 relative to the TSS in the same pBlue-TOPO vector (pBlueMT2Aprom) was measured. 
As expected, β-galactosidase specific activity in cell lysates transfected with the MT2A 
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plasmid construct showed a zinc-induced transcriptional up-regulation upon addition of 100 
µM compared with 3 µM zinc (panel B), confirming that cells responded to zinc as had been 
observed previously (Jackson et al., 2008). 
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Figure 3.4: Promoter activity of SLC30A5 and CBWD genes is repressed by zinc. 
Caco-2 cells were seeded at 3 x 105 cells/well in 12-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently transfected with pBlueSLC30A5promWT, 
pBlueCBWD1promWT or pBlueMT2Aprom (positive control) plasmids. Twenty four hours 
after transfection, cells were maintained in serum-free DMEM containing zinc chloride added 
at 3 µM (control medium) and 100 µM for another 24 h. After a further 24 h, cell lysates were 
prepared for measurement of promoter activity as β-galactosidase specific activity. Panel A 
shows results for pBlueSLC30A5prom and pBlueCBWD1prom while panel B shows the 
response of the pBlueMT2Aprom positive control. Data plotted as mean ± SEM normalised to 
the control condition for n ≥ 6. ***P < 0.001, **P < 0.01, determined by Student’s unpaired t-
test. 
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3.3.3 The effect of ZTRE mutation on zinc-induced transcriptional repression of SLC30A5 
and CBWD gene promoters  
To determine if the ZTRE rather than other sequences within SLC30A5 and CBWD promoter 
constructs mediates transcriptional repression in response to zinc, the sequence in the promoter-
reporter constructs was mutated to a random sequence. This was achieved using a PCR-based 
strategy that substituted the ZTRE sequence in pBlueSLC30A5promWT - CACTCCC (CC) 
GGGAGTG - with the sequence GGTAGCC (CC) GGGAGTG. The mutated construct is 
referred to as pBlueSLC30A5promMUT. The same mutation was introduced into the 
pBlueCBWDpromWT construct in place of the ZTRE sequence CACTCCC (CC) GGGAGTG 
to generate the mutant CBWD promoter-reporter construct pBlueCBWD1promMUT. Caco-2 
cells were transfected with these mutant constructs, treated with zinc and cell lysates were 
prepared for the measurement of beta-galactosidase specific activity as described previously. 
Background activity was measured in cell lysates transfected with vector (pBlue TOPO) 
containing no insert and the values were subtracted from all other data. Consistent with the 
predicted role of the ZTRE in zinc-induced transcriptional repression, both plasmid constructs 
carrying the substituted version of the ZTRE showed no transcriptional repression in response 
to elevated zinc levels (Figure 3.5). Beta-galactosidase specific activity measured in cell lysates 
prepared from cells transfected with the MT2A promoter reporter plasmid gave results 
consistent with its zinc-induced transcription, providing a positive control.  
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Figure 3.5: Mutation of the ZTRE in SLC30A5 and CBWD promoter sequences abrogates 
the response to zinc. 
Caco-2 cells were seeded at 3 x 105cells/well in 12-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transfected with pBlueSLC30A5promWT, 
pBlueSLC30A5promMUT, pBlueCBWD1promWT or pBlueCBWD1promMUT plasmids. After a 
further 24 h, cells were maintained in serum-free DMEM containing zinc chloride added at 3 
µM (control medium) or 100 µM for another 24 h. After a further 24 h, cell lysates were 
prepared for measurement of promoter activity as β-galactosidase specific activity. Panels A 
and B show response to zinc by SLC30A5 and CBWD1 while the response to zinc by MT2A 
(used as a positive control) is shown in panel C. Data are plotted as mean ± SEM normalised 
to the control condition for n ≥ 6. ***P <0.001, **P < 0.01, ns is non-significant determined 
by Student’s unpaired t-test. 
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3.3.4 The effect of deletion of the 5’ or 3’components of the SLC30A5 ZTRE on the 
response to zinc 
To determine if both 5’ and 3’ components of the ZTRE are required to mediate transcriptional 
repression in response to elevated extracellular zinc, site-directed mutagenesis was carried out 
to delete one or other of the two sides of the palindromic sequence. Mutagenic oligonucleotides 
incorporating the desired mutation (listed in Table 3.2) were used to amplify the promoter 
sequence containing the ZTRE in pBlueSLC30A5promWT in a PCR reaction. Products were 
then digested with DpnI endonuclease (target sequence: 5´-Gm6ATC-3´, Promega), which 
discriminates between the parental methylated DNA template and the newly synthesised (non-
methylated) mutation-containing plasmid. The plasmid was then transformed into Top10 
competent cells (Invitrogen) followed by screening of positive colonies by small scale plasmid 
preparation, then sequencing (MWG Eurofins) to confirm the deletion and fidelity of the rest 
of the sequence in the plasmid construct. Caco-2 cells were transfected with endotoxin-free 
preparations of the mutagenised pBlueSLC30A5_5’ZTREprom or 
pBlueSLC30A5_3’ZTREprom plasmids using Lipofectamine 2000 (Invitrogen) followed by 
zinc treatment and measurement of promoter activity as described previously. As shown in 
Figure 3.6 (A and B), the removal of either the 5’ or 3’ component of the palindromic sequence 
resulted in the loss of transcriptional repression in response to elevated zinc concentration. 
These results demonstrate that a functional ZTRE requires both sides of the linker region. 
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Table 3.2: Oligonucleotides used in site-directed mutagenesis of the SLC30A5 ZTRE  
In each primer set, the underlined sequence in the forward primer represents the end of the 
palindromic sequence that remained in the SLC30A5 promoter-reporter construct after deletion. 
Primer sequences are given in the 5’ to 3’ direction. 
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Figure 3.6: Both 5’ and 3’ ZTRE components are required to mediate transcriptional 
repression in response to zinc. 
Caco-2 cells were seeded at 3 x 105cells/well in 12-well plate and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently transfected with pBlueSLC30A5promWT, 
pBlueSLC30A5promMUT, pBlueSLC30A5_5’ZTREprom, pBlueSLC30A5_3’ZTREprom or 
pBlueMT2Aprom (positive control) plasmids. After a further 24 h, cells were maintained in 
serum-free DMEM containing zinc chloride added at 3 µM (control medium) and 100 µM for 
another 24 h. After a further 24 h, cell lysates were prepared for measurement of promoter 
activity as β-galactosidase specific activity. Data plotted are mean ± SEM from repeated 
experiments and normalised to control condition for n = 6 -12. ***P<0.001, **P<0.01, ns is 
non-significant determined by Student’s unpaired t-test. 
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3.3.5 Zinc selectivity of the SLC30A5 ZTRE in mediating a transcriptional response  
Previous experiments revealed that only zinc and none of a panel of other metals tested 
including cobalt, copper, nickel and magnesium could induce the binding of a regulatory factor 
to the ZTRE-containing SLC30A5 probe in EMSA. Similarly, only zinc could restore binding 
of the putative protein factor following inhibition by depleting zinc levels with a zinc chelator 
(Coneyworth et al., 2012), thus metals other than zinc were not promising candidates for 
ZTRE-dependent transcriptional regulation. Here, the effect of metals other than zinc on the 
promoter activity of the SLC30A5 gene was tested by treating Caco-2 cells transfected with the 
pBlueSLC30A5 promoter reporter plasmid with copper (Cu, 20 µM), nickel (Ni, 20 µM), cobalt 
(Co, 100 µM) in addition to zinc at 3 µM and 100 µM following the standard protocol as 
described previously. The concentrations of metals other than zinc were chosen based on 
previous observations that change in gene expression was observed at these levels. The 
response to these metals of the SLC30A5 promoter was assessed by measurement of β-
galactosidase specific activity in cell lysates. Results showed that the activity of the SLC30A5 
promoter was unaffected by all the metals tested as there was no difference in β-gal specific 
activity between cells incubated with control medium and cells treated with the metals at 
concentrations indicated (Figure 3.7, panel A), consistent with the previous EMSA results that 
the ZTRE-mediated response of SLC30A5 promoter is zinc-specific. The zinc-responsive 
metallothionein promoter reporter construct (pBlueMT2Aprom) showed the expected response 
to zinc (panel B), and was included as a positive control. 
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Figure 3.7: The SLC30A5 ZTRE-mediated response is zinc-specific. 
Caco-2 cells were seeded at 5 x 105cells/well in 12-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently transfected with pBlueSLC30A5prom or 
pBlueMT2Aprom (positive control) plasmids. Twenty four hours after transfection, cells were 
maintained in serum-free DMEM containing ZnCl2 added at 3 µM (control), 100 µM; CuCl2 
at 20 µM; CoCl2 at 100 µM; or NiCl2 at 20 µM for another 24 h. After a further 24 h, cell lysates 
were then prepared for measurement of promoter activity as β-galactosidase specific activity. 
Data plotted are mean ± SEM normalised to the control condition for n = 6 for 3 independent 
experiments. **P <0.01, ***P <0.001, ns is non-significant as determined using one-way 
ANOVA followed by Bonferroni post-hoc test. 
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3.4 Discussion 
Regulation of gene expression at the transcriptional level in response to environmental cues is 
mediated by the recognition and binding of regulatory proteins to specific DNA elements at 
promoters of target genes. Metal-induced transcriptional regulation of gene expression is a 
well-documented example of sequence-mediated transcriptional regulation that contributes 
towards restoring metal balance across many species. The bacterial transcriptional repressor 
Zur, for example, regulates the activity of zinc uptake proteins under zinc-limiting conditions 
by recognising and binding to a 7-1-7 consensus sequence (Shin et al., 2007). The yeast ZAP1 
mediates transcriptional regulation in response to perturbations in cellular zinc levels by 
binding to an 11 bp zinc responsive element (ZRE) within the promoter of its target genes 
including its own promoter (Zhao et al., 1998). The mammalian metal response element-
binding transcription factor (MTF-1) activates its target genes including SLC30A1 and 
metallothionein, by binding to a 7 bp MRE consensus sequence at these promoters. Binding of 
MTF-1 to MREs at other promoters such as those of human and mouse selenoprotein H genes  
(Stoytcheva et al., 2010), as well as in the gene coding for  Zip10 in mouse and zebrafish 
(Lichten et al., 2011, Zheng et al., 2008), can result in transcriptional repression, demonstrating 
the existence of a bimodal activity in response to changes in cellular zinc status that depends 
on MRE context. 
The work presented in this chapter was conducted to investigate the regulation of SLC30A5 
and CBWD genes by zinc at both transcript and promoter levels, and to investigate the 
importance of the ZTRE in mediating this response. The observed response to zinc of SLC30A5 
mRNA levels confirms previous reports using the same cell line model (Jackson et al., 2007). 
Similar observations of down-regulation at the mRNA level at higher zinc levels  have also 
been reported for the mouse Slc39a4 gene (Dufner-Beattie et al., 2003b), the human SLC30A1 
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gene (measured in a cohort of human subjects on zinc supplementation) (Cragg et al., 2005)  
and the Krüppel-like factor 4 (KLF4) gene  in HT-29 cells (Kindermann et al., 2005). In Caco-
2 cells, mRNA levels of MTF-1 and its homologue MTF-2 were reduced in response to 
increased extracellular zinc concentration (Jackson et al., 2009). The transcript levels of 
SLC30A10 (ZnT10 zinc efflux protein) were also reduced in both Caco-2 and human neuronal 
SH-SY5Y cells (Bosomworth et al., 2012) at higher extracellular zinc concentration. 
Repression of the mammalian CBWD gene transcripts by zinc, a gene for which no known role 
has been previously reported, and which is shown for the first time by work presented in this 
chapter, may be a component of the mechanism to restore balance in response to variation in 
external supply.  
The reduction in activity of a promoter-reporter construct containing the ZTRE upstream of 
the TSS in the CBWD1 gene promoter reveals that CBWD genes are repressed by zinc in a 
manner similar to regulation of SLC30A5. Replacement of the CBWD1 ZTRE with a random 
sequence (the same random sequence as used in an inactivated SLC30A5 promoter-reporter 
construct) resulted in abolishment of the transcriptional response to zinc, revealing 
functionality of the ZTRE as opposed to any other region of the promoter in this response. 
There are many examples of transcriptional regulation mediated by palindromic DNA 
sequences. However, there seems to be paucity of evidence concerning whether or not only 
one side of such a palindromic sequence can be functional. We thus deleted one or other 
component of the ZTRE in an SLC30A5 promoter-reporter construct and examined the effect 
on the response to zinc revealing that only when both elements were present was a response to 
zinc observed. It remains to be determined if retaining a sequence that is not palindromic yet 
has two components that each separately matches the ZTRE consensus sequence (CACTCCC 
(CC) GGGAGTG; (Coneyworth et al., 2012)) is still functional. Moreover, the length of the 
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inter-palindromic linker required is yet to be defined. Deletion mutations have also been 
employed in other work to study the activity or binding to DNA sequences of regulatory 
proteins such as the transcriptional repressor, Zur, in which deletion of the 3’ component of the 
Zur box palindromic sequence of the ZnuD gene, abrogated Zur binding (Pawlik et al., 2012). 
Also, transcriptional activity of yeast transcription factor HAP1 was curtailed when the 3’ side 
of the triplet CGG was substituted with CGC in the palindromic upstream activating sequence 
(UAS) of its target gene CYC1 (which encodes an isoform of cytochrome c (Ha et al., 1996)) 
and transcriptional enhancer activity of the hr5 (an Autographa californica multiple 
nucleopolyhedrovirus gene expression enhancer) was reduced when half site of its 28-bp 
palindromic sequence was replaced by site-directed mutagenesis (Rodems and Friesen, 1995). 
The observation that the promoter activity of SLC30A5 was non-responsive to metals tested 
other than zinc suggests that these metals cannot substitute for zinc in ZTRE-mediated 
transcriptional repression of the SLC30A5 promoter. It is reported that zinc homeostatic 
genes/proteins can show a response to zinc at different concentrations in what is described as 
a bell-shape curve. For example, the zinc transporter ZnT1 mRNA levels increased with 
increasing zinc concentrations and peaked at 150 µM but were reduced at 200 µM in Caco-2 
cells (Shen et al., 2008). Similarly, regulation of ZnT5 followed this pattern (Cragg et al., 
2005). However, it is yet to be determined if this response across a full range is dependent on 
the ZTRE, and would be an interesting area for further pursuit.  
Also, ZnT5 has been shown to localise as a dimer with ZnT6 to the Golgi apparatus, where it 
appears to supply zinc to enzymes of the secretory pathway (Fukunaka et al., 2009). Its 
repression by zinc may represent a mode of regulation consistent with its role in cellular zinc 
uptake (Valentine, 2007) rather than this alternative function.  
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In summary, the evidence presented reveals that CBWD genes in addition to SLC30A5 are 
regulated by zinc and demonstrates the involvement of the ZTRE in mediating this response, 
which appears to be zinc-specific. 
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Chapter 4 : Evidence that the zinc finger protein ZNF658 binds to the Zinc 
Transcriptional Regulatory Element (ZTRE) to mediate zinc-induced 
transcriptional repression 
4.1 Introduction 
ZNF658 was studied as a candidate regulatory protein that mediates transcriptional repression 
of genes that contain the ZTRE in response to elevated extracellular zinc concentration. It was 
discovered by MALDI-TOF mass spectrometry in the tryptic digest of a band seen using 
EMSA with an SLC30A5 probe containing the ZTRE sequence (unpublished work by John 
Tyson and Dianne Ford). Bioinformatics analysis shows that ZNF658 is a member of the 
ubiquitous C2H2 zinc finger-containing protein group and belongs to the Krüppel-like proteins, 
which were discovered on the basis of homology to the Drosophilla melanogaster Krüppel 
protein (Dang et al., 2000). This protein family has diverse cellular functions and represents up 
to 1% of human zinc-requiring proteins (Hoovers et al., 1992). However, only a few members 
of this group have been studied and none has been reported to mediate transcriptional down-
regulation of multiple genes in response to zinc. ZNF658 protein has five predicted isoforms 
designated X1 through X5 (according to NCBI Reference Sequence). Variants X1, X2 and X3 
have 1059 amino acids while X4 and X5 have 1053 and 751 amino acids respectively. 
Alignment of the amino acid sequence of isoform X1 with the Saccharomyces cerevisiae 
genome database at http://www.yeastgenome.org/ using BLASTP programme showed 
similarity with ZAP1 (Figure 4.1), the yeast transcription factor that plays a central role in zinc 
homeostasis. Inspection of the amino acid sequence of ZNF658 for the motif C-X2-C- X12-H-
X3-H revealed 21 zinc fingers, of which zinc fingers 12 -17 share of similarity with the ZAP1 
zinc fingers 3 -7, corresponding to the ZAP1 DNA binding domain (Figure 4.1). 
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4.2 Specific objectives 
The objectives of the work presented in this chapter were to investigate if: 
 ZNF658 binds directly to the ZTRE; 
 ZNF658 mediates zinc-induced transcriptional repression of genes that include the 
ZTRE; 
4.3 Results 
4.3.1 Identification of the Krüppel associated box (KRAB) domain in ZNF658 
Zinc finger-containing transcription factors can possess an effector motif called the Krüppel 
Associated Box (KRAB) domain, typically located at the N-terminal region (Bellefroid et al., 
1991, Lupo et al., 2013). The domain is evolutionarily conserved among many species and has 
been demonstrated to confer transcriptional repressor activity on the proteins that contain the 
domain (Margolin et al., 1994a, Lorenz et al., 2001). The KRAB-containing zinc finger 
proteins (KRAB-ZFPs) represent the single largest family of regulatory proteins in mammals 
(Urrutia, 2003), and they function by recruiting corepressors such as KRAB associated  protein 
1 (KAP1) (also called transcriptional intermediary factor 1 (TIF1)) (Looman et al., 2004). The 
KRAB domain in ZNF658 was identified through an in silico search for conserved protein 
domains using NCBI conserved domain search at 
http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi. The KRAB domain is represented with 
a hatched box in Figure 4.1 and its sequence alignment with the KRAB domain of some 
randomly selected members of the KRAB-ZFP family is shown in Figure 4.2. 
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Figure 4.1: Domain structure representation of the mammalian ZNF658 and the yeast 
ZAP1 proteins and amino acid sequence alignment highlighting regions of similarity 
The amino acid sequence of ZNF658 was aligned with the yeast genome database at 
(http://www.yeastgenome.org/). The alignment with the lowest E-value (3.7e-30) was with the 
ZAP1 protein. The 21 and 7 zinc fingers of both ZNF658 and ZAP1 proteins are indicated by 
vertical black boxes while open grey boxes show regions of similarity. The zinc-responsive 
domains (ZRDs) of ZAP1 are indicated as ZRD1 and ZRD2 with amino acid numbers 
indicated. Regions of ZNF658 zinc fingers 12 -16 that match exactly with ZAP1 zinc fingers 
3 -7 are shown. The amino acids representing the zinc finger motifs are indicated while 
conservative amino acids are underlined. Positions of the 21 ZNF658 zinc fingers are also 
indicated to the right of the figure. The hatched box at the N-terminus of ZNF658 represents a 
KRAB box domain. 
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Figure 4.2: The KRAB domain sequence of ZNF658 
The KRAB domain (and KRAB A) was identified through a search for conserved domains at 
http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi, using the amino acid sequence of 
human ZNF658 and 5 other randomly selected KRAB-ZFPs. Alignment by ClustalW2 of these 
sequences is shown. Amino acids highlighted in red, green, magenta and blue indicate 
hydrophobic, hydrophilic, basic and acidic, respectively. Asterisks (*) indicate fully conserved 
amino acids; the symbol : indicates amino acids with strongly similar properties; the symbol . 
indicates amino acids with weakly similar properties; a dash (–) indicates missing amino acids. 
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4.3.2 Demonstration that ZNF658 binds to the ZTRE-containing SLC30A5 probe  
Electrophoretic mobility shift analysis (EMSA) was used to determine if ZNF658 binds to the 
ZTRE. Protein extract prepared from Caco-2 cells transiently expressing recombinant ZNF658 
with a C-terminal myc tag  was incubated with a 204 bp SLC30A5 labelled probe 
(corresponding to bases -154 to +51 relative to the TSS (Figure 4.3; panel A), which was 
previously defined as the minimum length required that conferred zinc-responsive  
transcriptional repression to SLC30A5 (Jackson et al., 2007). This probe contains the ZTRE at 
position -91 to -76 relative to the TSS. In some binding reactions excess (200-fold) competitor 
oligonucleotide sequence that included the ZTRE (Figure 4.3; panel B) was included. As shown 
in Figure 4.4, incubation of protein extract from cells transfected with recombinant ZNF658 
resulted in a band that was retarded (lane 2) compared with the free probe (lane 1). Addition 
of the excess unlabelled double-stranded competitor oligonucleotide reduced the complex 
formed between the protein extract and the probe, demonstrating specificity of the band 
observed (lane 3). When anti-myc antibody was included in the binding reaction, a further shift 
in the complex (supershift) was observed, indicated by the arrow to the right of the figure (lane 
4), demonstrating that the complex formed represented the labelled probe with ZNF658 bound 
to the ZTRE. These results demonstrate that ZNF658 binds directly to the ZTRE. 
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Figure 4.3: Sequence of IRD700-labeled SLC30A5 probe used in EMSA experiments 
The 204 bp SLC30A5 promoter probe sequence (panel A) spanning the region -154 to +50 
relative to the transcription start site and including the zinc transcriptional regulatory element 
(highlighted in red) was amplified by PCR from the pBlueSLC30A5prom template to make a 
double stranded probe using IRD700-labelled (IDT) primers (underlined). Panel B shows the 
50 bp sequence of the double stranded competitor oligonucleotide used in competition EMSA 
with the ZTRE underlined. 
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Figure 4.4: ZNF658 binds specifically to the ZTRE in SLC30A5  
Caco-2 cells were grown in 6-well plate for 24 h. Cells were transiently transfected with 
pCMV6-ZNF658-myc-DDK (Origene) construct. After a further 24 h, nuclear extract from 
cells expressing ZNF658 were prepared. Five microgramme (5 µg) protein was incubated with 
50 fmol IRD700-labelled probe for 20 minutes at room temperature after which the mixture 
was electrophoresed through a non-denaturing 7.5 % polyacrylamide precast gel (Biorad) for 
70 minutes at 100 V. Competition EMSA included in the binding reaction a 200-fold excess 
over the probe (2.5 picomoles). Supershift EMSA included anti-myc antibody at 1µg in the 
binding reaction 20 minutes after binding reaction was incubated and a further 10 minutes 
before electrophoresis. Representative images of repeated experiments are shown. The arrow 
to the right of the figure indicates the supershifted band. 
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4.3.3 Identification of the DNA-binding region of ZNF658 protein and demonstration that 
ZNF658 binds only a ZTRE with both 5’ and 3’ components. 
To gain some mechanistic insight on the binding properties of the ZNF658 zinc finger modules, 
zinc fingers 12-15, which spans the region 770 – 905 in the amino acid sequence and is the 
region of ZNF658 homologous to the DNA binding domain of ZAP1 (Figure 4.1), were 
deleted. The deletion was created in the plasmid pCMV6, which contains the full ZNF658 
sequence fused to a myc-DDK epitope, using oligonucleotide primers listed in Table 4.1 to 
amplify the entire plasmid but excluding the region to be deleted (Figure 4.5). The mutant 
construct is designated ZNF658Δ770-904-myc-DDK. Protein extract was then prepared from cells 
expressing wild type recombinant ZNF658 and from cells expressing the mutant ZNF658. 
Protein extracts were incubated with either the SLC30A5 probe containing full ZTRE or where 
the 3’ component was excluded. No band was formed when cells were incubated the labelled 
probe with protein extracts from cells expressing the mutant protein. (Figure 4.6, lane 5), 
indicating that the ability of ZNF658 to bind the ZTRE is dependent on the presence of zinc 
fingers 12 -15.  Likewise, no complex formed when the probe lacked the 3’ component of the 
ZTRE and ZNF658 (lane 6), demonstrating that ZNF658 requires both 5’ and 3’ components 
of the ZTRE to bind. 
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Table 4.1: Oligonucleotide sequences and thermal cycling parameters used in PCR to 
delete zinc fingers 12 – 15 of ZNF658 
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Figure 4.5: Schematic diagram showing the inverse PCR technique used to delete zinc 
fingers 12 – 15 from ZNF658  
Primers (‘R’ and ‘F’) were designed to delete the 405 bp region, corresponding to zinc fingers 
12-15 (x, step 1) and represented in red as a wavy line in the expanded view through an inverse 
PCR procedure (step 2) using the wild type plasmid construct as template. The PCR product 
was then treated with DpnI to digest the parent template (step 3) and annealed to give a linear 
product, which was then phosphorylated and circularized by addition of T4 DNA ligase-
containing polynucleotide kinase (PNK) with ATP as the phosphate donor (step 4) to generate 
the mutant construct. 
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Figure 4.6: ZNF658 requires zinc fingers 12 -15 and both 5’ and 3’ components of the 
ZTRE to bind. 
Caco-2 cells were seeded at 5 x 105 cells /well in 6-well plates and grown in DMEM for 24 h. 
Cells were transiently transfected with pCMV6-ZNF658-myc-DDK (wild type; lanes 2 - 4) or 
pCMV6-ZNF658Δ770-904-myc-DDK (mutant; lane 5) constructs 24 h later. After a further 24 h, 
nuclear extracts were prepared and 5 µg protein in each case was incubated with 50 fmol 
IRD700-labelled SLC30A5 probe containing an intact ZTRE (lanes 2 -5) or labelled probe 
containing only 5’ end of the ZTRE (lane 6) for 60 minutes at room temperature after which 
the mixture was electrophoresed through a non-denaturing 7.5 % polyacrylamide precast gel 
(Biorad) for 70 minutes at 100 V. For competition and supershift EMSA, excess unlabelled 
probe (lane 3), and anti myc antibody were included in the binding reactions. A representative 
image of 3 repeated experiments is shown. NE indicates nuclear extract, wt indicates wild type. 
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4.3.4 Effect of zinc on transcript levels of ZNF658  
To examine if ZNF658 transcript levels were altered in response to increased extracellular zinc, 
ZNF658 mRNA levels were measured by RT-qPCR and expressed relative to GAPDH mRNA 
levels under control conditions (3 µM zinc) and at an elevated zinc concentration (100 µM). 
As indicated in Figure 4.7, there was no significant difference between ZNF658 mRNA levels 
under the two conditions, suggesting that ZNF658 transcript levels are unaffected by 
extracellular zinc concentration. 
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Figure 4.7: ZNF658 transcript abundance is unaffected by increased extracellular zinc 
concentration 
Caco-2 cells were seeded at 5 x 105 cells/well in 6-well plates and maintained in DMEM for 
24 h. Twenty four hours post seeding, cells were incubated in serum-free DMEM containing 
zinc chloride added at 3 µM (control medium) or 100 µM for another 24 h. Total RNA was 
extracted using Trizol reagent and reverse-transcribed to cDNA. ZNF658 transcript levels 
relative to GAPDH mRNA levels were measured by RT-qPCR and normalised to control 
condition. Data are expressed as mean ± SEM for n ≥ 6. NS indicates non-significant by 
Student’s unpaired t-test. 
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4.3.5 siRNA-mediated knockdown of ZNF658 in Caco-2 cells 
To determine if ZNF658 was responsible for the response to zinc of genes repressed by a 
mechanism dependent on the ZTRE, the effect of knockdown on these gene responses was 
determined. Two siRNAs targeted at different regions of the ZNF658 coding sequence (Figure 
4.8) were designed to reduce expression. Sequences including those of the siRNA and the target 
sequences on the gene are listed in Table 4.2. Oligonucleotides used to confirm knockdown 
including cycling parameters are shown in Table 4.3. Cells were transfected with the siRNAs 
and RNA was prepared for quantitative measurement of ZNF658 expression relative to 
transcript levels of GAPDH. When normalised to control siRNAs, the ZNF658-targeted 
siRNAs reduced expression of the gene by approximately 60 % (Figure 4.9), confirming the 
efficacy of siRNA to reduce gene expression.  
100 
 
 
 
Figure 4.8: The ZNF658 coding region indicating siRNA target sequences 
The portions of the sequence highlighted in red (from 5’ to 3’) were targets for siRNA-mediated 
silencing with siRNA 1(3/4 exon junction) and siRNA 2 (exon 5) respectively. 
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Table 4.2: Sequences of ZNF658 targeted for knockdown and the siRNA sequences used 
 
 
Table 4.3: Primers and thermal cycling parameters for confirmation of ZNF658 
knockdown 
 
 
 
102 
 
C
on
tr
ol
 s
iR
N
A
ZN
F6
58
 s
iR
N
A
C
on
tr
ol
 s
iR
N
A
ZN
F6
58
 s
iR
N
A
0.0
0.5
1.0
1.5
siRNA 1 siRNA 2
*** ***
Z
N
F
6
5
8
 t
ra
n
s
c
ri
p
t 
a
b
u
n
d
a
n
c
e
re
la
ti
v
e
 t
o
 G
A
P
D
H
 
Figure 4.9: ZNF658 mRNA expression was reduced by approximately 60% with 2 
different siRNAs  
Caco-2 cells were seeded in 6-well plates and maintained in DMEM for 24 h. Twenty four 
hours later cells were treated with 10 nM ZNF658-specific or control siRNAs 1 or 2. After a 
further 24 h, total RNA was extracted using Trizol reagent and reversed transcribed to cDNA 
using SuperScript® III reverse transcriptase (Life Technologies). ZNF658 mRNA levels 
normalised to control siRNA were expressed relative to transcript levels of GAPDH measured 
by RT-qPCR. Data presented are mean ± SEM for 3 independent experiments (siRNA1) and 2 
independent experiments (siRNA2) with each performed in triplicate. *** represents p < 0.001 
relative to control siRNA by Student’s unpaired two-tailed t-test.  
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4.3.6 Effect of siRNA-mediated knockdown of ZNF658 on the response to zinc of 
SLC30A5, SLC30A10 and CBWD genes at the transcript level 
To determine if knockdown of ZNF658 affect the response to zinc of genes known to be 
regulated via the ZTRE-mediated mechanism, the transcript levels of these genes were 
measured by RT-qPCR in cells with reduced expression of ZNF658. As shown in Figure 4.10, 
mRNA levels of SLC30A5, SLC30A10 and CBWD genes were reduced in response to treatment 
with zinc at 100 µM compared with 3 µM zinc when cells were transfected with the control 
siRNA. However, the effect of zinc on the transcript levels of these genes was abrogated as a 
consequence of transfection with ZNF658-specific siRNAs. siRNA1 treatment resulted in the 
reduction of SLC30A10 endogenous transcripts (panel B), while siRNA2 affected endogenous 
transcript levels of all the 3 genes (panels A, B, C). However, the response to zinc in each case 
was abolished. These results suggest that ZNF658 is involved in mediating the response of 
SLC30A5, SLC30A10 and CBWD genes to zinc. 
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Figure 4.10: Knockdown of ZNF658 by siRNA attenuates the response of SLC30A5, 
SLC30A10 and CBWD transcripts to zinc 
Caco-2 cells were seeded at 5 x 105 cells/well in 6-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transfected with 10 nM of either siRNA 1 or siRNA 
2 or negative control siRNA in each case, in 5 % serum-supplemented DMEM for 24 h. Cells 
were maintained in serum-free DMEM containing zinc chloride added at 3 µM (control 
medium) and 100 µM for another 24 h. After a further 24 h, total RNA was extracted using 
Trizol reagent and reverse-transcribed to cDNA. Transcript levels of SLC30A5, SLC30A10 and 
CBWD genes were measured by RT-qPCR relative to transcript levels of GAPDH reference. 
Data are expressed as mean ± SEM for n ≥ 6 normalised to 3 µM zinc condition. *P < 0.05, 
**P < 0.01***P < 0.001 by Student’s unpaired t-test. For multiple comparisons between 
different siRNAs, one-way ANOVA followed by Tukey’s post-test was used. 
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4.3.7 The effect of siRNA-mediated knockdown of ZNF658 on the response of   SLC30A5, 
SLC30A10 and CBWD genes to zinc at the promoter level 
To test further if ZNF658 is pivotal in the ZTRE-mediated response of SLC30A5, SLC30A10 
and CBWD genes to zinc, promoter activity of each of these genes was measured in response 
to zinc under condition of ZNF658 knockdown using promoter-reporter gene assay. The 
rationale behind this experiment was that if ZNF658 plays a role in mediating zinc-induced 
ZTRE-dependent transcriptional repression, then reducing its expression with siRNA would 
affect the response to zinc of promoters that contain the ZTRE. As shown in Figure 4.11, 
treatment with 100 µM zinc resulted in repression of expression of a reporter gene driven by 
SLC30A5, SLC30A10 and CBWD ZTRE-containing promoters in cells co-transfected with 
pBlueSLC30A5promWT, pBlueSLC30A10promWT or pBlueCBWD1prom constructs with 
control siRNA. However, this response to zinc was abolished under ZNF658 knockdown 
condition, in which cells were co-transfected with pBlueSLC30A10promWT or 
pBlueCBWD1prom constructs (panels B, C), whereas the response was attenuated in cells 
transfected with pBlueSLC30A5promWT plasmid (panel A). These results show that ZNF658 is 
required for the response to zinc of the SLC30A5, SLC30A10 and CBWD1 promoters and thus 
add to the evidence that ZNF658 plays an important role in orchestrating transcriptional 
repression of these genes in response to elevated extracellular zinc concentration. 
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Figure 4.11: Knockdown of ZNF658 by siRNA attenuates the response of SLC30A5, 
SLC30A10 and CBWD promoters to zinc  
Caco-2 cells were seeded at 5 x 105 cells/well in 6-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were co-transfected with 10 nM of either siRNA 1 or 
siRNA 2 or negative control siRNAs with SLC30A5, SLC30A10 and CBWD promoter-reporter 
constructs for 24 h. Cells were maintained in serum-free DMEM containing zinc chloride 
added at 3 µM (control medium) and 100 µM for another 24 h. After a further 24 h, cell lysates 
were prepared for measurement of reporter activity as specific β-galactosidase activity in 
arbitrary units. Data represented are expressed as mean ± SEM for n = 6 - 12 for 3 separate 
experiments (siRNA1) and 2 independent experiments (siRNA2). *P < 0.05, **P < 0.01***P 
< 0.001 by Student’s unpaired t-test and one-way ANOVA analysis was used for multiple 
comparisons. 
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4.3.8 Identification of additional transcription factor binding sites (TFBS) around the 
ZTRE region 
Identification of additional transcription factor (TF) binding sites close to known sites of 
binding and action of TFs known to regulate the expression of specific genes can indicate which 
other TFs may work in synergy to regulate gene expression in response to specific cues. To 
determine if the promoter regions of SLC30A5, SLC30A10 and CBWD1 genes contain the same 
or similar binding sites for additional transcription factors, thus indicating common interacting 
partners for the transcription factor that binds directly to the ZTRE, an in silico search for 
transcription factor binding sites (TFBSs) using Genomatix software MatInspector at 
www.genomatix.de was carried out. The promoter sequence spanning -50 to + 50 bp relative 
to the position of the ZTRE was searched for transcription factor binding sites in each of the 
gene promoters. Putative TFBSs were identified by modifying the matrix threshold defined by 
the programme with a significant probability set at p = 0.05. The TFBSs for NGRE, NOLF and 
SP1F transcription regulators were identified in all the three genes (Figure 4.12). 
 
 
 
 
 
 
110 
 
 
Figure 4.12: The ZTRE-containing SLC30A5, SLC30A10 and CBWD promoters share 
common transcription factor binding sites for NGRE, NOLF and SP1F proteins 
The promoter sequence corresponding to -50 to +50 bp relative to the position of the ZTRE as 
used in the SLC30A5, SLC30A10 and CBWD promoter-reporter constructs were used to search 
for possible common TFBSs using Genomatix software. TFBS for NGRE, NOLF and SP1F 
were identified based on defined significant p-value of 0.05. The position of the ZTRE is 
underlined in each panel. 
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4.4 Discussion 
The involvement of zinc in many processes requires that its levels are carefully controlled to 
prevent adverse physiological effects that may result from inadequacy or excess. Pivotal to this 
regulation are transcriptional regulatory proteins, which exert their effects through binding to 
DNA elements within promoter regions of target genes. Several of these important transcription 
factors that play roles in controlling zinc homeostasis have been identified in both prokaryotic 
and eukaryotic organisms. For instance, the bacterial transcription factors belonging to 
SmtB/ArsR families are repressors in non-metal bound form, however, on binding metal, 
dissociate from DNA to derepress expression of genes coding for proteins that confer cellular 
resistance to increased metal levels (including zinc) (reviewed by (Busenlehner et al., 2003, 
Ma et al., 2009)). The zinc-responsive regulator of bacterial ABC transporters Zur, belonging 
to the iron uptake regulator (Fur) family, in the presence of two or three zinc ions forms a 
protein-zinc complex that interacts with DNA resulting in transcriptional repression of genes 
belonging to the ‘‘zinc-response operon’’ (reviewed by (Hantke, 2001, Choudhury and 
Srivastava, 2001, Waldron and Robinson, 2009). In higher organisms, only a few transcription 
factors with roles in metal-induced transcriptional regulation have been reported. The 
Saccharomyces cerevisiae transcriptional regulator ZAP1 mediates up-regulation of many 
genes including those coding for the high affinity ZRT1 and low affinity ZRT2 under zinc 
limiting conditions by binding to zinc responsive element within these gene promoters (Zhao 
et al., 1998, Eide, 2009). In addition to the primary mode of regulation by ZAP1, it also 
mediates transcriptional repression of a subset of its target genes such as ADH1, ADH3 and 
ZRT2 under conditions of increased zinc concentration (Bird et al., 2006, Bird et al., 2004). 
Among metazoan zinc-responsive transcription factors is metal response element-binding 
transcription factor (MTF1), which appears to have been given most attention. The MTF1 
protein has a DNA binding domain comprising 6 zinc finger motifs at the N-terminus (Jiang et 
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al., 2003). Binding of up to 7 atoms of zinc by zinc fingers 1, 5, and 6, which are located at the 
N-terminal DNA binding domain (Günther et al., 2012), induces a conformational change in 
the protein, which appears to both drive translocation to the nucleus and induction of binding 
to the metal response element (MRE). Binding of MTF1 to MREs found in mammalian genes 
including those coding for the membrane zinc effluxer ZnT1 and metallothionein proteins 
generally (although not exclusively) result in transcriptional activation, resulting in 
detoxification of heavy metals or maintenance of essential homeostasis. In addition, MTF1 also 
mediates transcriptional repression of some genes such as those coding for Zip10 in both 
zebrafish (Zheng et al., 2008) and mouse (Lichten et al., 2011). Similarly, the zinc finger 
transcription factor Krüppel-like factor 4 (KLF4) has been attributed a role in mediating 
adaptive regulation of the zinc transporter ZIP4 by binding to the KLF4 response element within 
the Zip4 gene promoter (Liuzzi et al., 2009). A eukaryotic repressive transcription factor, loss of 
zinc sensing 1 (Loz1), which represses expression of genes such as zrt1 under zinc replete 
conditions has been identified in the fission yeast (Corkins et al., 2013). However, the identity 
of a transcription factor that mediates transcriptional repression of multiple genes to coordinate 
homeostatic control under conditions of increased zinc availability has not been reported in 
metazoans.  
The results presented in this chapter document evidence in support of ZNF658 being a mediator 
of zinc-induced negative regulation of genes that play significant roles in mammalian zinc 
homeostasis. Although amino sequence alignment shows that ZNF658 is most similar to the 
yeast ZAP1, which is described as the central player in yeast zinc homeostasis, their mode of 
gene regulation is in contrast to each other. The mode of regulation in which ZAP1 promotes 
up-regulation of transcription, as opposed to down-regulation by ZNF658, may be explained 
by the observation that certain regions of the proteins are not similar and these disparate regions 
could serve as sites of interaction for other regulatory/accessory proteins that may be required 
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to synergically orchestrate transcription.  This scenario appears to be prevalent among 
transcription factors. For instance, studies using chromatin immunoprecipitation and 
coimmunoprecipitation assays revealed the requirement for MTF-1 to work in concert with 
many proteins such as the histone acetyl transferase p300/CBP and with SP1 for induction of 
the mouse metallothionein 1 (MT-1) transcription in response to zinc (Li et al., 2008), and with 
hypoxia-inducible transcription factor-1 alpha (HIF-1 alpha) to mediate transcription of the 
MT-1 gene in response to stress posed by low oxygen condition (Murphy et al., 2008). 
Similarly, the mammalian transcriptional repressor delta EF1, a member of the Krüppel-type 
C2H2 family, has been shown to bind to the E2-box (CACCTG) with its 2 zinc fingers at 
promoters of its target genes, including the ER-α promoter, but acts to repress transcription 
through a transrepression mechanism by forming complexes with corepressors including C-
terminal-binding proteins 1 and 2 (CtBP1 and CtBP2) (Furusawa et al., 1999). Also, the five-
zinc finger-containing Krüppel-like transcription factor Gli-similar 2 (Glis2) orchestrates 
transcriptional repression (but can also be an activator) through interaction with CtBP1, as 
identified by two-hybrid analysis (Kim et al., 2005).  
The presence of numerous zinc fingers (in which a zinc ion is centrally coordinated by 2 
cysteine residues in β-sheet conformation and 2 histidine residues within α-helix conformation) 
on a single regulatory protein is characteristic of the ubiquitous C2H2 sub-family of 
transcription factors seen in many species. Examples include the 29 C2H2-carrying Rat O/E-1-
associated zinc finger protein (Roaz), involved in olfactory neuronal cell differentiation (Tsai 
and Reed, 1997), and the human zinc finger protein 268, which contains 24 zinc finger motifs 
and is implicated in early human liver development (Sun et al., 2004). Although C2H2 is a 
common motif in this protein family, differential DNA recognition and binding is conferred by 
the non-conserved amino acid residues that make up the zinc finger loop as well as the 
intervening amino acids between the zinc fingers (linker region), which differ widely (reviewed 
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by (Iuchi, 2001). In addition, the observed substitution of histidine (H) with arginine (R) in the 
16th zinc finger motif of ZNF658 may be important in influencing gene repression by acting as 
a receptor site for interaction with coregulators other than Krüppel-associated protein 1 (KAP1) 
as has been shown for the zinc finger protein Nizp1, which also contains this C2HR substitution 
(Nielsen et al., 2004). The multiple zinc fingers of ZNF658 may be a feature of the protein that 
allows binding to a diverse range of gene targets through motifs other than the ZTRE to mediate 
cellular function(s). Indeed, the KRAB-containing zinc finger proteins have been thought to be 
involved in a plethora of biological functions such as cell proliferation and cell cycle regulation, 
which may be facilitated by these multiple zinc fingers (reviewed by (Lupo et al., 2013). 
Inspection of the amino acid sequence of ZNF658 identified a 61-amino acid region located 
between 8 and 68 amino acids known as a Krüppel-like associated box domain (KRAB 
domain). Although the KRAB domain is a conserved region of about 75 amino acids, it has 
been established that a minimum of 45 amino acid residues is sufficient for transcriptional 
repression (Margolin et al., 1994b), thus it is not unreasonable to expect the 61 amino acids 
found in the ZNF658 KRAB to be functional. A subset of the amino acid string corresponding 
to amino acids 47 – 68 at the N-terminal end of the putative KRAB domain is identical to a 
sequence known to bind corepressor/accessory proteins including KAP-1 (Ryan et al., 1999).  
Thus, the large number of zinc fingers of ZNF658 and the presence of KRAB binding modules 
are likely to be involved in specific interactions with accessory proteins that play a role in zinc-
induced transcriptional repression.  
A previously observed increase in intensity of the band on EMSA seen when nuclear extracts 
from Caco-2 cells treated with zinc at 150 µM were incubated with the labelled zinc-responsive 
SLC30A5 promoter sequence (Jackson et al., 2007) (Coneyworth et al., 2012) seems to indicate 
increase abundance of  the binding protein, now known to be ZNF658, in the extract. However, 
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the current data show that an increase in zinc concentration does not affect ZNF658 transcript 
abundance. A possible explanation for this apparent discrepancy may be the difference in the 
concentration of zinc used (150 µM in the previous experiment but 100 µM in the present 
study). A more likely explanation is that the band represents a complex of proteins that include 
ZNF658 and that other proteins in the complex are expressed at greater abundance when zinc 
concentration is increased.  
Electrophoretic mobility shift analysis showed that binding of protein extracts from cells 
transfected with the recombinant ZNF658 protein to the ZTRE-containing SLC30A5 probe was 
specific, by virtue of competition with addition of excess unlabelled probe. The binding protein 
was confirmed as ZNF658 when antibody against the myc epitope attached to the recombinant 
protein was included in the binding reaction, leading to a major proportion of the original band 
being supershifted. A residual band of the original mobility remained in the presence of anti-
myc antibody in the binding reaction, and may be due to a complex of proteins rather than 
ZNF658 alone binding to the ZTRE-containing probe. This scenario is analogous to the zinc-
dependent transcriptional regulation of Mt1 promoter, mediated by the MTF1, in which the 
transcription factor forms a complex with the histone acetyltransferase p300/CBP and with the 
transcription factor Sp1(Li et al., 2008).  
The deletion of five zinc fingers located in the putative DNA-binding domain (DBD) resulted 
in loss of binding of ZNF658 to the ZTRE-containing probe, indicating that the ability of 
ZNF658 to bind to the ZTRE to mediate transcriptional repression may be resident in this 
region of the protein. Large deletions of over 600 amino acids have been used to map 
transcription factor DNA binding domains including that for ZAP1, which is located at the 
carboxyl-terminal region corresponding to amino acid residues 705-880 comprising the zinc 
fingers 3 -7 (Bird et al., 2000, Frey et al., 2011). The mapping of the binding function of 
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ZNF658 to this region suggests that the region, which is analogous to the ZAP1 DNA binding 
domain, may perform the same function. Future investigations should aim to identify specific 
amino acid residues that are central to its binding ability. Specific deletions have been 
employed to identify serine 98 (Ser98) as a necessary amino acid residue for the yeast ADR1 
transcription factor DNA binding ability in both in vitro and in vivo studies (Kacherovsky et 
al., 2008).  
Although siRNA-driven knockdown of ZNF658 could not be confirmed at the protein level 
owing to non-availability of commercial antibody, the use of 2 independent siRNAs to achieve 
knockdown lends confidence to the data. A similar strategy was used to confirm the function 
of the transcription factor KLF4 to reduce SLC39A4 gene expression (Liuzzi et al., 2009). We 
observed that knockdown of ZNF658 also resulted in reduction of the endogenous transcript 
levels of the target genes, indicating that the transcription factor may be required for basal 
transcription of these genes in addition to mediating transcriptional repression in response to 
zinc. A dual role for zinc finger-containing transcription factors appear to be prevalent. This 
assertion is supported by the discovery that a genome-wide chromatin immunoprecipitation 
followed by sequencing (ChIP-seq) in K562 cells revealed an appreciable number of gene 
targets that were found to be positively regulated by the KRAB-containing ZNF263 (Frietze et 
al., 2010). An alternative interpretation is that ZNF658 possibly mediates transcriptional 
repression with less zinc bound than is the case when it is required at the promoter region for 
gene transcription. Effects on endogenous transcript abundance of SLC30A5, SLC30A10 and 
CBWD genes were different between genes and between the two siRNAs. While siRNA1 
reduced the endogenous transcript levels of only ZnT10 (SLC30A10), siRNA2 resulted in the 
reduction of the endogenous transcripts of all 3 genes. A likely explanation for this apparent 
difference may be due to the fact that the two siRNAs target different combinations of variants 
of the ZNF658 gene. This explanation may be supported by the fact that the two siRNAs 
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targeted different regions of ZNF658 coding sequence, in which siRNA1 sequence targets 
exon5 but siRNA2 sequence targets the exon 3/4 boundary. Additionally, the position of the 
ZTRE relative to the TSS in each of the genes (that is upstream of TSS in SLC30A5 and 
CBWD1 but downstream of TSS in SLC30A10) (Coneyworth et al., 2012), may be responsible 
for the differential effects of siRNA1 on the endogenous transcript levels of these genes. Such 
differential location of a response element was noted to result in non-classical repression of the 
mouse Slc39a10 gene (Lichten et al., 2011). The most significant effect of ZNF658 
knockdown, however, is the loss of the zinc-induced transcriptional repression of these target 
genes, confirming involvement of this transcription factor in mediating this response.  
Genomatix matInspector using position weight matrix (PWM) (Kel et al., 2003) identified a 
huge list of possible transcription factor binding sites close to the ZTRE in SLC30A5, 
SLC30A10 and CBWD1 genes. Increased stringency and thus reliability was achieved by 
applying a statistical limit, which in this case was p-value adjusted to 0.05. Putative binding 
sites for NGRE, NOLF and SP1F factors were identified within 50 bp of the ZTRE in all three 
ZNF658 target genes, suggesting that these factors may interact with ZNF658 as possible 
coregulators to mediate zinc-induced transcriptional regulation. Although NOLF response 
elements have been recognised within the GABAA receptor subunit gene promoters (Steiger 
and Russek, 2004), evidence for specific involvement in gene regulation is scarce. On the other 
hand, NGRE binding sites are DNA sequences necessary for glucocorticoid-induced repression 
of gene transcription. This transcription factor has been have been shown to mediate repression 
of the bovine prolactin gene (PRL3) (Subramaniam et al., 1999) through a mechanism that 
includes (but not exclusively) competition with another transcription factor (AP-1) for binding 
to a site  that overlaps its own recognition sequence (Necela and Cidlowski, 2004). Similarly, 
the SP1F transcription factor family consists of a GC-Box enriched factor found within 
promoter sequences of some heat shock-responsive genes including those coding for HSP70 
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and HSP90. Its binding sequence is also a  potential binding site for KLF5/ SP1 transcription 
factors as well as specificity protein 1, and it is implicated in chromatin silencing (Augustin et 
al., 2011). Identification of these potential coregulator sites within promoters of ZNF658 target 
genes gives reason to determine through future work if these transcription factors act alongside 
ZNF658 in the zinc-responsive control of gene expression. 
In conclusion, the evidence presented in this chapter supports the hypothesis that ZNF658 plays 
important roles in orchestrating the transcriptional response of multiple genes whose products 
are involved in maintaining zinc homeostasis, thus providing the first report of a metazoan 
transcription factor with potential to coordinate gene expression in response to zinc through 
transcriptional repression. Compared with prokaryotic species, only a few metal-sensing 
transcriptional regulators have been documented in eukaryotes, thus identification of ZNF658 
fills a significant gap and advances our understanding of the molecular players that are involved 
in the complex eukaryotic metal-induced regulation of gene expression. 
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Chapter 5 :  Investigation of the role of CBWD gene products                                      
in metal homeostasis 
5.1 Introduction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
The human CBWD genes (coding for COBW domain-containing proteins) were initially 
identified through an in silico search for the presence of the ZTRE within promoters of human 
genes. The occurrence of the ZTRE in multiple isoforms of genes in the CBWD gene family, 
for which no known role in mammalian metal homeostasis has been established, was intriguing 
and motivated investigation into a likely involvement of CBWD gene products in cellular zinc 
homeostasis and also homeostasis of other metals. Recent analyses from comparative genomics 
and phylogenetic studies suggest that bacterial homologs of CBWD protein belonging to the 
metal homeostasis-associated COG0523 sub-family of P-loop GTPases may be important in 
prokaryotic metal biology (Haas et al., 2009, Sydor et al., 2013). The CBWD ZTRE has been 
demonstrated to mediate gene repression in response to increased extracellular zinc 
concentration in Caco-2 cells (see chapter three). The work presented in this chapter was 
carried out with the aim to gain some insight into a possible role for CBWD gene products in 
mammalian metal homeostasis by investigating regulation by metals other than zinc, regulation 
by zinc at the protein level, as well as the effect of increased expression of CBWD proteins on 
cell viability at different zinc concentrations and on cellular zinc distribution. The effect of in 
vitro methylation on CBWD promoter activity was also investigated, following publication of 
a data set identifying genes in mouse intestine that underwent a change in DNA methylation 
with ageing, in which CBWD was among the most affected genes (Maegawa et al., 2010). 
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5.2 Specific objectives 
Specific objectives addressed through the work in this chapter were to investigate:  
 the regulation of CBWD genes by  metals other than zinc;  
 the effect of zinc on CBWD expression at the protein level 
 the effect of overexpression CBWD protein on zinc distribution and on cell tolerance 
to variations in cellular zinc content; 
 the effect of in vitro DNA methylation on CBWD promoter activity  
5.3 Results 
5.3.1 Identification of the ZTRE in CBWD genes 
Following identification of the SLC30A5 ZTRE, an in silico search of the human genome using 
the programme Fuzznuc (EMBOSS) was conducted to determine if other genes include the 
ZTRE sequence in their promoters (Lisa Coneyworth, PhD thesis, 2009). The SLC30A5 ZTRE 
sequence (CACTCCC; representing the 5’ component of the palindromic sequence) was used 
for the search allowing only one mismatch in the 2 halves of the palindrome. Many candidate 
genes harbouring sequences similar to the SLC30A5 ZTRE sequence were identified. Of 
particular interest was the presence of the ZTRE in multiple isoforms of CBWD genes (boxed 
in Table 5.1) with a linker region comprising of 2 nucleotides similar to that present in the 
SLC30A5 ZTRE.  
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Table 5.1:  Multiple copies of CBWD genes contain the ZTRE 
In silico search of the human genome was conducted for matches to the SLC30A5 ZTRE using 
Fuzznuc software (EMBOSS). Candidate genes identified are shown in the table and include 
multiple copies of CBWD genes (indicated in red boxes). The ZTRE sequences, location on the 
chromosome and distance of the ZTRE from predicted transcription start site of each gene are 
also stated.  
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5.3.2 The response of CBWD genes to metals other than zinc 
The ZTRE has been shown previously to be indispensable for zinc-regulation of SLC30A5 and 
CBWD promoter activity through expression of promoter-reporter constructs in Caco-2 cells 
(sections 3.3.2 and 3.3.3). In addition, zinc-induced reduction of mRNA levels of SLC30A5, 
SLC30A10 (which also include a ZTRE) and CBWD genes had been demonstrated 
(Coneyworth et al., 2012) but response to other metals has only be carried out for SLC30A5 
(section 3.3.5) and SLC30A10 (Bosomworth et al., 2012). Here, the effect of other metals on 
expression of CBWD genes both at transcript and promoter levels was explored by treating 
Caco-2 cells with three different metals at the concentrations tested in experiments reported in 
section 3.3.5, which tested if they affect SLC30A5 activity. Similar to the results obtained for 
SLC30A5, the CBWD1 promoter showed no response to any metal tested other than zinc 
(Figure 5.1 panel A). The metallothionein promoter response to increased zinc concentration 
was included as a positive control (panel B). Intriguingly, however, there was significant 
response to all the metals tested of CBWD genes evidenced by reduction of the mRNA levels 
(measured by RT-qPCR using primers unable to distinguish between the different isoforms) 
compared with the control condition (panel C), suggesting that CBWD genes may be involved 
in handling metals  other than zinc in mammalian cells.  
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Figure 5.1: CBWD genes are regulated at the transcript level by metals but not at the 
promoter level by metals additional to zinc. 
Caco-2 cells were seeded at 5 x 105cells/well in 6-well plate and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently transfected with pBlueCBWDprom and 
pBlueMT2Aprom (control for reporter assay) plasmids. Twenty four hours after transfection, 
cells were maintained in serum-free DMEM containing ZnCl2 added at 3 µM (control), 100 
µM; CuCl2 at 20 µM; CoCl2 at 100 µM; and NiCl2 at 20 µM for another 24 h. After a further 
24 h, cell lysates were prepared for measurement of promoter activity as β-galactosidase 
specific activity expressed relative to protein concentration (panels A and B). For RT-qPCR 
measurements (panel C), total RNA was extracted 24 h following metal treatment at 
concentrations indicated in the figure. Data plotted are mean ± SEM normalised to the control 
condition for n = 6 for 3 independent experiments (gene-reporter assay); n= 6 for 2 independent 
repeats (RT-qPCR). *P <0.05, **P <0.01, ***P <0.001, ns indicates non-significant as 
determined using Student’s unpaired t-test (for MT2a data) and one-way ANOVA then 
Bonferonni post-hoc test for multiple comparisons. 
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5.3.3 The effect of zinc on CBWD protein levels in CHO and Caco-2 cells 
The effect of zinc on CBWD gene transcripts and on the promoter was explored in experiments 
documented in sections 3.3.1 and 3.3.2 respectively. A direct method to determine if zinc 
affects CBWD expression at the protein level was not possible owing to non-availability of 
CBWD antibody. Consequently, the effect of zinc on CBWD protein expression was examined 
by overexpressing recombinant CBWD protein with a FLAG/MYC epitope tag from a CMV 
promoter using the p3XFLAG-CMV10 vector (Sigma Aldrich) in Caco-2 cells. The 
recombinant CBWD protein with myc-DDK epitope tag had previously been expressed from 
the pCMV6 vector (OriGene) in CHO (Chinese Hamster Ovary) cells (Dianne Ford, personal 
communication) but expression was not achieved using the pCMV6 vector, hence the choice 
of a different vector (p3XFLAG-CMV10) to achieve expression in Caco-2 cells. In this 
experiment, the CBWD3 ORF was amplified from the pCMV6-myc-DDK entry vector using 
primers that included HindIII and XbaI  restriction sites as listed in Table 5.2 and sub-cloned 
as an N-terminal FLAG epitope tag into the p3XFLAG-CMV10 expression vector.  Competent 
Top 10 cells were transformed with the ligation reaction, then plasmid was prepared and 
digested with the same restriction endonucleases and analysed by agarose gel electrophoresis 
to confirm the presence and size of insert (Figure 5.2).  Plasmid preparations were also 
sequenced to ensure fidelity of the CBWD coding sequence. The construct containing the 
CBWD ORF is hereafter referred to as p3XFLAG-CMV10-CBWD3. Endotoxin-free 
preparations of pCMV6-CBWD3-myc-DDK and p3XFLAG-CMV10-CBWD3 were used to 
transfect CHO and Caco-2 cells respectively. Cells were treated with 3 µM (control) and 100 
µM concentrations of zinc and total protein was extracted for analysis by western blotting (see 
section 2.9). As indicated in Figure 5.3, CBWD protein expression detected by antibody against 
the FLAG/MYC epitope was significantly reduced by zinc at 100 µM in both Caco-2 and CHO 
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cells compared with 3 µM  (panel A), indicating an effect consistent with the observed down-
regulatory effect of zinc at the transcriptional level. Densitometric quantification of band 
intensities of the recombinant CBWD protein expressed in Caco-2 cells is represented in the 
graph (panel B). 
 
Table 5.2: Primers used for sub-cloning of CBWD3 ORF into the p3XFLAG-CMV10 
vector 
Sequences of oligonucleotides including spacer (underlined) and restriction sites (lower case) 
are shown.  
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Figure 5.2: Restriction digestion confirms CBWD cloning into 3XFLAGPCMV10 vector  
The CBWD3 ORF was amplified from the pCMV6-entry vector (Origene) with HindIII and 
XbaI restriction sites on the 5’ and 3’ ends respectively by PCR and was run on gel 
electrophoresis. The insert cut with HindIII and XbaI was ligated with T4 DNA ligase into 
3XFLAGPCMV10 vector cut with the same restriction enzymes. Successful subcloning was 
confirmed by restriction digestion using HindIII and XbaI of 3 randomly selected transformed 
E coli clones. M indicates DNA molecular weight marker; 1, 2 and 3 represent different clones 
selected for digestion. 
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Figure 5.3: CBWD protein expression is reduced by increased extracellular zinc 
concentration  
Caco-2 and CHO cells were seeded at 5 x 105 cells/cm2 in 6-well plates and grown in DMEM 
for 24 h. Twenty fours post seeding, cells were transiently transfected with 
3xFLAGCBWD3(Caco-2) and pCMV6-CBWD3(CHO) expression plasmids. Twenty four 
hours after transfection, cells were treated with zinc sulphate at 3 µM (control) and 100 µM. 
After a further 24 h, total protein was extracted for western blot analysis using α-tubulin as the 
loading control. Representative images are shown in panel A and densitometric analysis of 
CBWD band intensities (expressed in Caco-2 cells) as a ratio of α-tubulin expression is 
presented in panel B. Data are representative of 3 independent experiments. *P < 0.05 by 
Student’s unpaired t-test. 
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5.3.4 The effect of CBWD protein overexpression on intracellular zinc levels  
To determine the effect of increased CBWD expression on intracellular zinc levels, the changes 
in promoter activity of a zinc-responsive human metallothionein gene (MT2A) was measured 
in Caco-2 cells at extracellular zinc concentrations of 3 µM to 100 µM. The rationale was that 
promoter activity would be increased (possibly at both zinc concentrations) if CBWD increased 
intracellular zinc, and would be reduced if CBWD reduced intracellular zinc. CBWD protein 
expressed from the 3XFLAGpCMV10 vector (3xFLAGpCMV10-CBWD3 construct) was co-
expressed with a MT2A promoter-reporter construct (pBlue-MT2A). This method was 
employed previously to investigate the functional role of ZnT5 variant B (ZnT5B) in zinc 
uptake in the same cell line model (Valentine, 2007). Activity of the MT2A promoter was 
measured in cell lysates prepared from Caco-2 cells transfected with the plasmids and treated 
with zinc. As shown in Figure 5.4, overexpression of CBWD significantly reduced the activity 
of the MT2A promoter at both concentrations of zinc in cells transfected with pBlueMT2A plus 
3xFLAGpCMV10CBWD3 compared to cells transfected with the MT2A promoter reporter 
construct plus vector only (no CBWD insert), suggesting that CBWD plays a role in 
manipulating intracellular levels of zinc available to activate the MT2A promoter.  
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Figure 5.4: CBWD overexpression alters intracellular zinc status. 
Caco-2 cells were seeded at 5 x 105cells/well in 12-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently co-transfected with pBlueMT2A, plus 
either 3xFLAGpCMV10-CBWD3 or vector only (3xFLAGpCMV10). After a further 24 h, 
cells were maintained in serum-free DMEM containing zinc chloride added at 3 µM (control 
medium) and 100 µM for another 24 h. Cell lysates were then prepared for measurement of 
promoter activity as β-galactosidase specific activity. Data plotted are mean ± SEM for n = 6 
for 3 separate experiments; ns indicates non-significant determined by Student’s unpaired t-
test. 
 
 
132 
 
5.3.5 Effect of CBWD overexpression on cell tolerance to zinc  
It is well documented that cell viability is compromised at extreme levels of zinc availability. 
To gain some insight into the possibility that CBWD proteins may affect tolerance to extreme 
variations in zinc supply, reflective of a role in zinc homeostasis, the effect of increased 
expression of CBWD protein on the survival of Caco-2 cells exposed to zinc at increased and 
depleted levels was investigated. Cell viability was measured using dye exclusion (trypan blue) 
and MTT methods. Caco-2 cells were seeded at 5 x 105/well in 6-well plate for dye exclusion 
or 105 cells /well 96-well plate for MTT assays respectively. Cells were then treated with 150 
µM zinc or 10 µM TPEN (chosen because of an observed decrease in cell survival under these 
conditions), then cell survival was measured using exclusion of trypan blue. A range of 
concentrations of zinc (0, 50, 100, 150, 200 µM) and TPEN (0, 0.5,1,2,5,10 µM) were used for 
more detailed investigation using the MTT assay. For the dye exclusion assay, cells were 
prepared by centrifugation and cell pellets were resuspended in serum-free medium. Aliquots 
of cells were mixed with an equal volume of trypan blue dye (Invitrogen) for cell counting 
using a haemocytometer. Cell images were captured with an AMG EVOS XL digital inverted 
microscope (Bothel, WA, USA). For the MTT assay, cells were incubated with MTT solution 
following treatment with zinc and TPEN. Formazan crystals were dissolved in 10% DMSO 
and absorbance was measured at 570 nm with blank measurement at 630 nm. Absorbance 
measurement at 630 nm (blank) for each well was subtracted from the corresponding 
measurement at 570 nm.  The absorbance of non-treated cells (control) was set as the reference 
(100 % viability) and the viability of treated cells in the two groups (with or without CBWD 
protein) was expressed relative to this value. After treatment with TPEN, cells without CBWD 
overexpressed protein  and stained with Trypan blue were at lower density on visual inspection 
compared with cells that overexpressed CBWD, suggesting that CBWD increased tolerance to 
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zinc depletion (Figure 5.5, panel A), whereas there was no apparent difference in cell density 
in zinc-treated cells with or without CBWD overexpression (Figure 5.5, panel B). However, 
the results of the MTT assay, which is a quantitative measure of cell viability, revealed that 
cells that overexpressed CBWD protein showed more tolerance to both zinc depletion by TPEN 
and to increased zinc concentration compared with control cells (without CBWD 
overexpression) (Figure 5.6, panels A and B). These results indicate that the presence of 
CBWD protein extends the cells range of tolerance to altered zinc levels, suggesting a role in 
buffering/sequestering intracellular zinc and/or regulating zinc influx/efflux. 
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Figure 5.5: Increased CBWD protein expression enhances viability of cells exposed to zinc 
depletion or excess (dye exclusion method). 
Caco-2 cells were seeded at 5 x 105 cells /well in 6-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently transfected with the3xFLAGpCMV10-
CBWD3 expression construct. After a further 24 h, cells were maintained in serum-free DMEM 
containing zinc chloride at 150 µM or 10 µM for TPEN for another 24 h. Cells were prepared 
by centrifugation and cell pellets were resuspended in fresh medium. Equal volumes of cell 
suspension and Trypan blue were mixed and spotted onto a Haemacytometer (Neubauer) for 
counting using a light microscope (Olympus CK2) (result not shown). Cell images shown were 
taken using an EVOS XL digital inverted microscope.  
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Figure 5.6: Increased CBWD protein expression enhances viability of cells exposed to zinc 
depletion or excess (MTT assay). 
Caco-2 cells were seeded at 10,000 cells /well in 96-well plates and grown in DMEM for 24 h. 
Twenty four hours post seeding, cells were transiently transfected with the 3xFLAGpCMV10-
CBWD3 expression plasmid. After a further 24 h, cells were maintained in serum-free DMEM 
containing zinc chloride/TPEN at concentrations indicated on the x axes. Twenty four hours 
post treatment, cells were incubated with 5 mg/ml MTT, using 20 µl per well at 37oC for 4 h 
after which formazan crystals were dissolved by addition of 200 µl 10% DMSO. Absorbance 
was measured at 570 nm using a FLUORstar Omega plate reader (BMG Labtech) with 
background measurement at 630 nm. Data are presented as mean ± SEM for n = 6 for 4 separate 
experiments.  *P < 0.05; **P < 0.01 by one-way ANOVA.  
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5.3.6 Effect of zinc on CBWD protein localization  
To determine if localisation of CBWD protein was affected by zinc, Caco-2 cells were 
transiently transfected with the 3xFLAGpCMV10-CBWD3 construct or 3xFLAG-BAP control 
plasmid containing no CBWD insert (used as negative control) 24 h after seeding cells on 13 
mm cover slips in a 6-well plate. Twenty four hours following transfection, cells were treated 
with zinc at 100 µM or 3 µM. After a further 24 h, cells were fixed in 4 % parafomaldehyde 
(PFA) at room temperature for 20 minutes and thereafter permeabilised with 0.3 % Triton-100 
in PBS for 15 minutes, followed by incubation in 1 % SDS to unmask the antigen for 10 
minutes. Mouse anti-FLAG antibody (M2, Sigma) was prepared at a 1:250 dilution and cells 
were incubated in this overnight. Cells were then washed in PBS before incubating for 1 h with 
rabbit anti-mouse secondary antibody conjugated with Alexafluor 488 (ex/em = 496/519) at a 
1:1000 dilution. After three washes, cells were mounted on a microscope slide with DAPI-
containing Vectashield mounting medium and visualized using an Olympus BX61fluorescence 
microscope. As shown in Figure 5.7, the pattern of CBWD protein localisation appeared to be 
diffuse throughout the cells including the nucleus. There was no difference in the localisation 
of CBWD protein between cells at 3 µM zinc compared with cells treated with 100 µM zinc, 
suggesting that changes in extracellular zinc concentration did not affect CBWD localisation. 
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Figure 5.7: Increased zinc concentration did not alter CBWD distribution in Caco-2 cells. 
Caco-2 cells were grown on cover slips in 6-well plates for 24 h. Twenty four hours later, cells 
were transfected with 3xFLAGpCMV10-CBWD3 or FLAG-BAP (as negative control) 
followed by zinc treatment after a further 24 h. Cells were then fixed with 4 % parafomaldehyde 
and permeabilised with 0.3 % triton x-100. Cells were thereafter probed with mouse anti-FLAG 
antibody (1:250) overnight. After washing, cells were incubated with goat anti mouse 
Alexafluor488 for 1 h. Following washing, cells were mounted on a slide with Vectashield 
containing DAPI for nuclear staining and images were acquired by fluorescent microscopy. 
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5.3.7 Effect of CBWD overexpression on cellular zinc distribution 
As reported in section 5.3.5, cells that expressed CBWD protein at higher levels showed 
increased tolerance to zinc depletion and excess. We examined if this action of CBWD proteins 
is achieved through cellular redistribution of zinc. To achieve this, the zinc-sensitive 
fluorescent probe FluoZin-3 was used to visualise cellular location of zinc in cells that 
expressed the recombinant CBWD protein at increased levels compared with control cells. As 
shown in Figure 5.8, zinc appeared to be present in a punctate distribution in the cytoplasm of 
cells at endogenous levels of CBWD protein expression (panel A), whereas in cells with 
overexpressed recombinant CBWD protein this distribution of zinc appeared similar but 
somewhat less diffuse (panel B).  
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Figure 5.8: CBWD proteins appears to redistribute cellular zinc  
Caco-2 cells were grown on cover slips in 6-well plates for 24 h. Twenty four hours later, cells 
were preloaded with FluoZin-3 for 30 min before zinc treatment (panel A). In panel B, cells 
were transfected with 3xFLAG pCMV10-CBWD 24 h after seeding followed by preloading 
with FluoZin-3 and then zinc treatment after a further 24 h. Cells transfected with CBWD 
recombinant construct were treated with mouse anti-FLAG antibody and probed with goat anti 
mouse Alexafluor 594. Cells were then fixed, permeabilised and imaged using a confocal 
microscope (Leica SP2 UV).  
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5.3.8 The effect of DNA methylation on CBWD promoter activity  
The CBWD ZTRE includes proximal CpG sites within the promoter sequence included in the 
promoter-reporter construct that may be sensitive to DNA methylation. It is known that DNA 
methylation patterns are altered by factors such as age and environmental exposures, including 
nutrients. Identifying zinc-responsive genes that are sensitive to methylation, which could 
affect responses to changes in zinc levels, may give a better understanding of how zinc 
homeostasis is affected by factors such as ageing and different environmental exposures. It was 
found previously that methylation of the CpG dinucleotides in the ZTRE in SLC30A5 and those 
adjacent to it inhibited the ability of the competitor oligonucleotide to outcompete the binding 
of the protein factor (subsequently identified as ZNF658) in nuclear extracts prepared from 
Caco-2 cells to the SLC30A5 probe in EMSA (Coneyworth et al., 2012). This experiment 
indicated that methylation of the ZTRE affects binding of ZNF658. Moreover, a report of 
changes in DNA methylation in ageing mouse intestine found CBWD to be among the genes 
most affected (Maegawa et al., 2010). To investigate the effect of DNA methylation on 
promoter activity, in vitro methylation of the CBWD promoter sequence (containing 4 CpG 
sites around the ZTRE) in the pBlueCBWD1prom construct was undertaken using CpG 
methyltransferase enzyme (MSssI). Successful methylation was confirmed by agarose gel 
electrophoresis using methylation sensitive and methylation insensitive restriction 
endonucleases (HpaII and MspI respectively), after which the plasmid was purified and made 
transfection-ready by endotoxin-free plasmid preparations. Caco-2 cells were transiently 
transfected with the methylated and unmethylated constructs. A mouse Sushi repeat-containing 
protein, X-linked 2 (SRPX2) promoter-reporter construct, both methylated and unmethylated, 
was used as a negative control (to demonstrate that any effect of DNA methylation on β-
galactosidase specific activity driven by the CBWD promoter was not due to a direct effect on 
β-galactosidase ORF). Promoter activity was measured in cell lysates by measuring β-
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galactosidase activity. Cells that were transfected with the methylated plasmid showed 
decreased promoter activity, evident by a reduction in the β-galactosidase specific activity 
compared with the activity in cells transfected with unmethylated plasmid (Figure 5.9), 
indicating that  DNA methylation represses the activity of the CBWD promoter. As expected, 
there was no difference in promoter activity between the methylated and unmethylated SRPX2 
promoter-reporter construct.  
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Figure 5.9: Methylation of the CBWD promoter reduces its activity. 
Caco-2 cells were seeded at 3 x 105 cells/cm2 in 12-well plates and grown in DMEM for 24 h. 
Twenty fours post seeding, cells were transiently transfected with methylated and 
unmethylated pBlueCBWD1prom or mouse SRPX2 promoter-reporter plasmids (negative 
control). Twenty four hours after transfection, cell lysates were prepared for measurement of 
promoter activity as β-galactosidase specific activity expressed relative to protein 
concentration. Data are plotted as mean ± SEM for n = 9 from 3 separate experiments. **P < 
0.01 determined by Student’s unpaired t-test. 
 
 
144 
 
5.4 Discussion 
The CBWD gene family, whose names reflect the presence of a domain similar to the cobalamin 
synthesis protein cobW C-terminal domain in Pseudonomas denitrificans (Wong et al., 2004), 
have wide representation across the bacterial phylum. The CBWD genes were originally 
identified through genome screening of the human chromosome 2-fusion site, which revealed 
additional genes within the region that arose from segmental duplication events. Specifically, 
duplication of nine genes at 2qFus, 9pter, 9p11.2 and 9q13 sites uncovered four members of 
CBWD and FOXD4-like gene families with evidence of transcriptional activity (Fan et al., 
2002). The human CBWD gene family consists of six isoforms numbered from 1 to 6 and 
having different cytogenetic locations; CBWD1 is located in the sub-telomeric region of the p-
arm at 9p24.3, CBWD3, CBWD5 and CBWD6 are all located in the pericentromeric region of 
the q-arm of chromosome 9 at 9q13 and 9q21.11 respectively with CBWD4 (also at the same 
position) designated as a pseudogene. CBWD2 on the other hand is located within the 
pericentromeric region on the q-arm of chromosome 2 at a position equivalent to 2q13. Despite 
the different chromosomal location, the CBWD genes exhibit a remarkable nucleotide and 
amino acid sequence conservation as revealed by sequence alignment using ClusterW2 
software (see appendix F). Although no known function has been established for eukaryotic 
CBWD gene products, prokaryotic homologs have been proposed to have a role in the 
cobalamin biosynthetic pathway owing to their association with an operon of genes coding for 
known components of the pathway (Crouzet et al., 1991). Members of this operon encode 
proteins with characteristics similar to the G3E P-loop-containing GTPases subfamily of the 
COG0523 protein family, including a conserved putative metal binding CXXC motif at the N-
terminal domain and histidine-rich residues at the carboxy terminal domain, seen also in the 
Pseudomonas denitrificans CobW protein. The presence of a histidine-rich region in the C-
terminal domain of CBWD proteins suggests a metal-binding function. CBWD homologues 
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have also been identified within the zinc-dependent Zur regulon in Anabaena (blue-green 
algae) (Napolitano et al., 2012) supporting the assertion that these genes have roles in zinc 
homeostasis or the response to fluctuation in the zinc supply. Homologues of  CBWD in 
Bacillus subtilis appear to have roles in cell survival under conditions of zinc limitation 
evidenced by the fact that mutants defective in a protein belonging to the COG0523 family 
showed growth defects in zinc-deficient medium (Gaballa and Helmann, 1998), which was 
rescued following zinc repletion (Gaballa et al., 2002). Also, a metallochaperone function for 
members of the bacterial COG0523 family has been inferred (Haas et al., 2009). 
Metallochaperones with known roles in metal homeostasis such as the antioxidant protein 1 
(Atx1) for copper (Shin et al., 2012), and the mitochondrial iron-binding protein, frataxin for 
iron (Bulteau et al., 2004) have been identified. The copper chaperone for superoxide dismutase 
(CCS), which guides and also inserts copper into the apoprotein of SOD1(Ba et al., 2009), as 
well as fraxatin (iron-binding protein), which escorts iron to the point of entry into the 
metallocenter of ferrochelatase, the terminal enzyme in heme biosynthesis have also been 
identified. Given that a zinc metallochaperone has not yet been identified, determining if 
CBWD proteins perform this role would be an important contribution to metal biology. 
The effect of zinc availability on expression of CBWD gene transcripts in Caco-2 cells 
measured by RT-qPCR demonstrates zinc regulation of these genes at the transcriptional level, 
an observation that was replicated at the post-transcriptional level when recombinant CBWD 
protein was overexpressed as C-terminal and N-terminal MYC/FLAG-tagged forms in two 
mammalian cell lines. CBWD protein expression in this model was driven by the CMV 
promoter, but the possibility that zinc-induced down-regulation of CBWD protein may be a 
result of regulation of CMV promoter activity by zinc was ruled out based on previous reports 
demonstrating an increased (rather than reduced) β-galactosidase activity driven by the CMV 
promoter in response to increased extracellular zinc concentration (Coneyworth et al., 2012). 
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Had zinc had an effect on transcription of the transgene it would thus have been in the opposite 
direction to the change in protein levels observed in the present study. The findings thus 
indicate that either CBWD protein translation is reduced and/or degradation is increased at 
higher levels of zinc in mammalian cells.  
The effect of increased CBWD protein expression on intracellular zinc status was assessed by 
using a zinc-responsive MT2A promoter reporter construct. A reduction in β-galactosidase 
specific activity driven by the MT2A promoter was observed in cells that co-expressed CBWD 
along with the MT2A promoter. This effect was observed at extracellular zinc concentrations 
of both 3 µM and 100 µM. These results indicate actions consistent with the involvement of 
CBWD in zinc trafficking or buffering that resulted in decreased activation of the zinc-
responsive MT2A promoter.  
The effect of increased expression of CBWD protein on the range of cell tolerance to zinc was 
investigated by testing survival of Caco-2 cells exposed to depleted and excess levels of zinc. 
The observed decreased cell viability at low and high zinc concentrations in this study is 
commensurate with other published findings (for example (Shen et al., 2008)). Cells that 
overexpressed CBWD protein showed increased tolerance to the effect of zinc depletion or 
excess, suggesting that the presence of CBWD proteins may offer protection against deleterious 
effects of zinc. Functional studies of many proteins in protecting cells against metal-induced 
toxicity have been achieved through overexpression approaches. The contribution of the zinc 
efflux protein ZnT1 to increased resistance to zinc was demonstrated through overexpression 
of rat ZnT1 in baby hamster kidney (BHK) cells (Palmiter and Findley, 1995) and increased 
tolerance to cadmium-induced toxicity in human trophoblastic cells (McAleer and Tuan, 2001). 
ZnT2- mediated increased tolerance to zinc (Palmiter et al., 1996a) using this approach has 
been reported through this method while overexpression of a ZnT10 myc-tagged construct in 
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HEK293 cells resulted in improved cell viability as well as enhanced tolerance to zinc 
challenge (Patrushev et al., 2012). It has also been reported that the expression of rat HSP27 
cDNA in mouse embryonic stem (ES) cells conferred increased resistance to toxicity induced 
by metals including cadmium and mercury (Wu and Welsh, 1996). Enhanced expression of 
TRPV6, a calcium channel that has been implicated in the transport of cadmium and zinc, was 
similarly demonstrated to delay toxicity to cadmium and zinc in TRPV6-expressed HEK293 
cells (Kovacs et al., 2013).  
The discovery that CBWD increased the window of tolerance to zinc prompted investigation 
into whether this indicated role is effected by redistribution of zinc within the cell. The result 
showed that overexpression of CBWD protein appeared to modify the distribution of the 
intracellular zinc pool. In cells overexpressing CBWD there appeared to be a less punctate 
distribution of zinc compared to control cells. Punctate staining with zinc probes has been 
observed with RhodZin-3 in the mitochondria (Sensi et al., 2003) but of direct relevance to the 
pattern of staining observed in this experiment is the punctate staining of worms cultured with 
zinc added at 100 µM with Fluozin3 in the lysosome (Roh et al., 2012). Thus it is possible, 
though not yet demonstrated with any clarity, that CBWD may influence the uptake or efflux 
of zinc from lysosomes. The current data remain preliminary and there is a need to apply a 
more rigorous approach to studying the effect of CBWD expression on intracellular zinc 
distribution for example through parallel use of markers of specific sub-cellular compartments 
such as LysoTracker. 
Methylation of CpG dinucleotides within a promoter sequence can block binding of regulatory 
proteins to recognition sites. Electrophoretic mobility shift analysis of the effect of methylating 
residues within the binding site for the growth factor independence (Gfi-1) protein at its target 
promoter sequences interfered with binding (Zweidler-Mckay et al., 1996). Similarly, binding 
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of the transcription factors cAMP response element-binding protein (CREB) and specificity 
protein 1 (SP1) in nuclear extracts prepared from neuroblastoma cells to the mammalian type 
1 neurofibromatosis (NF1) regulatory region was impeded as a result of methylation of CpG 
dinucleotides at this site (Mancini et al., 1999). The binding of a regulatory protein (now 
identified to be ZNF658) in cellular extracts prepared from zinc-treated Caco-2 cells to the 
ZTRE was inhibited as a result of the methylation of the CpG sites within and around this motif 
in the SLC30A5 promoter (Coneyworth et al., 2012). We show here that in vitro methylation 
of the CBWD promoter repressed expression of the β-galactosidase reporter gene in a promoter-
reporter construct demonstrating that methylation of sites within this region affects 
transcription, presumably through influences on the binding of transcription factors. Given that 
the ZTRE in CBWD includes 4 CpG pairs that could potentially be methylated and that, as 
shown in chapter 5, ZNF658 knockdown can affect endogenous levels of CBWD expression, 
methylation of the ZTRE specifically may contribute to this suppressed transcription. Further 
work, for example using EMSA to determine directly if there is an influence of methylation on 
ZNF658 binding, is however required to determine if this is the case.  
The findings presented in this chapter give preliminary but plausible evidence in support of the 
involvement of CBWD gene products in cellular zinc homeostasis; however, future 
investigation is be required to fully explore this proposition. 
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Chapter 6 : The effect of endothelial cell senescence on cellular zinc 
homeostatic processes 
6.1 Introduction 
Zinc plays a regulatory role in nitric oxide (NO) signalling, a process necessary for maintaining 
membrane integrity of endothelial cells (Meerarani et al., 2000). Endothelial cells form the thin 
monolayer that lines the interior surface of the entire cardiovascular system (comprising the 
blood and lymphatic vessels). They form an interface between the circulating blood and the 
vessel wall and fulfil a selective barrier function. Zinc deficiency or excess can induce pro-
inflammatory events in endothelial cells likely to have negative consequences for vascular 
health. Also endothelial cell senescence has been implicated in ageing-related vascular 
degeneration (Kovacic et al., 2011, Shan et al., 2014); thus, understanding the link between 
endothelial cell function in health and disease and zinc homeostasis may be valuable in 
targeting approaches to mitigate the effects of vascular disease. 
Cellular senescence (CS), first described by Hayflick in 1965, is a phenomenon involving a 
permanent state of cell cycle arrest that is characterised by loss of proliferative capacity, which 
is a hallmark of ageing. Cellular senescence is induced by factors including telomere 
shortening, as a result of which cells gradually reach their Hayflick limit after many rounds of 
cell divisions triggering the DNA damage response (DDR). This form of senescence due to 
erosion of the proliferative telomere barrier is often referred to as replicative senescence. 
Telomere shortening was shown to be critical for replicative senescence in experiments where 
the catalytic component of the human telomerase holoenzyme hTERT (human telomerase 
reverse transcriptase) was overexpressed from a CMV-driven pCI-neo-hTERT-HA construct 
in human fibroblasts (Counter et al., 1998), which resulted in abolishment of the end of 
replication block thereby allowing continuous replication. Other factors such as stress or 
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mitogenic signals (aberrant expression of oncoproteins) can induce senescence independent of 
telomere shortening and it is termed premature senescence. Stress-induced premature 
senescence (SIPS) may result from the presence at critical concentrations of nutrients or growth 
factors or exposure to sub-cytotoxic stressors such as hydrogen peroxide. Stress-induced cell 
cycle arrest was shown to be a telomere-independent mechanism of cellular senescence in 
human fibroblasts, in which changing culture conditions to represent physiological conditions 
resulted in immortalised cells showing no decline in telomerase activity or telomere length 
(Ramirez et al., 2001). Also, in mouse embryonic fibroblasts (MEFs), non-telomere-driven 
senescence was  demonstrated through inactivation of p53 and could be achieved despite 
ablation of the retinoblastoma protein (pRb) family of genes, which are important in replicative 
senescence (Dannenberg et al., 2000). On the other hand, oncogene-induced senescence (OIS), 
which was first observed to cause cell cycle arrest following expression of human RAS 
(HRAS) in normal human fibroblasts (Serrano et al., 1997), was shown to induce cellular 
senescence in concert with p53 (Ferbeyre et al., 2002, Campisi and di Fagagna, 2007). Under 
these conditions, overexpression of hTERT failed to abrogate induction of senescence, 
indicating that OIS is independent of the pathway mediated by telomere shortening (reviewed 
by (Kuilman et al., 2010). Irrespective of the triggers or mechanisms, progression to cellular 
senescence appears to be through a common pathway involving p53 and p16INK4a/Rb 
(Larsson, 2011, Mirzayans et al., 2010). Common traits of senescence include growth arrest, 
activation of senescence-associated β-galactosidase and secretion of cytokines, chemokines, 
growth factors and proteases. Collectively these features comprise the senescence-associated 
secretory phenotype (SASP) (Figure 6.1) (Rodier and Campisi, 2011). These features, along 
with activation of the mammalian target of rapamycin complex1 (mTORC1), which is 
emerging as an additional marker (Hasty et al., 2013), distinguish senescent cells from their 
quiescent counterparts. 
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A general view, supported by an accumulating body of evidence, is that cellular senescence is 
a mechanism that prevents neoplastic transformation (Dimri et al., 2000). However, this 
proposed tumor-suppressive effect of cellular senescence is still controversial, and it appears 
that cellular senescence can promote some forms of cancer growth, depending on the 
physiological context (reviewed in (Campisi, 2013). Cellular senescence is also thought to 
accelerate the ageing phenotype through alteration of tissue microenvironments, which also 
promotes age-related diseases (reviewed by (Malavolta et al., 2014)). In particular, endothelial 
cell senescence is associated with cellular dysfunction, which may result in the onset of age-
related cardiovascular diseases. Cardiovascular diseases (CVDs), are the leading cause of 
mortality globally (Alwan, 2011) and are predicted to remain the single leading cause of death 
worldwide (Mathers and Loncar, 2006). Although a specific contribution of cellular senescence 
to the pathogenesis of CVD is unresolved, the presence of senescent cells  in human aorta at 
sites of atherosclerosis has been shown (Vasile et al., 2001). Improved understanding of the 
molecular mechanisms that underlie these associations might offer useful opportunities for 
developing therapeutic strategies against age-related diseases in general and cardiovascular 
diseases in particular. Recently, a role for micronutrients such as zinc in ameliorating 
incidences of age-related disorders due to its effects on the health of endothelial cells has been 
reported in some studies, but the molecular details are still poorly understood. Zinc safeguards 
endothelial cell integrity by providing protection against apoptosis (Meerarani et al., 2000). 
Variations in zinc supply may modulate the activity of senescence-inducing factors. 
Consequently, maintenance of zinc homeostasis is central to the health and function of the 
vasculature and may contribute to reducing the progression of senescence-driven age-related 
pathologies such as atherosclerosis. Emerging evidence suggests that cellular senescence, 
which is a component of the mammalian ageing may be affected by alterations in cellular zinc 
homeostasis (Patrushev et al., 2012). In the preceding chapters, we explored the mechanism of 
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zinc-induced transcriptional repression of genes with roles in zinc homeostasis and identified 
the regulatory factor that mediates this component of zinc homeostasis. Given that 
dysregulation of zinc homeostasis is a feature of many ageing-related diseases, understanding 
the molecular mechanism that underlie this association would be important in the effort to 
develop intervention strategies to ameliorate effects arising from perturbations in zinc balance 
on the ageing phenotype.  
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Figure 6.1: Hallmarks of senescent cells. 
Senescent cells differ from other nondividing (quiescent, terminally differentiated) cells in 
several ways; although no single feature of the senescent phenotype is exclusively specific. 
Hallmarks of senescent cells include an essentially irreversible growth arrest; expression of 
SA-Bgal and p16INK4a; robust secretion of numerous growth factors, cytokines, proteases, 
and other proteins (SASP); and nuclear foci containing DDR proteins (DNA-SCARS/TIF) or 
heterochromatin (SAHF). The pink circles in the nonsenescent cell (left) and senescent cell 
(right) represent the nucleus (adopted from (Rodier and Campisi, 2011). 
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6.2 Specific objectives 
The specific objectives of the work reported in this chapter were to investigate using an 
endothelial cell model: 
 the effect of zinc on endothelial cell growth and progression to the senescent state; 
 changes in expression of the transcription factor ZNF658 and its target genes.  
6.3 Methods  
Cell culture and RNA extraction were performed at Dr Marco Malavolta’s laboratory at the 
National Institute of Health & Science on Ageing, Ancona, Italy. Human Coronary Artery 
Endothelial Cells (HCAECs) were purchased from Clonetics Corporation (Lonza) and cultured 
in endothelial basal medium (EBM) supplemented with EGM-2 or EGM-2/MV SingleQuots 
containing 0.1% rh-EGF (human recombinant epidermal growth factor), 0.04% 
hydrocortisone, 0.1% VEGF (vascular endothelial growth factor), 0.4% rh-FGF-B (human 
recombinant fibroblast growth factor), 0.1% rh-IGF-1 (insulin- like growth factor) 0.1% 
ascorbic acid, 0.1% heparin, 0.1% GA-1000 (gentamicin sulfate plus amphotericin B) and 5 % 
fetal calf serum. For experiments, cells were plated at a seeding density of 2,500 cells/cm2 in 
T25 flasks and incubated at 37 °C and 5% CO2 with normal medium or normal medium 
supplemented with 50 μM ZnSO4.  The medium was changed every 48 hours. Cell cultures 
reached confluence after 6-7 days, as assessed by light microscopic examination, and they were 
passaged at weekly intervals. After trypsinization and before replating, harvested cells were 
counted using a haemocytometer and the number of population doublings (PDs) were 
calculated using the following formula: population doubling = 3.32*(log10F – log10I) (where 
F indicates the number of cells at the end of the passage and I the number of cells when seeded), 
according to the original method (Maciag et al., 1981). Endothelial cell aging was studied by 
subjecting endothelial cells to subsequent passages until two consecutive population doublings 
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equal or below 0 associated with senescence morphological changes revealed by microscopy 
examination. Cumulative population doubling (CPD) was calculated as the sum of all the 
changes in PD. At the end of each passage, each cell aliquot was frozen. Total RNA was 
extracted from HCAECs using the RNeasy Mini Kit (Qiagen, Hilden, Germany), according to 
the manufacturer’s instructions. RNA concentration was determined by Nanodrop and samples 
were kept at -80 °C for measurement of gene expression using RT-qPCR.  
6.4 Results  
6.4.1 Effect of zinc on HCAEC cell growth 
To determine whether the presence of zinc affected the growth of HCAECs, cells were 
subjected to serial passage and growth was monitored as cumulative population doubling. As 
indicated in Figure 6.2, cells in both untreated and zinc-treated groups appeared to undergo 
growth arrest after passage nine; however, zinc-treated cells underwent earlier growth arrest 
compared with control cells, suggesting that zinc stimulated transition to senescence in 
endothelial cells. These results were confirmed by observation of changes in cell morphology. 
Cells grown at higher zinc concentration were larger in size, had increased expression of the 
senescence marker p16 and had increased senescence-associated β-galactosidase staining 
compared with control cells. These experiments were conducted by Dr Marco Malavolta. 
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Figure 6.2: Zinc promotes endothelial cell growth arrest 
Human Coronary Artery Endothelial Cells (HCAECs) cultured in endothelial basal medium 
(EBM) supplemented with growth factors were treated with zinc at 50 µM or grown under 
control conditions and allowed to grow until 6-7 days. Cells were passaged serially and 
harvested cells counted. Cumulative population doubling (CPD) were calculated using the 
formular 3.32*(log10F – log10I) over consecutive population doublings where F is the number 
of cells at the end of the passage and I is the number of cells when first seeded. The red line is 
in arbitrary threshold shown to emphasize the difference in the growth curves. Each different 
coloured line shows an independent population of cells (n = 6 for each condition). 
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6.4.2 Effect of zinc-induced endothelial cell senescence on expression of p16 
To examine if HCAEC cells underwent replicative senescence induced by zinc, mRNA levels 
of p16, a cell cycle inhibitor known to regulate senescence pathway were measured by RT-
qPCR. As shown in  
 
 
Figure 6.3, mean expression of p16 relative to mean expression of β-actin was consistently 
increased with increasing passage number in zinc-treated cells compared with untreated cells, 
suggesting that zinc promotes progression of endothelial cells from quiescent to senescent state. 
Measurement of p16 mRNA was carried out by Dr Marco Malavolta. 
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Figure 6.3: Zinc-induced endothelial cell growth arrest increased p16 expression 
Human Coronary Artery Endothelial Cells (HCAECs) cultured in endothelial basal medium 
(EBM) supplemented with growth factors were treated with zinc at 50 µM and allowed to grow 
until 6-7 days. Upon confluence, cells were subjected to serial passages until the end of two 
consecutive population doublings. Cells were then frozen and RNA was subsequently prepared 
using the SV total RNA isolation system (Promega, Madison, USA). Transcript levels of p16 
were measured by RT-qPCR expressed relative to transcript levels of β-actin. Data are 
expressed as mean ± SEM for n = 3 and compared between the control condition and zinc 
treatment. *P < 0.05 (for passage number comparison), §P < 0.01 (for treatment comparison) 
by Student’s unpaired t-test.  
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6.4.3 Effect of zinc-induced senescence on expression of ZNF658 and its target genes in 
HCAECs 
To examine the effect of zinc-induced endothelial cell senescence on the expression of ZNF658 
and its target genes, mRNA was prepared from cells at each passage under both control and 
supplemented conditions and levels of specific mRNAs were measured by RT-qPCR. 
Expression of each gene was assessed relative to GAPDH as a mean over early (≤ 7) and late 
(≥ 8) passage numbers. As shown in Figure 6.4, ZNF658 mRNA expression was up-regulated 
as cells progressed towards the senescent state (panel A). In contrast, transcript levels of the 
ZNF658 target genes (ZnT10, ZnT5 and CBWD) were down-regulated (panels B, C and D), 
consistent with the known repressive effect of ZNF658 on these targets. 
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Figure 6.4: Expression of ZNF658 and its target genes are regulated by cellular 
senescence 
Human Coronary Artery Endothelial Cells (HCAECs) cultured in endothelial basal medium 
(EBM) supplemented with growth factors were treated with zinc at 50 µM and allowed to grow 
until 6-7 days. Upon confluence, cells were subjected to serial passages until the end of two 
consecutive population doublings. Cells were then frozen and RNA was subsequently prepared 
using the RNeasy Mini Kit (Qiagen). Transcript levels of ZNF658, ZnT10, ZnT5 and CBWD 
were measured by RT-qPCR expressed relative to transcript levels of GAPDH. Data are 
expressed as mean ± SEM for n = 3 and compared between the control condition and zinc 
treatment between earlier ≤ 7 and later ≥ 8 passages. *P < 0.05, **P < 0.01 by Student’s 
unpaired t-test.  
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6.5 Discussion 
We established in an epithelial cell line (Caco-2) that the ZNF658 transcription factor represses 
the expression of genes coding for members of the CDF zinc transporter family and CBWD 
gene family in response to elevated zinc levels, suggesting an important role for this factor in 
zinc homeostasis. Here, we present preliminary evidence that up-regulation of ZNF658 and 
down-regulation of its known target genes (SLC30A5, SLC3OA10 and CBWD) are associated 
with a senescent phenotype in human coronary artery endothelial cells. This gene expression 
profile appears more robust as the cells transit from early to late passages, entering growth 
arrest after passage nine (9). Senescent cells are defined by specific gene expression signatures, 
which include secretion of pro-inflammatory factors such as interleukins 6 and 8 (IL-6, IL-8), 
vascular endothelial growth factor and matrix metalloproteases (Coppé et al., 2010), together 
characterising what is generally termed the senescence-associated secretory phenotype. 
Accumulation of senescent cells over time is known to alter the tissue microenvironment and 
predisposes cells to age-related decline in adaptive immunity (immunosenescence) 
(McElhaney and Effros, 2009) and other age-associated pathologies. A marker of cellular 
senescence used over the years has been senescence-associated β-galactosidase (SA-β-gal), 
which is a histochemical marker that distinguishes senescent cells from quiescent ones  in many 
cell models including human vascular endothelial cells of the aorta (Vasile et al., 2001) and 
arteries (Minamino et al., 2002). Examination of cell morphology and the SA-β-gal staining 
pattern of cultured HCAECs at different passage numbers revealed increased cell size, with 
positive SA-β-gal staining, at late passages (≥ 8) compared with early passages (≤ 7) (Dr Marco 
Malavolta, unpublished data). These results are consistent with other findings that indicate 
growth arrest and progression to senescence for aortic endothelial cells at late passages (8 -10 ) 
(Wang et al., 2008).  
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The observation that expression of cyclin-dependent kinase inhibitor 2a (p16) was increased in 
late passages (≥ 8) compared with lower passage (≤ 7) appears consistent with the expression 
pattern of this marker in our model. This protein (p16) regulates the cell cycle by inactivating 
cyclin-dependent kinases that phosphorylate pRB, which is necessary for cell progression from 
G1 to S-phase, has been a useful marker of cellular senescence. These results are in agreement 
with elevated levels of p16 mRNA and protein levels in human fibroblasts undergoing 
senescence (Alcorta et al., 1996) (Beauséjour et al., 2003). Similarly, up-regulation of p16 
expression has been shown to correlate with replicative senescence in human fibroblast 
(Mirzayans et al., 2010) and in human airway epithelial cells (Fischer et al., 2013) at later 
passages compared with early passages. Our data also indicate that the presence of a higher 
concentration of zinc (50 µM) in the medium expedited the transition of cells into the senescent 
state, and corresponding augmented responses of ZNF658 and its target genes were observed. 
It thus appears that zinc promotes senescence in endothelial cells. The mechanism underlying 
this transition is unknown. The mTOR pathway is an attractive candidate mechanism given 
that its activity has been shown to be modulated by zinc (Lynch et al., 2001). Statistical analysis 
(Dr Marco Malavolta, personal communication) revealed that p16 expression correlated 
positively with repression of SLC3OA10 (ZnT10) and CBWD genes, and with the ratio of 
ZNF658 to ZnT10 but not with SLC30A5 (ZnT5). The correlation with p16 expression was 
particularly marked for the ratio of ZNF658 to ZnT10, thus this ratio may be a good potential 
marker of senescence to explore in future work. For example it would be of interest to 
determine if the ratio correlates with clinical features of vascular disease and/or ageing.  
Given that cellular senescence contributes to suppression of tumorigenesis in vivo (Ogrunc and 
d’Adda di Fagagna, 2011), and that zinc appears to drive this process, an avenue for 
pharmacological intervention against cancer development may be possible when further 
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evidence to support these findings becomes available. Also, given the fact that cellular 
senescence is cell-type specific (Bianchi-Smiraglia, 2012), identification of markers in 
senescent phenotypes may also be diverse. Thus, the ZNF658/ZnT10 ratio may represent a 
plausible marker of cellular senescence specific for endothelial cells. 
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Chapter 7 : Summary and conclusion 
7.1 Summary  
Zinc has attracted much interest in the last decade owing to its pleiotropic involvement in 
cellular processes relevant to life. Coordinated regulation of multiple genes in response to 
changes in zinc supply is a central tenet of cellular zinc homeostasis that is essential for the 
survival of every organism. Many aspects of zinc homeostatic control are not fully understood 
in spite of the increasing body of research output documenting identification and 
characterisation of zinc transport proteins. In mammals these transporters comprise two 
families each with multiple members. The overall aim of this study was to investigate the 
mechanism of zinc-induced transcriptional repression of genes with likely roles in zinc 
homeostasis by identifying the regulatory protein that mediate this response through the 
previously discovered zinc transcriptional regulatory element (ZTRE).  
In chapter three, we refer to a search of the genome for occurrences of the ZTRE discovered 
initially within the zinc-responsive SLC30A5 gene promoter, which codes for the zinc 
transporter ZnT5. The search revealed that the ZTRE appears in many genes within the human 
genome out of which a functional copy has been found in SLC30A10 (coding for the zinc 
transporter ZnT10) (Bosomworth et al., 2012). Of particular interest in this study is the 
discovery that CBWD genes (coding for COBW domain-containing proteins) also harbour this 
zinc-responsive element; and has been shown through the current work that the ZTRE in 
CBWD1 is functional in the context of it mediating transcriptional repression in response to 
increased extracellular concentrations of zinc. The ZTRE was shown here to be functional only 
with both sides of the palindromic motif intact by virtue of the fact that promoter-reporter 
constructs lacking either side did not respond to zinc. 
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 Chapter four reports the identity of the transcription factor that binds to the ZTRE – zinc 
finger protein 658 (ZNF658). Work presented in this chapter shows that ZNF658 mediates 
transcriptional repression of SLC30A5, SLC30A10 and CBWD genes at elevated extracellular 
zinc concentrations. ZNF658 was initially identified through mass spectrometry analysis of a 
DNA-protein complex detected by electrophoretic mobility shift analysis (EMSA) using 
nuclear extracts prepared from Caco-2 cells and was shown to be similar to the yeast ZAP1 
protein, which mediates the transcriptional response to a low zinc supply. The fact that the 
primary mode of zinc-response gene regulation mediated by ZAP1 and ZNF658 are different 
could be due to non-similar regions of the two proteins, which may recruit different co-
regulators and/or other accessory proteins. We show here using nuclear extracts prepared from 
Caco-2 cells overexpressing recombinant ZNF658 protein with a myc epitope tag that ZNF658 
binds specifically to the ZTRE by demonstrating a supershift of the corresponding band on 
EMSA using an anti-myc antibody.  We also show by deletion of part of the protein that the 
DNA binding domain is at the C-terminus (consistent with the presence of this domain in other 
members of the KRAB-containing zinc finger transcription factors. This region incorporates at 
least some of zinc fingers 12 to 15, which is consistent with the alignment with the known 
DNA binding domain of yeast ZAP1. We demonstrate that reduced expression of ZNF658, 
achieved using siRNA, attenuated or abrogated the response of SLC30A5, SLC30A10 and 
CBWD genes to zinc load, thus confirming the role of this factor in this process. Work presented 
in chapter four thus reveals the identity of the first known mammalian transcription factor that 
is responsible for coordinating repression of multiple genes in response to increased 
extracellular zinc supply, indicating a central role in mammalian zinc homeostasis. An 
unexpected observation was that knockdown of ZNF658 using one of the two siRNAs (and 
both siRNAs in the case of SLC30A10) reduced endogenous transcript levels of SLC30A5 and 
CBWD genes studied, which may indicate a role for the ZNF658 in stabilizing the mRNA levels 
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of its target genes in addition to mediating the transcriptional response to zinc, or may reflect 
that ZNF658 is required for basal transcription of its target genes as shown for some 
transcription factors.   
 In chapter five, we consider the likely role of the human CBWD gene products in metal 
homeostasis. As well as responding to zinc, CBWD genes also responded to other metals 
including copper, nickel and cobalt, suggesting a more general role in metal homeostasis. A 
role for CBWD protein in buffering zinc is suggested based on the observation that cells 
overexpressing the recombinant protein could better tolerate zinc restriction and excess 
compared with control cells. CBWD proteins appear to affect the cellular distribution of zinc, 
as shown by a less diffuse and more punctate pattern distribution of zinc fluorophore FluoZin-
3 in cells that expressed the recombinant protein. These findings are consistent with CBWD 
having a function in zinc homeostasis, which remains to be understood. 
Preliminary evidence suggesting the role of zinc in promoting cellular senescence is 
documented in chapter six. In addition, it is reported that the senescent phenotype features an 
increase in ZNF658 expression and a reduction in the expression of (some of) its target genes. 
In particular the ZNF658/ZnT10 mRNA ratio showed a tight correlation with expression of the 
senescence marker p16, and thus is a possible additional biomarker of cellular senescence 
worthy of further investigation. 
7.2 Conclusion 
In conclusion, results from this research have made significant contributions towards 
advancing the understanding of molecular mechanisms that underlie cellular homeostatic 
control in response to fluctuation in zinc availability through identification of a novel 
transcriptional regulatory protein, ZNF658. Although a transcription factor with the primary 
role of gene repression under excess zinc has been identified in the fission yeast 
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Schizosaccharomyces pombe, this study reports the first primarily repressive zinc-responsive 
transcription factor in the mammalian cell. Preliminary observations suggest that ZNF658 and 
its expression relative to its gene targets, in particular SLC30A10, may be a biomarker of 
cellular senescence.  
7.3 Recommendations for further work 
 The presence of the ZTRE in many candidate genes, some of which include heat shock 
proteins, may reflect wider roles for ZTRE-dependent gene regulation in mammals and 
thus merits further investigation for example by work based on measurement of the 
responses to zinc of specific transcript levels or using promoter-reporter constructs 
under conditions when ZNF658 expression is manipulated, analogous to the work on 
SLC30A5, SLC30A10 and CBWD presented in this thesis.  
 Further work is needed to identify the specific sub-cellular location for CBWD proteins 
for example by immunofluorescence using trackers that are targeted at specific cellular 
compartments. This method would give insight into the specific location within the cell 
in which CBWD may influence zinc uptake/efflux/sequestration. 
 The findings that CBWD transcript levels were altered by metals other than zinc, 
suggest that ZNF658 acting at the ZTRE may play important roles in a homeostatic 
response to metals additional to zinc, which should be investigated. Approaches could 
include determining if CBWD overexpression affect cell tolerance to extreme 
concentrations of these additional metals and investigate how CBWD overexpression 
affects the intracellular distribution.  
 To gain more insight into the function of CBWD proteins, future work should identify 
CBWD binding partners through approaches including co-immunoprecipitation 
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coupled with mass spectrometry. In addition, EMSA could be employed to study the 
effect of methylation of the CpG sites around CBWD ZTRE on the binding of ZNF658. 
 Our results using site-directed mutagenesis and EMSA mapped the ZNF658 DNA 
binding domain to the carboxyl-terminal 135 amino acids, which comprises the zinc 
fingers 12 -15. Further research should identify which of the finger (s) is/are most 
important in zinc sensing and/or binding by sequential individual knockout. 
 To gain insight into the metalloregulatory function of ZNF658, biophysical techniques 
such as isothermal titration calorimetry (ITC) could be employed to measure the 
strength of zinc binding using purified recombinant zinc finger peptides comprising for 
example, zinc finger pairs from the putative ZNF658 DNA-binding domain. The 
affinity of ZNF658 to metals other than zinc to ZNF658, could be tested by using ITC 
also and/or NMR spectroscopy.  
 The mechanism behind the putative dual roles of ZNF658 in mediating transcriptional 
repression in response to zinc and stabilising transcripts of its target genes and/or being 
a requirement for basal transcription of its gene targets should be explored. Approaches 
could include measurement of mRNA turnover/degradation (mRNA steady-state-
expression) by RT-PCR after blocking transcription using actinomycin D in cells 
expressing wild type ZNF658 compared with cells in which the expression ZNF658 has 
been manipulated.  
 Better understanding of the global role of ZNF658 in gene regulation may be obtained 
if the full complement of the genes regulated by this transcription factor is identified, 
for example through chromatin immunoprecipitation followed by sequencing (ChIP-
seq). Alternatively, more precise and effective approaches for gene knockdown, such 
as the CRISPR/CAS9 system, could be employed to manipulate the expression of 
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ZNF658 for downstream functional studies on the response to zinc of ZNF658 gene 
targets. 
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7.5 Appendices 
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2: p3XFLAG-CMV vector map  
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3: pBlue-TOPO vector map  
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4: p3XFLAG-CMV vector map  
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5: p3XFLAG-CMV vector sequence 
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6: Protein sequences alignment of the human CBWD isoforms using ClusterW2  
 
 
 
 
